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Abstract
In 2011, more than 160 children died in an unprecedented outbreak of Hand foot 
and mouth disease (HFMD) in Vietnam, predominantly associated with 
enterovirus 71 (EV-A71). The occurrence of encephalitis outbreaks in children at 
vulnerable developmental stages raised concerns of long-term consequences. 
Limited retrospective outcome studies in the literature lack either a healthy 
comparison group or a locally validated neurodevelopmental assessment tool. 
Brain MRI retrospective observations identified stereotypical patterns of brainstem 
lesions predominantly in severe EV-A71 HFMD cases with conflicting opinions on 
the prognostic role of MRI.
I adapted the “Bayley Scales of Infant and Toddler development (3rd edition)” for 
Vietnam and demonstrated that the adaptation was reliable and valid. I conducted 
a prospective observational cohort study to test the hypothesis that children with 
severe HFMD, graded per Vietnam Ministry of Health classification, would have 
lower cognitive, language and motor Z scores than a healthy comparison group. 
All HFMD cases had virological samples taken and a sample of severe HFMD 
cases had brain MRI scans.
All Z score 95% confidence intervals were within 2 standard deviations of the 
comparative healthy cohort mean suggesting outcomes at six months were not 
significantly lower than the healthy comparative group. I identified novel non­
specific brain white matter abnormalities on MRI in all severity grades, lower 
motor Z scores in grade 2b children with MRI abnormalities and that 
Coxsackievirus A10 (CV-A10) was significantly associated with MRI
abnormalities.
These findings support surveillance of all enteroviruses during HFMD outbreaks 
and suggest MRI may be predictive of motor impairment in a subset of severe
III
HFMD cases. No significant impairment was identified at six months follow-up, but 
more complex developmental skills are yet to emerge. Hence the study continues 
for an eighteen-month follow up to robustly determine emergence of long-term 
sequelae.
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1. Introduction And Literature Review
Morbidity from central nervous system infections covers a wide spectrum of 
manifestations. Understanding these is important to identify potential points of 
intervention, as well as to measure the burden of disease on society and prioritise 
public health resource allocation.
Over the last twenty-five years, hand foot and mouth disease (HFMD) has 
emerged as a threat to early childhood development in South East Asia. The 
infection itself, and the supportive care needed during the acute illness, may both 
give rise to long-term sequelae but the delicate health care systems operating in 
these regions are typically unable to provide follow-up care or support after the 
acute phase.
This chapter will explain the relevance of hand foot and mouth disease to Vietnam 
and the surrounding region, and outline the rationale for the research project.
1.1 H and foo t and m outh  disease (H F M D )
The clinical syndrome of a vesicular rash on the palms of the hands and soles of 
the feet with ulcers in the mouth was first described in New Zealand in 1957 in 8 
children,12 but no virological studies were reported at the time. In 1958, 60 people 
were investigated following a mild febrile illness with a maculopapular or vesicular 
exanthem associated with pharyngeal lesions;3 34 were children less than 5 years 
of age and all resided within a housing estate in Toronto, Canada. Virological 
studies confirmed a group A coxsackievirus (current nomenclature: Enterovirus A)
13
which was already known to cause a self-limiting febrile illness with mouth 
ulcerations, termed ‘herpangina’ 4 In 1959, the term, ‘hand foot and mouth 
disease’ (HFMD) was coined in a publication describing 83 cases, of which 24 
occurred in Birmingham, UK.5 14 of the 24 were children less than 5 years old. 
Coxsackievirus A16 was isolated from the vesicle fluid of one patient. By 1970, 
further reports of HFMD from the United States of America, England and New 
Zealand confirmed the outbreak nature of this mild clinical disease mainly 
affecting children.6
1.1.1 Viruses associated w ith HFM D
HFMD associated Group A coxsackieviruses (CVA) belong to the species 
Enterovirus A, genus Enterovirus, family Picornaviridae. HFMD associated viruses 
all belong to the species Enterovirus A. Since the initial isolation of coxsackievirus 
A16 from vesicular fluid in 1959, other enteroviruses belonging to the species 
Enterovirus A (types coxsackievirus A2-8, 10, 12, 14, 16 and enterovirus 71, 76 
and 89-92), have been associated with HFMD.7
1.1.2 Enteroviruses
Enteroviruses are the most common human viruses worldwide, presenting either 
asymptomatically or with a diverse range of clinical manifestations depending on 
the age and immune status of the host. The taxonomy of enteroviruses continues 
to evolve as improvement in molecular and biological techniques identifies further 
serotypes and re-classifies others. Currently, there are twelve species within the 
genus Enterovirus, with seven that affect humans as their only host. These are 
Human Enterovirus A-D and Human Rhinovirus A-C. There are more than 100 
serotypes of human enteroviruses A-D in total.8 Enteroviruses are small RNA non­
14
enveloped viruses, which are susceptible to chlorine and iodine based detergents 
under certain conditions, but which are not susceptible to ethanol. Enteroviruses 
are acid-resistant, replicate in the tonsils and can pass through the stomach after 
ingestion after which they replicate in the gut. Transmission is generally oro- 
faecal, although enteroviruses can be found in respiratory secretions. It is also 
possible that onward transmission may occur from asymptomatic individuals to 
cause disease. Outbreaks of HFMD are most commonly associated with CVA16, 
with more recent outbreaks associated with CVA6 and CVA10.9"13 Sporadic cases 
of HFMD have been associated with other pathogens (CVA2, CVA4, CVA5, 
CVA9, Echovirus 4).14-17 Table 1.1 lists common clinical syndromes associated 
with enteroviruses.
Table 1.1 The c lin ica l syndrom es associated w ith  enteroviruses
Enterovirus A Enterovirus B Enterovirus C Enterovirus D
H e rp a n g in a P le u ro d y n ia P a ra ly t ic  P o lio R e s p ir a to r y
in fe c t io n
A c u te  ly m p h a t ic  o r  
n o d u la r  p h a ry n g it is
A s e p t ic  m e n in g it is A s e p t ic  M e n in g it is
A s e p t ic  m e n in g it is S e v e re  s y s te m ic  
in fe c t io n  in  in fa n ts ,  
m e n in g o e n c e p h a l i t is
P a ra ly s is M y o c a rd it is
H a n d  fo o t  a n d  m o u th P e r ic a rd it is
d is e a s e
P n e u m o n it is  o f  in fa n ts U p p e r  r e s p ir a to ry  
i l ln e s s
C o m m o n  c o ld H e p a t it is
H e p a t it is A s e p t ic  m e n in g it is
In fa n t  d ia r rh o e a G u il la in -B a r re
A c u te  h a e m o r rh a g ic  
c o n ju n c t iv it is
H e rp a n g in a
Meningoencephalitis
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1.1.3 Enterovirus 71
Enterovirus 71 (EV-A71) was first isolated from stool in 1969 from a 9 month old 
child with encephalitis.18 Retrospective analysis from untyped isolates in the 
Netherlands identified EV-A71 circulating in 1963.19 In 1975, Bulgaria reported 
705 cases of central nervous system (CNS) disease, of which 149 (21%) 
presented with acute flaccid paralysis (AFP). 20,21 In total there were 44 deaths. 
92 strains of EV-A71 were isolated from 65 cases. 338 (48%) of total cases, 121 
(81%) of paralytic cases and 41 (93%) of fatal cases were in children less than 5 
years old.22,23 Neurological manifestations were prominent with no mention of 
rash or oral manifestations during this outbreak of EV-A71. In Hungary in 1978, 
1550 cases of CNS disease, with a small number associated with the typical 
features of HFMD, resulted in 47 deaths.24 30 deaths were in children less than 6 
years old. This was thought to be a mixed outbreak of a tick-borne encephalitis 
virus and EV-A71, with EV-A71 affecting mainly children.21 Although interest in 
EV-A71 arose before its association with HFMD, this connection with a common 
disease of childhood, previously considered to be benign, cemented its profile as 
an emerging viral infection of importance.
1.1.4 HFM D and neurological disease: emergence o f Enterovirus 71
In New York in 1972, among 10 cases with CNS disease (e.g. aseptic meningitis,
encephalitis), some of whom had clinical signs of HFMD, EV-A71 was isolated in
all cases.25 In the summer of 1972-3, there were 39 cases in Melbourne with
aseptic meningitis. In 6 children under 5 years with meningitis a rash was also
present, described as ‘either a fine erythematous maculopapular rash lasting 24-
48 h (4 patients), scattered vesicles on the hands and feet (1 patient), or a mixture
of vesicles, macules, and papules (1 patient).26 Over the same period, 5 cases
presented with rash only, 2 of whom were diagnosed with HFMD. The virus
16
isolated in all cases was EV-A71. Sweden reported a large outbreak of aseptic 
meningitis and HFMD associated with EV-A71 between April and September 
1973.27 41 (21%) cases were in children less than 3 years old. In 1973, there was 
a large outbreak in Japan with more than 3200 cases.21,28,29 Hagiwara et al. 
reported the highest incidence of CNS disorders were in children less than 1 year 
with onset of CNS complications 2-4 days following a rash.28 They also noted 
myoclonus in 26% of 81 children as a clinical feature indicating CNS disease 
onset. Further cases of EV-A71 associated HFMD were reported in New York in 
1977 and again in Japan in 1978.21,29-31
1.1.5 South East Asia outbreaks
In 1997, in Sarawak, Malaysia, more than 2000 cases of HFMD were reported 
with 31 deaths (26 less than 6 years old). 39 cases had aseptic meningitis or 
acute flaccid paralysis (AFP).32,33 Around the same time, mainland Malaysia also 
reported a few thousand HFMD cases with 4 deaths. Post mortem examinations 
of fatal cases identified EV-A71 as the causative pathogen of both HFMD 
outbreaks.33,34 Further large EV-A71 outbreaks continued to occur in the region. 
In 1998, Taiwan reported more than 129,000 cases of HFMD with 78 fatalities;35, 
36 91% of the fatalities were among children less than 5 years, and in 92% of the 
fatal cases EV-A71 was isolated. In the next decade outbreaks of EV-A71 
associated HFMD were reported in Australia, Japan, Singapore, Taiwan, 
Thailand, Malaysia, China and Vietnam (Table 1.2, Figure 1.1, Figure 1.2).37"47
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1.1.6 Incidence and disease burden
Estimations of the incidence of HFMD vary by region and year. An 
epidemiological study in Singapore reported that the HFMD annual incidence rate 
per 100,000 in the general population increased from 125.5 in 2001 to 435.9 in 
2007.73 In Taiwan seroepidemiological surveys estimated the incidence of EV-A71 
infection among children between 1994 and 1999 to range between 13-22%, 
depending on the age of the child.54 Estimations from the 2008 Hong Kong 
outbreak suggest an EV-A71 incidence of 1.4/100,000 in the general population, 
but the rate was higher, at 27.9/100,000, in children under 5 years.84 Of note, the 
EV-A71 seroprevalence rate prior to the Taiwan 1988 outbreak in the age range 6 
months to 3 years was inversely related to this age group’s specific mortality rate 
during the epidemic, and their severity of disease.89 A prospective study in Taiwan 
measured EV-A71 antibody levels in serum of 749 healthy neonates at 0, 6, 12, 
24 and 36 months during the 2008-2009 HFMD epidemic.90 There were 28 EV- 
A71 infections, and of these 8 were asymptomatic, including 2 infants less than 6 
months of age. The authors calculated a cumulative incidence of 15% for EV-A71 
by 36 months, despite losses to follow-up, which resulted in samples from only 
51% of the cohort being obtained at 36 months. The risk of EV-A71 infection 
increased after 6 months of age, in line with the expected trajectory for decay of 
maternal antibodies.
The first cases of EV-A71 were reported in Vietnam in 2003, from 12 patients with 
encephalitis complicating HFMD 46 Further HFMD outbreaks occurred from 2005 
onward with increasing numbers, in 2008 HFMD became notifiable and for the 
year 2011, 110,897 cases and 166 deaths were reported.91
A meta-analysis of 14 studies from Vietnam, Singapore, Hong Kong, South Korea
29
and China over the period 1998-2012 representing a total population of 112,546 
children calculated a pooled case-fatality of 1.7% (95% confidence interval 1.2- 
2.4).92 The largest population based study on HFMD was carried out in China. 
Chinese surveillance data from 2008-2012 of over 7 million children with HFMD 
reported an annual incidence rate of 1.2 per 1000 person-years between 2010 
and 2012. The highest HFMD incidence was in children aged 12-23 months (38.2 
cases per 1000 person-years). Children aged less than 6 months had the highest 
risk for severe and fatal disease, with the risk declining with increasing age. 1.1% 
of the children had neurological or cardiopulmonary complications, of which 3% 
died.93
Case fatality rates in Taiwan range from 96.96/100,000 in children age 6-11 
months to 3.34/100,000 in children aged 3 years.54 Hong Kong reported a case 
fatality rate of 1.0%.84 The case-fatality rate of EV-A71 HFMD cases from a 
prospective referral hospital based study in Ho Chi Minh City in 2011 was 0.2%, 
lower than the 2005 case-fatality rate of 1.7%.46,86 This may be due to increased 
awareness of the disease and its complications, earlier hospital admission, and 
consistent use of treatment guidelines. The Chinese population based study 
reported a case-fatality rate of 0.03% (n=2457), with 93% of the laboratory 
confirmed deaths (n=1737) associated with EV-A71.93 This study likely gives the 
best estimates of incidence and case-fatality in endemic/epidemic settings, based 
on clinical diagnosis of probable HFMD cases.
1.1.7 Structure of Picornaviridae and EV-A71 receptors
EV-A71 and the other HFMD associated types of Enterovirus A belong to the
family of Picornaviridae. They are non-enveloped, small (30nm in diameter)
virions with a positive single stranded RNA genome. The genome is
30
approximately 7500 nucleotides long. The enterovirus (EV) virions have an 
icosahedral capsid made of 60 identical subunits. Each subunit consists of the 4 
structural proteins, VP1-VP3, plus a small internal peptide VP4.94 VP4 is hidden 
within the virion, facing inwards to the RNA, and is not detected by the host 
defence system.95,96 Five subunits create a pentamer, and 12 pentamers make 
the virion. VP1 is located around the five-fold axis, whilst VP2 and VP3 are 
around the three-fold axis. EV subtypes are commonly identified using the 
complete coding sequence of VP1.
Viral replication occurs in the host cell cytoplasm. EV needs to attach to a cell 
receptor in order to initiate a configuration change in the virion, which uncoats the 
virion and then expels the RNA into the host cell.
Suckling mice, 3-4 week old cotton rats, vervet monkeys and rhesus macaques 
are susceptible to EV-A71, and are used as animal models to investigate the 
pathophysiology of the disease.97 So far two receptors for EV-A71 have been 
identified: scavenger receptor class B member 2 (SCARB2), a ubiquitous 
membrane protein and P-selectin glycoprotein ligand-1 (PSGL-1). Both have been 
found to increase sensitivity to EV-A71 infection in mouse models.98,99 Antibodies 
to both receptors reduce mouse infectivity. PSGL-1 is primarily expressed on 
leucocytes so does not explain the infection of neurons and other host cells. 
SCARB2 also appears to play an important role for CVA7, CVA14, and CVA16, 
which are closely related to EV-A71. However CVA2, CVA3, CVA4, CVA5, CVA6, 
CVA8, CVA10, and CVA12 appear not to be dependent on SCARB2 for cell 
infection in vitro.100 It is not clear how binding to these receptors results in 
conformational change in the virion and host cell entry. One study looked at 
SCARB2 and PSGL-1 expression in tissues of fatal EV-A71 cases from China.101
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They identified that SCARB2 expression occurred in tissue cells with evidence of 
viral infection, such as the CNS and tonsillar crypts, but that it was also expressed 
in tissue not infected by EV-A71. This suggests SCARB2 alone does not 
determine EV-A71 infection. PSGL-1 was expressed in various cells which did not 
show evidence of EV-A71 infection suggesting its role in infection may be 
limited."
1.1.8 EV-A71 lineages
EV-A71 is hypothesised to have evolved from coxsackievirus A16 around 1940, 
subsequently diverging into 3 lineages, A, B and C.102 Lineages B and C are 
further divided into subgenotypes, B1-B5 and C1-C5 according to nucleotide 
sequence divergence. Although genetically different, all lineages and sub­
lineages represent one serotype of EV-A71. Molecular epidemiological studies 
have identified that all lineages are circulating in Asia, with a few in Europe. 
Lineage B predominated in the Malaysia and Singapore outbreaks, while lineage 
C predominated in the Australian, Vietnamese and Chinese outbreaks.103 
Analysing genetic diversity for the VP1 region of EV-A71 suggested a correlation 
between the HFMD outbreaks in the 1990s and transient increases in genetic 
diversity of certain subgenotypes.102 However, genetic diversity persists between 
outbreaks and the cyclical 2-3 yearly outbreak patterns observed in countries 
such as Japan, suggests that accumulation of a susceptible population also 
contributes to triggering outbreaks.102 In vitro studies suggest there is cross­
neutralisation of antibodies between subgenotypes of EV-A71, but there are 
differences in antigenicity between subgenotypes.104 In vitro, subgenotype C 
appears more difficult to neutralise and hence may be more transmissible which 
has implications for vaccine development.104 Sera taken weeks post vaccination
with the C4 subgenotype cross neutralise B and other C subgenotypes.105 It is not
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clear if this persists with time but persistence may be related to multiple infections 
with related subgenotypes. Supporting this theory is the broad range of 
neutralizing activity found in sera from healthy individuals in Japan, where EV-A71 
is endemic.104
1.1.9 Seasonality and seroepidemiology
Based on US surveillance data from 1970-2006 a seasonal pattern has been 
identified, with EV infections being more common from June to October.106 The 
dominance of different serotypes changes over time with both epidemic and 
endemic circulation apparent. Endemic serotypes demonstrate stable low-level 
circulation whereas epidemic serotypes show large fluctuations, at times 
becoming the most prevalent serotypes in circulation. Since 1983, EV-A71 cases 
reported in the US were mainly from children less than 5 years. Seventy per cent 
of reported infections were within the ‘enterovirus season’ (summer and autumn) 
with incidence suggesting endemic circulation.
Following the 1997 Sarawak HFMD outbreak, Malaysian surveillance data 
identified a 3-year cyclical pattern of EV-A71 HFMD outbreaks.107 Surveillance 
data in Japan also identified a 3 yearly pattern with increased EV-A71 HFMD 
cases in 2000 and 2003, while CVA16 HFMD was more prevalent in 2001-2.39 A 
longitudinal study in Taiwan found a decrease in circulation in EV-A71 in the 4 
years prior to the large 1998 outbreak. It was suggested that during this time of 
low circulation, there was an accumulation of susceptible, immunologically naive 
hosts that exceeded the threshold density needed to trigger an outbreak.108 This 
may be one of the factors that contribute to this cyclical pattern.109
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Studies from Germany, Singapore, Taiwan and China consistently find lower 
seroprevalence of EV-A71 in children less than 5 years old compared to adults.89, 
110-113 Maternal antibodies detected in infants at birth were undetectable by 6 
months of age in cohorts from Taiwan and Vietnam.114,115 This suggests that 
children between 6 months and 5 years are at greatest risk. A Singapore 
seroprevalence study, using residual hospital sera (excluding patients with HFMD 
symptoms), identified that there was lower prevalence of EV-A71 antibody in the 
age group 1-6 years but higher neutralizing titres in this age group compared to 
older children.116 This suggests most children acquire the infection 
asymptomatically during early childhood.
1.1.10 Diagnostics
There is no cheap sensitive rapid diagnostic test available for EV-A71, so formal 
laboratory diagnosis is usually reserved for severe hospitalised cases. The 
traditional method is isolation in cell culture followed by serotype identification 
using neutralization with monoclonal antibodies. Direct methods of identification 
include the indirect immunofluorescence assay (IFA) and Real Time Reverse
Transcriptase Polymerase Chain Reaction (rRT-PCR). Primary specimens that
can be sampled for culture include throat swab, vesicle fluid, stool samples or 
rectal swabs, cerebrospinal fluid (CSF) and blood. The yield for both CSF and 
blood is very low, but suggests disseminated disease when positive.68,117,118 EV- 
A71 may be isolated in a variety of human and primate cell lines including African 
green monkey kidney (Vero) cells, human lung fibroblast (MRC5) cells and human 
rhabdomyosarcoma (RD) cells. However, cell culture is laborious, slow (weeks) 
and costly.
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rRT-PCR can be applied directly to clinical samples such as throat and rectal 
swabs, vesicle fluid, stool samples and cerebrospinal fluid (CSF). Caution must be 
used when interpreting the findings for samples from non-sterile sites, such as 
throat and rectal swabs/stool, to distinguish asymptomatic shedding from disease. 
EV-A71 can persist in respiratory secretions for up to 4 weeks and in stool up to 5 
weeks, although shedding for several months is also reported.119 Between 2000 
and 2003, Ooi et al. attempted virus culture on 2,916 samples from 628 children 
with HFMD.120 Throat swabs were the most useful specimen, although the authors 
advise to sample vesicles when possible. Otherwise they advise throat swab 
combined with rectal swab. Vesicle fluid is most desirable as it is a sterile site. 
CSF from three of 102 HFMD cases with aseptic meningitis grew enterovirus on 
viral culture (of which two were EV-A71). A similar trend was found from a 
prospective study of 66 children with encephalomyelitis in Taiwan.121 These 66 
children had a clinical diagnosis of herpangina/HFMD with neurological signs (one 
or more of; ataxia, myoclonic jerks, cranial nerve dysfunction, MRI brain stem 
changes); and positive pleocytosis, defined as more than 5 white cells per mm3 
with no bacteria detected in CSF. Eleven (16.7%) cases had EV-A71 detected in 
the CSF by RT-PCR, versus none detected by viral culture. This CSF detection 
rate was lower than for throat and rectal swabs, in which RT-PCR detected EV- 
A71 in 40.9% and 42.4%, respectively.
Aseptic meningitis is defined as CSF pleocytosis without bacteria detected. A 
variety of aetiologies may result in these findings including viral, fungal, and 
parasitic infections, autoimmune pathologies and malignancy. With the advent of 
RT-PCR, the most commonly detected causes of aseptic meningitis are viral 
infections, particularly enteroviruses during annual spring outbreaks of viral 
meningitis or HFMD, when they can be detected in CSF, and in swabs from throat 
and/or rectum.122,123
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rRT-PCR diagnosis depends on knowledge of the most up-to-date sequences of 
circulating subgenotypes of EV-A71, requiring molecular surveillance.
1.1.11 Pathophysiology: viral entry and spread to central nervous system
Enteroviruses typically replicate in the tonsils and the Peyer’s patches in the gut.
Spread to the regional lymphoid tissue results in a mild primary viraemia. Most
infections are controlled at this point although asymptomatic carriage may occur,
with continued shedding in respiratory secretions and stool. It is not clear how
CNS infection arise. This may be from spread through the reticulo-endothelial
system and then through a disrupted blood-brain barrier. Another route that has
also been implicated from autopsies of EV-A71 cases and in animal models is
retrograde axonal transport.124 Seven autopsies from Malaysia found the degree
of inflammation decreased from the anterior horn cells to the motor cortex, along
the distribution of the motor pathways.125 It was hypothesised that secondary
viraemia infecting skeletal muscle may infect the neuromuscular junction. From
here there may be spread through the peripheral motor nerves to the anterior
horn cells, followed by further spread up the corticospinal tracts to the motor
cortex. The sensory and autonomic neuronal pathways appeared spared.
However evidence of viral replication in skeletal muscle or peripheral nerves has
not been found from autopsy material.101, 125 Typical autopsy features indicate
inflammation of the central grey matter of the spinal cord and medulla oblongata,
specifically involving the dorsal nucleus of the vagus, the tractus solitarius, the
reticular formation of the medulla and pons, the inferior olivary nuclei, various
cranial nerve nuclei, the basis pontis, the substantia nigra and red nuclei of the
midbrain, the hypothalamus, and the subthalamic and dentate nuclei, with sparse
viral inclusions found at these sites.101, 126*128 The function and connections of
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these regions are illustrated in Figures 1.3-1.5 and Table 1.3. The inflammatory 
changes observed were mainly perivascular cuffing by mononuclear cells with 
occasional neutrophils, and areas with clusters of neuronal necrosis and 
neuronophagia, microglial nodules and microabscesses. One autopsy reported 
involvement of focal areas of the white matter in the cerebellum.22 Enteroviral 
antigens and nucleic acids have been reported in neurons and neuronal 
processes in the spinal cord and brainstem, with electron microscopy visualizing 
picornavirus like particles and viral inclusions in neurons from spinal cord 
tissue.128 Additionally, autopsy findings in 5 neonates with fatal EV-A71 infection 
included cerebral oedema and brain herniation. (Abstract only in English)129 
These findings are not consistent with Lui et al. noting panencephalitis and mild 
non-specific changes in the spinal cord of an 8 month old fatal case.130 Zang et al 
ran a prospective study of EV-A71 encephalitis cases admitted to the Fuyang 
Hospital PICU in 2008. Thirty-six children required mechanical ventilation. Seven 
patients died with one patient noted to have brainstem oedema.131 Brainstem 
oedema may not be routinely identified on MRI scans or post mortem resulting in 
variability of its reporting in the literature.
Autopsy evidence in a case with pulmonary haemorrhage showed no significant 
alveolar damage or inflammation and no viral inclusions. The heart did show 
evidence of discrete myocardial mononuclear infiltrates in the right ventricle, but 
with no viral inclusions or myocyte damage.128 In contrast, in ten autopsies of 
infants aged 13-36 months EV-A71 antigen was found in the heart, and in the 
bronchial lining epithelial cells as well as in alveolar macrophages.132 Additionally 
some antigens were detected in the kidney and spleen. The majority of antigens 
were detected in the central nervous system. The absence of Nissl bodies was 
evidence of irreversible neuronal necrosis. There were a large number of
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inflammatory cells in the small and large intestine, which also had a significant 
presence of EV-A71 antigen. Autopsies from Taiwan and China identified reactive 
hyperplasia in the Peyer’s patches.101,127 Viral antigens have been found localised 
to the squamous epithelial cells of the tonsillar crypts, suggesting that this may be 
an important site for viral shedding and transmission and a possible entry route to 
the CNS.101 Autopsy results from an 8 month old child who died in China showed 
the highest tissue viral loads in the brainstem and mesenteric lymph nodes, with 
the lowest viral loads in the ileum and stomach.130 These findings support the 
hypothesis that the mesenteric lymph nodes are the main replication site and the 
brain the main target for viral invasion.
Figure 1.3 Outline of Brainstem
M idbra in
Pons
— Cerebellum
M edulla
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Figure 1.4 Locations o f regions affected by b ra instem  encephalitis  in severe 
HFMD (purple text). Cranial nerves are num bered.
W m
MIDBRAIN Reticular formation
Solitary tract
PONS
Dorsal root of vagus
Nucleus ambiguus 
(vagus)10 Vagu
MEDULLA
OBLONGATA Inferior olivary 
nucleus
Figure 1.5 Image o f dentate pathway and red nucleus affected by severe HFMD 
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1.1.12 Autonomic dysfunction and cardiopulmonary compromise 
The brainstem contains important physiological systems that regulate 
temperature, heart rate, and respiratory rate and pattern. It contains the important 
nuclei that form part of the autonomic nervous system (ANS). The ANS regulates 
visceral organs such as the heart, stomach and intestines. It consists of the 
sympathetic nervous system that stimulates the ‘fight flight response’ of increasing 
heart rate and blood pressure and is generally activated during stressful 
situations, and the parasympathetic system, which regulates the organs when not 
under stress. The parasympathetic system, reduces blood pressure and heart 
rate, and stimulates digestion. The sympathetic nervous system mainly releases 
noradrenaline at the effector organs and stimulates the adrenal medulla to 
produce adrenaline. Acetylcholine is the neurotransmitter for the parasympathetic 
system. The ANS mediates communication between the peripheral nervous 
systems and the brain. Most organs, including the heart receive parasympathetic 
innervations through the vagus nerve. The vagus nerve nuclei are located in the 
brainstem. Inflammation of the vagal nuclei, as found in EV-A71 autopsies, may 
result in unbalanced sympathetic stimulation of the heart and a resulting 
tachycardia. The respiratory centre is located in the reticular formation in the 
medulla. (Figure 1.6). Inflammation of the nucleus and tractus solitarius and 
nucleus ambiguus will result in irregular breathing. Temperature regulation occurs 
through circuitry involving the thalamus, with autonomic control located in the 
hypothalamus. Peripheral information is relayed through the spinothalamic tracts 
to the thalamus and hypothalamus, and the hypothalamus has effector pathways 
that mediate vasomotor tone, sweating, shivering and piloerection. Autopsy 
results from 4 deaths following EV-A71 associated pulmonary haemorrhage 
identified extensive destruction of the ventral medulla, which is a central 
depressor area. Kao et al. hypothesised that excessive sympathetic activation
results in systemic vasoconstriction resulting in shift of blood to the pulmonary 
circulation. To evaluate this, they ran a 2 year prospective study recruiting 48 
HFMD patients (age 6-18 years) whom they evaluated during periods of 
respiratory distress. Peripheral arterial pressure (AP) and heart rate (HR) were 
continuously recorded with use of a polygraph and a tape recorder. These were 
used retrospectively to determine HR variability. Four cases died and the authors 
state “Consent for autopsy of patients who died of acute PE was obtained from 
the patients themselves (in 4 cases) or from their relatives.” 147 All cases who died 
were noted to have acute respiratory distress syndrome (ARDS) and developed 
severe haemorrhagic oedema (post-mortem finding). Prior to onset of ARDS (not 
defined in the paper) the AP and HR were reported to be within normal limits but 
changed following the onset of ARDS. The study identified that arterial pressure 
and heart rate variability suggested sympathetic activation one hour after onset of 
ARDS and 30 minutes prior to death.
1.1.13 Immune pathways
The inflammatory response is regulated by cytokines, which influence immune cell
generation and specialization. In the CNS they are predominately produced by
glial cells and the immune T helper cells and macrophages.148 Outside the CNS,
macrophages, monocytes, lymphocytes and vascular endothelial cells produce
cytokines. Cytokines are signalling molecules, which a large variety of cells
produce to communicate with other cells in response to infection or inflammation.
They can have local and systemic effects. Cytokines consist of many different
molecules, such as monokines, interleukins (IL), colony-stimulating factors,
interferons (INFs), tumour necrosis factor (TNF), and can act on non-immune
cells. Chemokines, such as IL-8 attract immune cells to sites of inflammation or
infection. They also communicate between the neural-endocrine-immune
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system.149 Cytokines can be pro- or anti-inflammatory, neuroprotective or 
destructive, depending on their state and concentration.150 In the CNS, blood 
borne or CNS immune cells, brain endothelial cells, astrocytes, microglia, and 
neurons can stimulate cytokine production. Pro-inflammatory cytokines include 
TNF-a, IFN-y, IL-1, IL-6, and IL-18, while anti-inflammatory cytokines include IL-1 
receptor antagonist, IL-4, IL-10, IL-11, and IL-13, and transforming growth factor 
(TGF)-p, with IL-6 falling in both categories.151
The hypothalamus is sensitive to peripheral and central cytokines such as IL-1 p 
and TNF-a. In disease states, the brain upregulates IL-1 p and TNF-a expression 
which can exacerbate the inflammatory response, resulting in a cytokine storm.152 
IL-1 p is produced by blood monocytes as a result of infection or injury. It leads to 
fever, hypotension and stimulates other pro-inflammatory cytokines such as IL- 
6.153 A small study in 33 children found significantly raised IL-1 p, TNF-a and IL-6 
levels in CSF and blood of severe EV-A71 HFMD cases.154 Direct inflammation of 
the hypothalamus/thalamic areas plus up regulation of CNS released cytokines 
may contribute to the persistent hyperthermia seen in some cases with severe 
EV-A71 HFMD.
1.1.14 Autonomic nervous system and immune modulation
The autonomic nervous system (ANS) plays a fundamental role in mediating
interactions between the nervous and the immune system. Constituents of the
immune system enlist the ANS to coordinate sympathetic and parasympathetic
discharges, which modulate immune organs and cell activities. As reviewed by
Kenney et al, intravenous or intrathecal IL-1 p administration changes sympathetic
nerve inputs to the kidney, spleen, and adrenal glands.155 IL-1 p also adapts the
sympathetic system to acute physical stress and in vagotomised rats IL-1 p
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release was enhanced, suggesting a vagal parasympathetic role in modulating 
the sympathetic response to raised IL-1 p.156 Similarly, systemic TNF-a and INF-a 
enhance sympathetic activity in animal models.155
Granulocyte colony stimulating factor (G-CSF) is a hematopoietic growth factor, 
involved in myeloid cell differentiation.157 It is used therapeutically to mobilise 
haematopoietic stem cells from the bone marrow to the blood. One study 
suggests that G-CSF alters noradrenaline and adrenaline levels in humans.158 
Baseline levels of G-CSF are usually undetectable but rapidly increase with an 
infection and reduce with recovery. Endothelial and epithelial cells can produce G- 
CSF when stimulated by TNF-a, INF-p and IL-1. Raised G-CSF stimulates 
neutrophil mobilisation out of the bone marrow and may even modulate the 
function of the neutrophil at the site of infection and inhibit its apoptosis.157 In mice 
models, G-CSF mobilisation is interrupted by pharmacological sympathetic 
blockade.159
Prostaglandin E2 (PGE2) production in blood-brain barrier microvascular and 
endothelial cells is induced by cytokines. PGE2 activates the sympathetic nervous 
system and the hypothalamic-pituitary-adrenal axis (HPA axis) resulting in 
fever.160
The vagus is believed to play an important role in communication to the central 
nervous system and IL-1 p receptors are found on abdominal branches of the 
vagus paraganglia.161 However, the lack of a parasympathetic effect of IL-1 p 
receptor stimulation in rats in vitro raises questions over the significance of the 
pathway.162 Other non-neural pathways include a) cytokines accompanying the 
transport across the blood-brain barrier through TNF/IL-1 receptors, b) 
lipopolysaccharide (LPS, a bacterial endotoxin) and IL-1 systemically inducing
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PGE2 (in brain microvascular cells) and cytokines at the blood-brain barrier, and 
c) direct entry of immune mediators into the brain parenchyma in regions where 
the blood brain barrier tight junctions are deficient around the third and fourth 
ventricles.163 Different immune mediators can activate differential or multiple 
pathways to communicate with the central nervous system, depending on the 
dose and route of entry of the immune stimulant.
The literature suggests that increased cardiac vagal tone is associated with 
decreased levels of IL-6 in healthy adults and in adults with cardiovascular 
disease, supporting the parasympathetic down regulating role in immune 
pathways.164 The parasympathetic system also modulates the peripheral 
inflammatory response to suppress pro-inflammatory cytokines and activate anti­
inflammatory cytokines.155 This process may occur with low levels of cytokines in 
a specific location and before there are cytokines present in the systemic 
circulation. The vagus can also activate the innate humoural immune system by 
relaying information to the medullary reticular formation, locus coeruleus and 
hypothalamus and indirectly stimulate the anterior pituitary gland to secrete 
adrenocorticotrophin (ACTH), stimulating glucocorticoid production.165 Animal 
models of vagus nerve stimulation suggest there are beneficial anti-inflammatory 
responses in haemorrhagic and toxic shock syndrome and in myocardial 
ischaemia/reperfusion.166 Inflammation and pathological states of the vagal nuclei 
in the brainstem may inhibit protective anti-inflammatory systemic responses of 
the vagus in severe HFMD.
1.1.15 Immune mediators and autonomic nervous system dysfunction in H F M D
Systemic hypertension is believed to be an early indicator of potential progression
to cardiopulmonary compromise. It may be the effect of unopposed sympathetic
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stimulation and catecholamine release on the systemic and pulmonary circulation. 
This leads to increased peripheral vasoconstriction and raised pulmonary 
pressure resulting in pulmonary oedema or haemorrhage. This is termed 
‘neurogenic’ pulmonary oedema.167 There are reports of left-ventricular 
dysfunction associated with raised catecholamine levels.168 The same 
researchers identified changes consistent with catecholamine cardiotoxicity in 
seven cardiac autopsies. In a retrospective comparison of 5 fatal cases of EV-A71 
meningoencephalitis with 16 survivors, significantly reduced cardiac function and 
raised troponin I levels was found in the fatal cases.169 The authors suggested 
that there may have been non-ischaemic myocardial damage although the timing 
of echocardiography and troponin I measurements was uncertain and cannot be 
conclusively assumed to be taken prior to shock. Prospective invasive 
measurement of pulmonary arterial and central venous pressures in five children 
with EV-A71 brainstem encephalitis complicated by pulmonary oedema found 
minimal changes in pulmonary arterial and central venous pressures.170 The 
authors hypothesised that pulmonary oedema resulted from changes in 
pulmonary vascular permeability following a systemic inflammatory response 
induced by brainstem damage.
It is hypothesised that the cytokine profiles reflect severity of disease in 
HFMD/EV-A71 brainstem encephalitis. In a small study significantly raised IL-1 (3, 
TNF-a and IL-6 levels were found in the CSF and blood of 8 children with 
cardiopulmonary compromised EV-A71 associated HFMD compared with 21 
healthy controls.154 There were no significant differences in levels between 
controls (21 cases) and those with encephalitis (8 cases) and uncomplicated EV- 
A71 (17 cases) infection. However, in another study when the levels of CSF IL-1 (3 
and IL-6 were measured in the first 48 hours of admission in 24 EV-A71 cases
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with diverse clinical manifestations, no differences were seen in levels between 
those with CNS manifestations, despite progression in some cases to 
cardiopulmonary failure within the same timeframe.171 The authors speculate that 
CNS inflammatory derivatives may cross the disrupted blood-brain barrier and set 
off a systemic inflammatory response. However, the serum cytokine levels in this 
cohort were not as high as those in CSF and did not seem to correlate with the 
CSF levels. Wang et al. found high levels of IL-6 and IFN-y in CSF samples from 
9 children with pulmonary oedema (PE), when compared to 48 less severe EV- 
A71 associated disease manifestations.172 Both IL-1 (3 and IFN-y are neuro- 
inflammatory and may result in disruption of the blood brain barrier. IL-1 (3 was 
only found in the CSF of the 9 PE cases. The authors hypothesised its role was to 
permit cytokines to be released from the CNS into the systemic circulation172,173 
IL-1 p may additionally increase CNS catecholamine production through its effect 
on the locus coeruleus, the most important source of noradrenaline in the brain.174 
To explore whether CNS mediation could activate a systemic response resulting 
in increased pulmonary vascularity, 73 EV-A71 cases were age matched to 15 
healthy controls and specific cytokines were measured in plasma.175 Levels of 
plasma IL-10 was significantly higher in the group with pulmonary oedema than 
those with brainstem encephalitis. IL-10 is an anti-inflammatory cytokine, reducing 
lung permeability and is closely related to catecholamine release. The authors 
suggest IL-10 has an immune-regulatory role in the CNS and is activated by 
unopposed sympathetic stimulation following direct EV-A71 brainstem invasion. 
Although IL-10 may protect the pulmonary vasculature from leakage, it can 
increase thrombocytopenia and this process may adversely affect the pulmonary 
vasculature and contribute to pulmonary oedema. The study also found raised 
plasma IL-13 in all EV-A71 cases. The authors’ hypothesis that the increased
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airway hyper-responsiveness and over production of mucus as a result of raised 
IL-13, may contribute to PE formation.
The study evaluated IFN-y levels in 73 EV-A71 cases and 15 controls since this 
cytokine is known to mediate microvascular leakage. IFN-y levels were elevated 
in 34 patients with brainstem encephalitis and 14 cases with pulmonary oedema 
but not elevated in the 25 cases with autonomic dysfunction.176 Kinetic evaluation 
from a child with PE found IFN-y levels rise a day after IL-10 and may play an 
important role in PE genesis. Sympathetic release of catecholamines including 
adrenaline and noradrenaline stimulate pre- and post-synaptic receptors on 
immune cells.177 These catecholamines inhibit the production of TNF-a, IL-1 p and 
IL-6 whilst up-regulating anti-inflammatory IL-10.178 Catecholamines influence the 
differentiation of CD4 T cells and their proliferation, although the exact nature of 
the relationship is not understood.178
Wang et al. identified depleted CD4+ T cells, CD8+ T cells, in 14 patients with 
pulmonary oedema and suggest that as a result of sympathetic activation on the 
systemic circulation, immune responses are impaired resulting in delayed viral 
clearance of EV-A71.175 Zhang et al. evaluated the cytokine and chemokine 
profile in 153 children with differing severity of HFMD, of which 99 were EV-A71 
positive and 31 CVA-16 positive.179 Levels were compared to 19 healthy controls. 
They found certain cytokines and chemokines were more common in EV-A71 
disease than CA16, and others had higher concentrations in the CSF compared 
to plasma in cases with CNS complications. Griffiths et al measured serum and 
CSF chemokine and cytokine profiles in 88 EV-A71 infected children, of differing 
severity, of whom 4 died.180 They identified that a serum G-CSF to IL-5 ratio >100 
on admission was predictive of death in their study cohort. Raised IL-1 p and TNF-
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a levels were associated with the need for inotropic intervention, consistent with 
their known negative inotropic effects on cardiac contractility. The patterns of 
serum and CSF mediators detected in the study suggest CNS activation of the 
peripheral immune system. This has also been observed following stroke, 
possibly due to sympathetic activation of the spleen and lymph nodes.181
In summary, the HFMD immune mediator profile in the CSF and serum are 
different, suggesting that the CNS response may modulate the systemic response 
through the autonomic nervous system (Figure 1.6). However the complexity of 
the pro- and anti-inflammatory mediator levels found in each compartment 
indicate that further prospective evaluation is needed to establish whether any 
markers show a prognostic association with short or long term outcomes.
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Figure 1.6 Schematic d iagram  o f b ra instem  connections
Damage to vagus nerve centres in the brainstem inhibits the anti-inflammatory 
response following cytokine detection by the peripheral nervous system (efferent 
vagus response), and inhibits the parasympathetic response controlling heart 
rate, respiration and blood pressure.
The NTS (nucleus tractus solitarius) has projections to several structures in the 
limbic system including the hippocampus, thalamus and midbrain, and modulates 
emotion and attention.
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1.2 C lin ica l features and stage based management
HFMD is usually a benign, self-limiting febrile disease of childhood. Typically 
children present with a maculopapular rash or vesicular lesions on the palms, 
soles and buttocks, and/or ulcers in the mouth. Rarely severe complications can 
arise with CNS features. There is an increased risk of CNS complications such as 
aseptic meningitis, acute flaccid paralysis and brainstem encephalitis associated 
with EV-A71 as highlighted in the South East Asian HFMD outbreaks. There are 3 
stages of severe disease; a) CNS involvement, followed by b) autonomic 
dysfunction which may lead to c) cardiopulmonary collapse and shock. Children 
may develop a) or b) without progressing to c). Disease progression tends to be 
rapid, usually occurring within 3 days of disease onset.182
Clinically, CNS signs such as myoclonus or cranial nerve palsies may herald 
disease progression, but there may also be more subtle signs of brainstem 
encephalitis such as autonomic nervous system (ANS) dysfunction. However, 
ANS dysfunction can be difficult to identify, and requires continuous monitoring to 
detect the changes in blood pressure and heart rate before progression to 
cardiopulmonary compromise. Early outbreaks highlighted the lack of CNS signs 
prior to rapid cardiopulmonary collapse.182 However one consistent sign that was 
identified was a raised white cell count in CSF, indicating CNS involvement but 
requiring lumbar puncture.
Current aims of the stage-based management are to identify early signs of CNS 
involvement, instigate early invasive monitoring for pre-emptive supportive care. 
Following the large HFMD outbreak in Taiwan and based on the management 
system there, a local stage-based management system was developed in 
Vietnam.183 It grouped the clinical features of HFMD as listed in Table 1.4. The 
WHO published a similar management strategy.47
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1.2.1 Current therapeutics
Intravenous immunoglobulin (IVIG) consists of the pooled immunoglobulin G (IgG) 
fraction from the plasma of a thousand or more blood donors. It is sterile and 
contains more than 95% unmodified IgG, with minimal amounts of 
immunoglobulin A (IgA) or immunoglobulin M (IgM). Pooled IVIG contains 
neutralizing antibodies against a wide spectrum of common infectious agents 
including enteroviruses. Components of IVIG are also believed to suppress 
various inflammatory mediators, including cytokines and chemokines.185 There is 
anecdotal evidence that intravenous immunoglobulin (IVIG) may be beneficial in 
severe HFMD. IVIG may influence the cytokine network, and neutralise EV- 
A71.186 Neutralising EV-A71 antibodies levels rise quickly in HFMD and do not 
correlated with clinical severity.187 Cellular immune responses are believed to be 
more critical in determining disease progression. Wang et al. administered IVIG to 
22 children with EV-A71 infection and compared specific cytokine levels within 12- 
24 hours to 13 age matched healthy children.18812 children had ANS dysfunction 
and 10 had pulmonary oedema. There was no significant change in EV-A71 
antibody titres post administration of IVIG, but there was a reduction in the plasma 
concentration of IL-6, IL-8, IL-10, IL-13, and IFN-y in both groups with EV-A71. 
The authors suggest that IL-8 affects vascular permeability and reduction of this 
cytokine may inhibit progression to pulmonary oedema.
An observational study using historical controls suggests some benefit of IVIG in 
HFMD, but multiple management changes occurred between the two study 
periods resulting in earlier referral and supportive intervention in severe cases.183 
Another Malaysian observational study found more survivors of severe HFMD had 
received IVIG compared to fatal cases. However interpretation is confounded by 
the time-dependent bias, where the most severe cases may not have had time to
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receive IVIG.189 A randomised controlled trial is needed to determine the efficacy 
of IVIG in severe HFMD.
Antiviral therapies against EV-A71 are limited. Ribavirin has activity against DNA 
and RNA viruses including respiratory syncytial virus and herpes viruses. In mice 
models, it inhibits EV-A71 replication in infected cells but was less effective in 1 
day old mice compared to 12 day old mice.190,191 Pleconaril is another agent 
which inhibits picornavirus uncoating and blocks attachment to host cell receptors. 
In mice models it appears more promising against EV-A71191 with small studies 
showing benefits in paediatric enteroviral meningitis.192 A multi-site placebo 
controlled double blind study in 221 children, aged 4-14 years old with a clinical 
diagnosis of viral meningitis (181 had confirmed enteroviral infection), randomised 
the children into three groups.193 One group received placebo and the other two 
groups received different doses of pleconaril for 7 days. There was statistically 
significant improvement in a clinical score in the pleconaril-treated groups, but this 
improvement was small.194 In those receiving high dose pleconaril, the proportion 
of subjects reporting headache was reduced initially but the effect was not 
sustained.193 A study of 21 infants with enteroviral meningitis was insufficiently 
powered to confidently show benefit with pleconaril.194,195 However a prophylactic 
study in picornavirus respiratory infection suggested that pleconaril may interfere 
with metabolic pathways, which could result in reducing the efficacy of 
contraceptives and HIV medication.194 As a result the FDA did not license 
pleconaril as the modest benefits were insufficient to outweigh the risks for the 
intended use in mild respiratory infections.194
Milrinone, a phosphodiesterase inhibitor class 3 (PDE3) elevates intracellular
cyclic adenosine monophosphate (cAMP), resulting in and increase of the heart’s
contractility and a reduction of pulmonary vascular resistance and peripheral
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vascular resistance.196 It is used for congestive cardiac failure and low-output 
cardiac conditions post cardiac surgery.196 However there is a risk of arrhythmias 
with prolonged use so it should be used with caution.197 In the last decade 
milrinone has been increasingly used in neonates with persistent pulmonary 
hypotension198 post cardiac surgery for congenital heart disease,199 and as 
adjuvant therapy for vasocontricted septic shock.200,201
Elevated cAMP can inhibit inflammation-related chemotaxis, lysosomal enzyme 
and histamine release, mitogenesis, and lymphocyte mediated toxicity.202 
Cardiopulmonary bypass (CPB) surgery results in acute inflammation which 
predisposes to postoperative complications such as respiratory dysfunction, and 
potentially to multi-organ failure.203,204 In a randomised controlled trial on 24 
patients undergoing CPB surgery, 12 received intravenous milrinone from 
induction of anaesthesia until 24 hours post surgery, 12 did not.205 Clinical 
outcomes were the same in both groups, with no deaths and no difference in 
length of ITU stay or duration of intubation. However the levels of IL-1 p and IL-6 
were significantly lower in the milrinone group, supporting its immune modulatory 
role. Increasing pulmonary cAMP may protect or strengthen the microvascular 
barrier and thus increase clearance of alveolar fluid, reducing the reperfusion 
injury post CPB surgery.206
A small historical controlled trial suggested milrinone might help survival following 
cardiopulmonary collapse due to pulmonary oedema.207 An open label 
randomised controlled trial of milrinone was carried out in Vietnam;208 22 children 
were administered milrinone intravenously within 2-6 hours of the onset of 
cardiopulmonary collapse (brainstem encephalitis with cardiopulmonary collapse, 
hypotension, and/or pulmonary oedema) and compared to 19 children with
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standard treatment. Mortality at one week was significantly lower in the milrinone 
treated group.208 Despite no evidence that milrinone has any beneficial effect 
when given prior to cardiopulmonary collapse, it has become standard 
management in managing hypertension associated with autonomic dysfunction 
with severe HFMD in Vietnam. The rationale is that milrinone may suppress the 
cellular immune processes associated with disease progression in addition to its 
vasodilator effects.186
1.2.2 Drugs and vaccines research
There are promising results from phase III trials of a Chinese inactivated EV-A71 
vaccine (sub-lineage C4), with 90-97% efficacy against HFMD associated with 
EV-A71.209-211 However, there are still many questions regarding whether the 
vaccine is suitable for the whole region, whether it will protect from severe 
disease, and particularly if the C4 sub-lineage will also provide protection against 
other EV-A71 sub-lineages or related viruses associated with HFMD. Taiwan and 
Singapore are also currently conducting vaccine research 212,213 Further research 
is needed to determine the target population, the age at which they should be 
vaccinated, and the overall cost effectiveness of vaccination.214
1.3 R isk  factors fo r  severe H F M D
A prospective observational study carried out in Malaysia between 2000 and 2006 
identified three independent risk factors for CSF pleocytosis (used by the authors 
to define neurological involvement) among 725 children admitted with HFMD.215 
These were total duration of fever > 3 days, peak temperature > 38.5°C and 
history of lethargy. A retrospective questionnaire and serological study from the 
1998 HFMD outbreak in Taiwan identified the following factors to be associated
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with severe disease: attendance at a kindergarten/child care centre; contact with 
HFMD/herpangina cases in 1998; a greater number of children in a family; and 
residence in a rural area.89 During an EV-A71 HFMD outbreak in China in 2008, 
176 children were compared to 201 asymptomatic healthy children who were 
frequency matched by status of residence.216 Retrospective questionnaires were 
administered to all parents to identify specific exposures and behaviours. The 
children with HFMD were more likely to have visited an outpatient clinic for 
another problem less than one week prior to onset of symptoms, played with 
neighbourhood children, and had poor hand washing hygiene practices, as did 
their parents. The community exposure in the HFMD cohort was significant even 
in those infants that did not attend kindergarten or pre-school. Hence the authors 
advocate control measures to include strict hand-washing and hygiene practices 
as well as restriction of community gatherings during an outbreak.
A case-control study in China, found exclusive breastfeeding in the first 6 months 
of life was possibly protective up to 28 months of age against severe HFMD, 
compared to mixed feeding (breast and supplements).217 In a small retrospective 
study from the 1998 Taiwan outbreak, three groups of EV-A71 culture confirmed 
cases were compared.182 11 children with pulmonary oedema were compared to 
38 children with CNS involvement without pulmonary oedema and 105 
uncomplicated cases. The study identified hyperglycaemia, leucocytosis, and limb 
weakness as risk factors for pulmonary oedema following CNS involvement. 
Another small study found fatal outcomes in 8 children following cardiopulmonary 
shock were significantly associated with elevated troponin I (p=0.001) and CSF 
leucocytosis (p=0.002) compared to 19 survivors.218 Following the 2000 HFMD 
outbreak in Singapore, 7 fatal cases were compared to 131 controls.219 A raised 
total white cell count, vomiting and absence of mouth ulcers were predictive of a
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fatal course. Similarly, Yang et al. ran a retrospective frequency matched case 
control study in 2010 and 2011 with 89 severe HFMD cases and 267 mild 
cases.220 The study found oral ulcers were associated with mild disease whilst 
persistent fever >39 degrees for more than 3 days, “leg trembling" (authors clarify 
as “clinical manifestation of legs shaking uncontrollably which may be due to 
weakness after illness") and detection of EV-A71 infection were significantly 
associated with severe disease and neurological complications. In 665 EV-A71 
virus culture confirmed cases, myoclonic jerks appeared to have poor positive 
predictive value for EV-A71 infection (0.48), severe disease (0.2) and neurological 
complications (0.09) but good negative predictive outcome for severe disease 
(0.95) and neurological sequelae (0.99).221 A systematic review of 19 studies 
including those published in Chinese concluded that the following factors 
significantly increased the risk of severe HFMD: duration of fever for more than 3 
days, odds ratio (OR) 10.09 (95% confidence interval (Cl) 6.22-16.35); body 
temperature more than 37.5 °C (OR 4.91, 95% Cl 1.26-19.18); lethargy (OR 7.75, 
95% Cl 3.78-15.89); hyperglycaemia (OR 2.77, 95% Cl 2.06-3.71); vomiting (OR 
8.83, 95% Cl 1.05-74.57); increased neutrophil count (weighted mean difference 
(WMD) 0.61, 95% Cl 0.52-0.70); EV-A71 infection (OR 5.13, 95% Cl 3.11- 8.46); 
and young age (WMD -0.44, 95% Cl 0.69 to -0 .19).222
A prospective cohort study from Taiwan investigated the relationship between 
viraemia (RT-PCR positive for EV-A71 in a blood sample) and clinical severity in 
EV-A71 cases.223 224 children were enrolled and 26% were confirmed to have 
viraemia, of which 68% were detected within 3 days of illness. There was no 
association between the presence of viraemia and complications, although those 
who had viraemia after 3 days had significantly more complications. No viraemia 
persisted after 7 days, even if clinical symptoms persisted, suggesting that
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progression after 7 days is unlikely. However the study did not have a large 
enough cohort with complications and did not take kinetic samples to determine 
correlation of viraemia with severe disease, with the single sampling method 
reporting a snapshot rather than trends. Due to the neurotropic nature of EV-A71, 
prolonged viraemia may permit CSF viral entry but is only one aspect of the 
pathogenesis.
1.4 M agnetic  resonance im aging (M R I)  find ings in  H F M D  
The central nervous system consists of grey and white matter. The grey matter 
contains mainly neuronal cell bodies, glial cells and synapses, with very few 
myelinated axons. In contrast, the white matter consists mainly of myelinated 
axons, communicating between sections of grey matter. Grey matter participates 
in muscle control, hearing, vision, language, memory, cognition, self-control and 
emotions. The cerebellar and cerebral cortices consist of grey matter, whilst the 
interior of the hemispheres and cerebellum are mainly white matter. However 
there are grey matter structures within the hemispheres such as the basal ganglia. 
In the spinal cord, the interior consists of grey matter surrounded by white matter. 
Different disease states, such as multiple sclerosis,224 Japanese encephalitis 
(JE)225 and herpes simplex encephalitis (HSE)226 can be distinguished by their 
localization or pattern of distribution in brain tissues. Magnetic Resonance 
imaging (MR) is the modality of choice for imaging grey-white matter 
differentiation and lesions in the brainstem. MR works on the principle that when a 
magnetic field excites protons from different tissues, the protons relax (return to 
their previous resting state) at different rates when the excitation stops. Protons 
from water and fat containing tissues relax differently and hence MR is useful in 
differentiating soft tissues. Increased proton density results in darker areas. There
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are several types of MR imaging sequences where pulses of magnetic forces are 
applied and relaxation of protons are measured; T1 and T2. T1 images are bright 
when there is haemorrhage or calcification and are useful for identifying the 
border between brain and CSF. Water and fluid are bright on T2 scans and so T2 
is preferred to assess oedema. Diffusion weighted imaging (DWI) measures the 
diffusion of water into surrounding tissue, which may be restricted in stroke or 
altered in demyelination. Fluid attenuated inversion recovery (FLAIR) is a 
technique where T2 weighted images are used and the CSF signal is nulled or 
cancelled out. It is useful for differentiating grey matter lesions.
The brain tissue changes of encephalitis typically go through an acute phase in 
the first few days of illness, followed by a healing process of gliosis (scarring) and 
atrophy which becomes increasingly evident from the end of the first week or early 
2nd week through to the 4th week. The chronic phase of disease is when the final 
stages are relatively static and this is usually reached at 2 -  3 months and 
beyond. The MR sequence, T1, T2, DWI or Flair, that gives the most information, 
depends on the specific pathology being investigated and the time of the scan in 
relation to the illness onset. For example, DWI has been shown to be useful in 
HSE, but has less utility in adults with scans taken more than 7 days after onset of
227, 228
Availability of MRI is increasing in low and middle-income countries (LMIC), 
sparking interest in its possible prognostic utility. In practice, expertise in 
transportation of critically ill patients in such countries is lacking and very sick 
ventilated children are often unable to undergo scans even within the same 
hospital. Also, MRI requires children to be very still (for approximately 10-20 
minutes for brain imaging), usually requiring some form of sedation. These factors
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currently limit widespread application for patients with less severe disease, 
although imaging is more likely to be used in severe cases and may contribute 
prognostic information.
In EV-A71 HFMD outbreaks, MR scans have been carried out for clinical 
indications and then retrospectively reviewed. Published papers are detailed in 
Table 1.5. Typically lesions were found in the pontine tegmentum, medulla 
oblongata, midbrain and dentate nucleus within the first week of illness. Later 
scans, performed after 7-12 days, identified atrophy and gliosis of the brainstem. 
However, a variety of retrospective grading systems were used to classify disease 
severity and in some cases the timing of the scans was uncertain. Most lesions 
were identified on T2 series but there is a suggestion that DWI may be more 
sensitive in the acute phase in detecting lesions.229 Early findings (day 1-5) may 
not persist and it is difficult to collate data from scans taken at different time 
points. This may explain why there does not appear to be a clear correlation 
between MRI changes, clinical presentation and outcome. In addition, scans have 
rarely been performed in patients with mild disease meaning that similar changes 
to those observed in severe disease may be present but go undetected. Since 
EV-A71 can present without rash and in many different clinical guises, it is 
possible that MRI scans could be very useful in aiding diagnosis. Currently there 
is no information on the correlation between MRI changes and outcome, 
especially long-term outcome. Despite its cost, access to MRI in LMIC is 
improving. However, research is needed to define how much the findings from this 
imaging modality can contribute to improving diagnosis and guiding management, 
potentially resulting in better outcomes.
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1.5 Outcomes fo llow ing  H F M D
There are limited data on long-term clinical outcomes of survivors. Since children 
less than 5 years are at particular risk, there are concerns about the long-term 
effects of infection during a potentially critical period of brain development. 
However, there is poor understanding of when the critical periods of brain 
development are, and the role of brain plasticity in recovery.244,245
1.5.1 Biological p lausibility: normal brain development
There is a preset programme of brain development from gestation onwards, with 
neurons migrating to specific sites to form neural networks.246 Different regions 
and layers of the brain develop at different rates and the whole process is 
influenced by gene expression and environmental conditions such as maternal 
nutrition 247 The prenatal period sees the development of the neural tube into 
recognizable cerebral and CNS structures. Interruptions to normal development at 
this point result in gross abnormalities of brain structure, or dysplasia of cortical or 
subcortical structures.247 There is a careful balance between proliferation of 
neurons, dendritic development, synaptogenesis (a prerequisite for cerebral 
connectivity), differentiation (i.e. commitment to specialised systems with specific 
function) and apoptosis (programmed cell death).247 After birth, there is on-going 
maturation in a set sequence into early adulthood.248 Between 8 months to 2 
years there is rapid dendritic growth and synaptogenesis, concomitant with 
pruning of the CNS as a result of environmental influences 247 249 It is thought that 
the rapid production of dendrites and synapses allows for more adaptability of the 
brain, with the potential for functional reorganization if an insult occurs at this 
time.250 Myelination ensures efficient transport of electrical signals. Peaks of 
myelination occur at 2, 7-9 and 11-12 years.244
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The concept of ‘critical’ or ‘sensitive’ periods of brain development arose as there 
are specific times when inputs to the brain stimulate reorganization resulting in 
either a particularly good or bad outcome.251 An example is the visual system. 
Failure of normal visual input due to squint during early life leads to reorganization 
of the visual pathways resulting in amblyopia. The same lesion in later childhood 
once development of the vision has occurred does not result in a permanent 
visual deficit. However, the timing and nature of the different critical periods 
relevant to different areas of the brain and its function remain poorly 
understood.252
Injury to the brain may result in neuronal death, damage to axonal tracts and/or 
altered neurotransmitter balances.253 Later the impact of scarring can delay 
recovery. Following injury to the brain the recovery processes are hypothesised 
from adult studies to consist of two main processes; restitution and reactivation of 
pathways, and substitution/functional reorganization from damaged to healthy 
areas.254 Most examples of restitution and substitution were identified in animal 
models, and it remains uncertain whether these processes are necessarily 
beneficial or preserve function, even if they do occur with more efficiency in early 
childhood.
Two patterns of recovery are well described following insults such as stroke, 
meningitis or trauma: either an apparent absence of deficit at the initial 
assessment but problems with emerging functions, or a delay in initial 
development followed by catch-up growth later.244 These two patterns are 
dependent on the age at which the child had the insult and how long afterwards 
they were assessed. Short-term evaluation may not be able to discriminate 
emerging skills, or evaluate the effect of age at insult has on outcome.244 A review
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of outcomes following viral encephalitis in children identified most recovery 
occurred within 6-12 months of the insult, and the authors advised follow-up for at 
least 1 year.255 With time however, there may be catch-up of skills that were 
delayed, although there may be secondary consequences on higher demanding 
skills in related functions. Thus for example a cohort of children who had bacterial 
meningitis were followed up at both 7 and 12 years following the insult;256 initial 
findings included impaired reading ability at 7 years which had resolved by the 12 
year follow-up, but had lead to later verbal learning impairment. In addition more 
functions need to be carried out by the non-damaged areas of the brain as time 
goes on. Attention, emotional control and executive function rely on a complex 
system of neural interaction and pathways, so functional reorganization may be 
difficult. As a result these functions may suffer disproportionately more following 
brain injury, than areas where functional reorganization is efficient.257 Recovery 
post insult depends not only on the age of the child, the timing of the event and 
whether the pathological process is progressive or not, but also on external 
factors that can influence recovery such provision of a rich and stimulating 
environment.253 This is particularly important in the younger child, and the impact 
is not usually seen until after the acute phase of the insult has resolved. Children 
who are exposed to an enriching, stimulating environment have been shown to 
increase their learning capacity, and hence this provides a potential opportunity 
for therapeutic intervention.258 However the optimal timing for intervention is not 
known, and neither the simplistic theories of plasticity or vulnerability can explain 
the variety of outcomes seen following brain insults.244
1.5.2 Role of the brainstem on child development
The brainstem is evolutionary the oldest part of the brain. It consists of the
medulla, pons and midbrain,259 and is comprised of a complex system of nuclei
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and cranial nerves which are part of the sensory and motor systems.260 The 
brainstem plays a vital role in coordinating the behavioural and physiological 
responses that occur during foetal development, including breathing movements, 
heart rate, and gross movements of the body and head. Later the brainstem takes 
on a major role in determining the sleep-wake cycle, and influencing heart-rate 
variability (i.e. physiological variation in beat to beat heart rate changes 
modulated by the autonomic nervous system).259,261 These hard-wired functions 
do not require higher input from cortical reasoning. There is evidence of some 
plasticity in neuronal network development within the brainstem through evidence 
of habituation to sound, and preference to maternal voice up to 6 weeks before 
birth.262 However, it is generally agreed that the brainstem mediates reflex 
responses, as opposed to engaging true cognitive processing to result in 
purposeful behaviours and higher cognitive function.259 Postnatally, the brainstem 
mediates the infant’s reaction to hunger, resulting in crying. Smiling at 6 weeks is 
also a reflexive response and can be produced by brainstem stimulation. Later, as 
the child and the brain develop, the hypothalamus begins to exert some 
regulatory control over the midbrain. Normal development sees the appearance 
and then loss of some brainstem mediated reflexes such as the stepping reflex, 
and the grasp and Moro reflexes, as the forebrain begins to exert higher 
control.263
Porges et al. developed a theoretical model of the autonomic nervous system as 
hierarchically mediated, with social communication (vocalization, expression and 
listening) designated as the most superior function, followed by the defensive 
mechanisms - firstly mobilization through fight-flight responses, and lastly 
immobilization through vaso-vagal syncope and “behavioural shutdown”.123 
According to this model, following exposure to a challenge the evolutionarily
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newest circuit, i.e. social communication, is employed first. If that fails, then the 
mobilisation circuit comes into play next, followed lastly by the oldest 
immobilisation circuit. The newest circuit is operative by 6 months of age, 
correlating with increased myelination of the vagus nerve.264 Disruptions occurring 
at this time due to illness or environmental stresses (such as neglect), may result 
later in difficulties with self-control and reciprocal social communication, as 
reviewed by Calkins et a l265
1.5.3 Outcome following brain stem pathology
The major CNS manifestation in HFMD is brainstem encephalitis (BE). 
Irrespective of cause, BE is rare in early childhood and, thus, literature on 
outcomes in this age group is limited. There is some data from adults. In 7 adults 
with brainstem lesions due to ischaemia or haemorrhage, cognitive deficits and 
attention problems were detected at follow-up.266 Neuropsychological tests 
suggested that the fronto-cortical areas, which are involved in attention and 
executive function, were affected, indicating that the brainstem has intrinsic neural 
circuitry connecting it with the hemispheres. Hence it appears that the influence of 
the brainstem on the cortex and higher functioning is significant in the fully formed 
brain. In children however, in whom cortical development is still on-going, it 
remains unclear what effect the brainstem may have on cognition or attention and 
emotional regulation of responses.
1.5.4 Immune system and cognitive development
The immune system plays an important role in tuning brain activity during normal 
functioning, with complex immunological and brain interactions responding to 
environmental demands.267 Neural plasticity is the process of fine-tuning neural
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circuits by formation and pruning of axons and dendrites with synapses 
throughout life. This process steers learning and memory formation following 
experience. The baseline neuroimmune circuits, involving IL-1 p, IL-6 and TNF-a 
also interact with the endocrine and autonomic nervous systems.268 Animal 
studies in proinflammatory states suggest IL-1 (3, IL-6 and TNF-a may have 
detrimental effects on learning and memory although this has not been a 
consistent finding with in vivo studies in disease states such as multiple sclerosis, 
underlining the poor understanding of the mechanisms involved.267
In summary, predicting developmental outcomes after brainstem encephalitis in 
children is difficult, in part due to the wide variety of possible effects on the 
developing brain that may occur across the range of ages that are commonly 
affected. Detailed assessment, covering as many aspects of development as 
possible, is necessary to ensure problems are identified and appropriate 
management strategies / rehabilitation are put in place.
1.5.5 Literature summary of outcome assessments following EV-A71 associated 
H F M D
The age range of children affected, as well as the increased severity of disease 
seen in younger children, has prompted several research groups to try to assess 
developmental and neurological outcomes after severe HFMD. However, in 
general these studies have been conducted retrospectively rather than 
prospectively.
For the purposes of formal assessment, child development is categorised into a 
number of domains, cognitive, language, motor, adaptive, and socioemotional, as
described in Table 1.6. One limitation of measuring child development in low and 
middle-income countries (LMIC) is the lack of locally standardised tests with local 
normative comparative data. In particular socioemotional and adaptive skills are 
commonly assessed by parental report using questionnaires, and these domains 
can be challenging to adapt, as cultural expectations differ widely in different 
contexts. Unfortunately, attempts to develop more relevant questions based on 
engagement with local focus groups can be problematic, and in at least one report 
from an LMIC have resulted in poor psychometric quality.269 More research is 
needed to develop appropriate tools in the social and adaptive areas, which can 
be used to monitor child development in LMICs.
A summary of outcome studies in HFMD is listed in Table 1.7. The largest study, 
involving 142 children with confirmed EV-A71 infection, found that a younger age 
at disease onset may have consequences for verbal comprehension and that 
worse outcomes were associated with more severe disease.270 However, the 
researchers also found that parental education influenced the IQ scores, making it 
difficult to draw clear conclusions about how large the impact of age of onset was 
on verbal comprehension. As with all retrospective studies, there is also the 
inherent risk of sampling bias since the patients that were not traceable may have 
been the most severe cases or from lower socioeconomic groups.
Extracorporeal life support was incorporated into the Taiwanese management 
guidelines for severe HFMD disease in 2010.271 This was amidst controversy as it 
was not clear what the long-term outcomes were following this high-risk 
intervention. The 10 patients who were followed up had MRI scans, of which in 5 
there was evidence of complications of extracorporeal life support. Survival 
improved but this study failed to demonstrate improved long-term outcomes.
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Mechanical ventilation and ECMO also carry risks to neurodevelopment.272 It is 
estimated that MRI changes due to ECMO occur in 30-50% of cases and severe 
neurological complications occurs in 14-20% of cases.273,274
Overall, the literature suggests that language, cognitive and motor difficulties 
occur in the most severe cases associated with isolation of EV-A71, and perhaps 
that behavioural and later cognitive difficulties may occur in less severe cases 
without cardiopulmonary failure. However, it is clear that both detailed 
assessments and long follow-up are needed, to ensure better understanding of 
the difficulties that may arise as complex higher functions become established.
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A variety of tools have been used in different studies, ranging from screening 
tests to formal assessments with a control comparison group. However, screening 
tools have poor diagnostic utility and are not appropriate in high risk groups.286 
Also, as mentioned above retrospective studies have an inherent selection bias, 
and in the only prospective study performed to date the follow-up consisted of a 
single clinical examination at 2 months. It is clear that this is insufficient to allow 
identification of problems occurring during the period of rapid development in 
early childhood. The studies were also inconsistent in their findings between 
outcomes at different grades of illness severity, probably due to limited sample 
sizes. In addition, most countries do not have standardised neurodevelopmental 
assessment tools validated either for clinical or research use. However, despite 
these difficulties the studies so far have suggested that, aside from the major 
sequelae that are usually apparent at discharge, problems may develop in verbal 
comprehension in children who were affected by HFMD when aged less than 2 
years. Detailed follow-up, repeated at several time points during the crucial period 
for rapid brain development in early childhood should help to elucidate whether 
these areas of concern are real, and if present, whether the problems persist or 
not.
Severe HFMD has emerged as a serious CNS infection in early childhood across 
Asia. Understanding long-term outcomes is of great importance for the design and 
implementation of vaccination programs, as well as for management and 
intervention during the acute phase of illness or during convalescence. Current 
research has been limited by a number of factors, including the retrospective 
nature of the classification of disease severity, which has not always been
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consistent or comparable between studies. Secondly, neurodevelopmental 
assessments have not always included the major domains commonly assessed, 
and the duration of follow-up has been short. Information about the quality of 
testing and about the assessment tools used is lacking, and comparative control 
groups (generally considered essential to provide a culturally relevant gold 
standard) were not routinely included. Finally, neuroimaging, if performed, was 
carried out during different phases of the illness and/or recovery period, making it 
difficult to assess or quantify the evolution and resolution of lesions according to 
the evolution of the clinical disease, and thus limiting use of neuroimaging findings 
as potential predictors of severe disease or sequelae.
EV-A71 is commonly implicated as the main pathogen associated with severe 
HFMD and development of sequelae, but outbreaks with neurological 
complications have continued to occur with other co-circulating enteroviruses.255 
In the literature the focus has been on EV-A71 positive cases in HFMD 
outbreaks, and only Tsai et al. noted that two EV-A71 RT-PCR, serology and 
culture negative cases had neurological sequelae and MRI changes241 A 
prospective study is needed to evaluate the potential of other pathogens to 
cause severe HFMD and to increase the body of knowledge on the entire 
spectrum of ‘severe HFMD’.
1.7 Research in V ietnam : Background
The total population of Vietnam in 2012 was 88.78 million, with gross national 
income (GNI) per capita of 1,550 USD, putting it in the bracket of lower middle 
income countries.287 It is estimated that 43% of the population are under 25 years. 
The median age is 28 years and 31% of the population reside in urban areas.288 
Government policy in reducing fertility has been successful but the desirability for
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a son in the Vietnamese culture has seen a sex shift with more boys born than 
girls (1.12:1 ).288 Approximately 20% of the population live below the national 
poverty line.289
The National Assembly holds the constitutional and legislative rights of the 
Socialist Republic of Vietnam. It consists of 498 members, and has the 
responsibility to elect the President of the Republic, the Chairman of the National 
Assembly and the Prime Minister as well as approve all appointments of 
Ministers. The Head of State is elected by the National Assembly from among its 
deputies to represent the Socialist Republic of Vietnam.
1.7.1 Local governm ent
Vietnam is distributed into administrative units called provinces and cities under 
direct central rule. The province is further divided into provincial cities, towns and 
rural districts. The cities are divided into urban districts, rural districts and towns.
Figure 1.7 Vietnamese adm inistrative divisions. 290
City
C ity under d irec t
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The country is made of 58 provinces and 5 municipalities (including the capital Ha 
Noi and the largest city: Ho Chi Minh City), which are further divided into districts. 
Each district is again split into wards, and further split into communes. Ho Chi 
Minh City is made of 19 inner districts and 5 suburban ones.
1.7.2 Health Provision
The health care administration in Viet Nam is organised in a three-level system 
centrally controlled by the Ministry of Health (MoH). The MoH has the 
responsibility to execute health policy and programmes in the country.
At primary level are the district health centres, commune health stations and 
village health workers. The organisations are summarised in Figure 1.8.291 In 
2013, there were 1.19 doctors per 1,000 population.292
Figure 1.8 Healthcare provision in Vietnam
Government Ministry of Health (MOH)
r
Pro vine ai people - Provincial Health bureaus
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The review by Dao details the changes in healthcare provision in the last three 
decades and the on-going challenges the system faces.293 In summary, prior to 
1986, primary healthcare was free, but there were limited services and staff to 
provide appropriate healthcare for the nation. In 1986, economic reform allowed 
commercialisation of the health sector, with the introduction of private primary 
care clinics and user fees. From 1992, there was government health insurance for 
government employees and war heroes and voluntary participation by the public. 
However, general knowledge about the system was poor, resulting in limited 
extension out of government sector staff. By 2002, only 17% of the population had 
government health insurance and user fees were now a major financial burden on 
the poor and rural Vietnamese households. Out of pocket expenditure is common 
for many developing countries, where formal taxation is difficult as the populations 
are farmers or self-employed. However, significant health costs can cause 
catastrophic expenditure, pushing households into debt that claims all assets and 
high interest loans, which prevent the household escaping poverty. Recognising 
rising inequalities in healthcare provision, the government used tax revenue to 
pay for health insurance for the poor, rural communities called Healthcare fund for 
the Poor (HCFP). In 2005, the government started Free Healthcare for Children 
under 6 years (FHCCU6). This insurance covers inpatient and outpatient care in 
public facilities, lab and generic medicines approved by the Vietnamese Ministry 
of Health. It was estimated that in 2010 approximately 81% of children in the 
country were insured under FHCCU6.294 Nguyen et al. reported that the FHCCU6 
was helping relieving the pressure off tertiary centres, as to claim the insurance 
required formal referral from secondary care.295 However, due to constant 
overcrowding, the hospitals commenced services, which were quicker but non- 
FHCCU6 and usually paid out-of-pocket (OOP). These include services such as a 
private room. If a private room service was used, none of the hospital episode
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cost could be claimed through FHCCU6. Hence OOP payments remain high, 
estimated to be >50% of all the healthcare financing in Vietnam.296
Despite the inequalities, Vietnam has made significant progress in reaching the 
Millennium Development Goals in child and maternal health. There has been a 
decline in under-5 mortality from 58 per 1000 live births in 1990 to 24 per 1000 in 
2009.297
1.7.3 Early childhood education
Under the administrative regions described previously, each commune has at 
least one pre-school centre, one primary school and one lower secondary school. 
In towns or districts there is at least one upper secondary school and higher 
education or technical colleges. Provinces have further specialised colleges such 
as educational centres and the major universities are located in the large cities 
including Hanoi, Ho Chi Minh City, and Da Nang.298
Early childhood care and education (ECCE) starts at subsidised creches that take 
children from 3 months to 3 years and kindergartens, which start at 3 years up to 
6 years of age. ECCE units are under the authority of the District People’s 
Committee but there are also privately run centres. The main focus of the ECCE 
is to ensure school readiness.298
1.7.4 Childrens' rights and role in Vietnam
Vietnam was the second country in the world to ratify the United Nations 
Conventions on the Rights of the Child. The rights are detailed in Vietnam’s 2004 
Law on Child Protection, Care and Education.299
87
1. The right to have birth registered and acquire nationality (Article 11)
2. The right to be cared for and brought up (Article 12)
3. The right to live with parents (Article 13)
4. The right to be respected and have their life, body, dignity and honour 
protected (Article 14)
5. The right to health care (Article 15)
6. The right to study (Article 16)
7. The right to join recreational, entertainment, cultural, art, physical, sport 
and tourist activities (Article 17)
8. The right to develop aptitudes (Article 18)
9. The right to have assets (Article 19)
10.The right to access information, express opinions and participate in social 
activities (Article 20)
Additionally there are 5 social pillars described by President Ho Chi Minh for 
children to follow Vietnamese cultural values. (Final draft 25/2004/QH11 on Child 
Protection, Care and Education, June 15 2004).300
1. To love, respect and be dutiful to grandparents and parents, to respect 
teachers, to be polite to adults, to love minors and unite with their friends, 
and to help the elderly, disabled people and people with difficulties, 
according to their capabilities.
2. To study diligently, to observe hygiene, to do physical exercise, to observe 
public order and traffic safety, to protect public properties, respect the 
properties of other people and to protect the environment.
3. To love labour and to help their families through jobs suitable to their 
health.
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4. To be modest, honest and ethical, to respect the laws, to observe school 
rules, to live a civilised lifestyle and build cultured families, and to respect 
and preserve the national cultural identities.
5. To love their homeland, their country and fellow country folk; to have sense 
of building and defending the Fatherland of the Socialist Republic of 
Vietnam, as well as of international solidarity.
Article 22 also stipulates what a child must not do:
1. Drop out of school or leave their families to lead a vagrant life.
2. Infringe upon the life, body, dignity, honour or assets of others or disturb 
the public order.
3. Gamble, use alcohol, cigarettes or other stimulants harmful to their health. 
Exchange, share or use violence-provoking or culturally depraved products 
or play with toys or games harmful to their healthy development.
Childs rights and responsibilities show that Vietnam’s cultural deference to its 
history, nationality and family influence the relationship between parents and 
children. Expectations on children’s behaviour and their role in family and society 
are enshrined in law. This has implications when adapting child developmental 
tools for Vietnam, where social expectations and behaviours from children differ 
from the culture the tool was originally developed.
1.7.5 Disability in Vietnam
Population census data collected in 2009, report almost 6.1 million people over
the age of 5 years, or 7.8 per cent of the population, live with one or more
disability in seeing, hearing, walking or cognition with 385,000 individuals
classified as having severe disabilities, which was the total number of individuals
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receiving regular support from the Ministry of Labour, Invalid and Social Affairs 
(MOLISA).301 In addition, the 2009 Census data show that 3.8 per cent of the 
population aged 5 years or older or as many as nearly 3 million persons have 
multi-domain disability. Disability is disproportionately distributed with higher 
prevalence in rural areas. Disabled individuals have fewer opportunities to attend 
school, and shorter durations of study impacting on employment opportunities, 
which contribute to individuals remaining in poverty. Research within Vietnam 
found the development of infrastructure and services for rehabilitation improve 
families’ capacity to care for members with disability.302
There has been expansion in legal provisions for people with disabilities (PWD) in 
Vietnam. The 1992 and 2001 constitution guarantees the rights of all citizens 
including government support for PWD.301 In 2007, Viet Nam signed the United 
Nations (UN) Convention on the Rights of Persons with Disabilities (CRPD) - a 
major international convention that has rapidly gained recognition around the 
world (UN, 2006).
Shin et al. evaluated the predictors of parenting stress by studying 120 children 
aged 3-6 years, enrolled in schools and kindergartens and identified by the 
teachers as having cognitive delay (of which 22% also had additional difficulties, 
such as epilepsy and cerebral palsy).303 Fourteen percent of the parents did not 
agree with the teachers’ report of cognitive delay. 119 children without 
developmental delays were used as a comparison. Using standardised 
questionnaires, carried out by trained staff, the mothers of children with cognitive 
difficulties reported higher levels of stress, tended to be older, poorer, less 
educated and have less social support. After controlling for demographic and 
psychosocial predictors of stress, having a child with cognitive delay was the most
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robust predictor. Further research is needed to identify which aspects in the 
child’s difficulties that contribute most to parental stress, and may be a focus of 
intervention.
1.7.6 Services for children with disabilities
There is recognition of the discrimination children with disabilities face with 
regards to access to health and education. Vietnam is moving towards inclusive 
education with a combined project with UNICEF to train teachers on inclusive 
education.304
In 2009, 66.5% of children with disabilities (CWD) aged 6-10 attended primary 
schools, compared to the national rate of 97.0%. Many CWD repeat grades until 
they are too old for general education, as the system does not adapt for their 
needs. Approximately 33.0% of all CWD who have been to school leave prior to 
completion of education.305
A mixture of government and non-governmental organisations (NGOs) provide 
health and rehabilitation services for CWD. The government plans to develop a 
systematic and comprehensive rehabilitation network for the country but is limited 
by the lack of trained professionals, infrastructure and funding.306 Many NGO 
projects are focused on a specific need and fail to integrate well within 
government systems. Information about programs is not well disseminated and 
may be short-term and region-specific. Government therapy services are 
provided in large hospitals, which are oversubscribed. These services are not 
covered by the government health insurance system.
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1.8 Outcome measures
Outcome measures are used to evaluate areas affected by a disease process or 
intervention. In HFMD we required an objective measure of neurological function 
and child development (cognitive, motor and language domains) that could 
monitor changes in children aged 0-4 years. Outcome measures can be objective 
or subjective. Velentgas et al. discuss the conceptual models of health outcomes, 
incorporating objective clinical measures, quality of life measures and biological 
and societal influences as well as models incorporating economic costing.307 The 
HFMD study age group makes self-evaluation or reporting a challenge and 
parental reporting on child development may be biased and miss subtle 
developmental disorders.286 Hence, objective measures of child development 
using standardised child developmental assessment tests (CDATs) and 
neurological assessment were used. Neurological examinations have an 
important role in predicting outcome, particularly as later predictive validity of a 
CDAT can be moderate at best.308,309 In encephalitis, acute focal neurological 
signs are associated with worse outcomes at discharge,310 but normal 
neurological examinations at discharge do not exclude long-term problems.255
1.8.1 Child developmental assessment tools (CDATs) in low middle income countries 
(LMICs)
There are two types of CDAT that either assess or screen children’s abilities. 
Screening tools are administered quickly, using a limited sample of items 
representing an area of ability (domain) and rely on pre-determined cut-off points. 
Screening tools are designed to identify children who may have impairment and 
require a comprehensive assessment. However, screening tools have poor utility 
in assessing subtle delays that may have a significant impact on subsequent child
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developm ent.286
In order to characterise a child’s strengths and weaknesses more accurately, or to 
monitor changes over time or due to an intervention, specialised standardised 
CDATs are required.286,311 These require skilled assessors with specific training. 
All CDATs have a threshold that a child must achieve for the assessor to be 
confident that there are no current developmental concerns. A norm-referenced 
test is usually administered in a standardised manner and the individual child’s 
scores in each domain are compared to scores from a large representative 
sample of children of the same age and sex (normative data). Scaled scores allow 
comparison between scales evaluating the same domain and monitoring of 
individuals at different ages.312 However, there are concerns that the rapidly 
changing nature of society means that normative data become out-dated very 
quickly.313 To counter this, inclusion of a control group is now considered crucial 
for research studies, even when the normative population is contemporaneous 
and comes from the same linguistic and cultural background as the study 
population.314
CDATs in LMICs follow one of the following formats: a) a standard western CDAT 
with no adaptations; b) a western CDAT translated (linguistic equivalence) and/or 
adapted for the local cultural environment (cultural equivalence); c) an 
amalgamation of a number of translated and/or adapted items from several 
different western CDAT; or d) a locally developed, culturally specific CDAT 
consisting of original items designed to be relevant to the population of 
interest.315-317 The format of CDAT adaptation depends on criteria set by the 
particular study and whether the study will compare within same cultural groups or 
cross-cultu rally.
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It is important that the original psychometric properties of the western CDAT are 
robust. Developmental domains are a theoretical concept, typically referred to as 
‘constructs’ in the psychometric literature. These cannot be directly measured but 
are inferred through the child’s performance on a number of observed variables 
(test items).318 Reliability is the variability of scores obtained by an individual if 
repeatedly given the same test. There are widely cited levels of acceptable 
reliability for testing319, however the result should be interpreted in context. For 
example, re-test reliability can be influenced by developmental maturation over 
the time interval, or training by the caregiver following mistakes seen in the first 
assessment.320 Validity is the accuracy of the score representing the construct of 
interest.318 There should be sufficient evidence of the CDATs reliability and 
validity as detailed in Table 1.8.
There are no locally normed CDATs in Vietnam. Clinicians and psychiatrists in 
Vietnam use an internationally recognised screening tool called Denver-ll. This 
measures social contact, fine motor skill, language, and gross motor skill. It was 
originally created and validated in Denver, Colorado, USA in 1967 and re­
standardised to the current version in 1990.321 Glascoe et al. evaluated Denver-ll 
in 104 children aged 3-72 months attending day-care centres in the USA.321 They 
found Denver II had a high sensitivity rate (83%), but over half of the normally 
developing children had “abnormal, questionable or untestable” scores. The 
conclusion was to avoid using Denver II till further modifications and research was 
done to improve the psychometric properties of the test, and is currently excluded 
from several US states list of acceptable screening tools.322
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In view of a lack of locally available tools, and the unacceptable high time and 
cost in creating and validating a detailed assessment tool from scratch, the study 
adapted a western CDAT for Vietnam.
A list of mandatory and ideal criteria was created in order to decide which western 
CDAT would be adapted for the study (Table 1.9). Following review of the 
literature on adaptation of CDATs for LMIC275, the “Bayley Scales of Infant and 
Toddler development (3rd edition)” (Bayley III) fulfilled the majority of the criteria, 
despite the high cost of the license fee, equipment and training.
1.8.2 Bayley scales of Toddler and Infant Development, 3rd Edition (Bayley III)
The “Bayley Scales of Infant and Toddler development (3rd edition)” was created 
by Nancy Bayley, who directed the Berkeley Growth study (birth years 1928-1929, 
n=61)323,324 which followed up a birth cohort for 36 years 325 The aim of the study 
was to describe psychological, motor and physical development from birth with 
growing maturity. She devised the ‘California First-year and Pre-school’ 
assessments to evaluate early years development of the cohort.326 The 
experiences from the birth cohort lead to the first edition of Bayley Scales in 1969. 
The scale was then standardised on 1262 American children aged 2-30 months 
(referenced by Niccols et al.)327 This standardization was not from a wide range of 
socioeconomic backgrounds. The significance of this work was recognised in 
1966, with Bayley the first woman to receive the APA Distinguished Scientific 
Contribution Award.328
95
1.8.2.1 Bayley Scales worldwide
The influence of Bayley Scales has been global. Items from Bayley Scales (1969) 
were used to develop Baroda norms, which became widely used in India.329 
Studies in Kenya and the Netherlands also adapted the Bayley for local language 
and culture as an outcome measure.330,331 A paper published in 1986 highlighted 
inflated scores above the mean in 436 low socioeconomic 12 month olds in the 
US.332 This raised concerns that the normalization sample from Bayley (1969) 
was out of date. Subsequently, revisions were made, extra items added and a 
new Bayley Scales of Infant Development (BSID-II) was published in 1993.325 
Fernald et al. reviewed early child development in LMIC and found more than 60 
studies in low-income countries had used Bayley (1969) or BSID-II, mostly without 
detailed adaptation for local use.318 In the UK, the BSID-II was chosen as the 
assessment tool for follow-up of neonatal cohorts in the original population based 
study of survival and later health status in extremely premature infants, Extremely 
Premature Infants Cure (EPICURE) cohort.333 The EPICURE studies continue to 
influence the debate on the limits of viability in perinatal medicine.334
1.8.2.2 Bayley III development
In 2004, the Individuals with Disabilities Education Improvement Act (IDEA) were 
passed in the United States. This law ensures early intervention for children and 
stipulates assessment should occur in five domains: cognitive, language, motor, 
social-emotional and adaptive behaviour.335 Prior to this, the Bayley scales (1969 
and BSID-II) measured a mental development and physical developmental index 
only. The scale was modified to measure the five domains as stipulated by the 
IDEA (2004). The Bayley III standardization was on year 2000 U.S. census- 
stratified sample of 1700 children aged 1 month to 42 months. Children who did
96
not speak or understand English were excluded from the sample.336 The technical 
manual reports detailed data regarding the reliability and validity of Bayley III, with 
additional evaluation of special groups to increase its clinical utility. The special 
groups assessed in validation process were; children with Down’s syndrome, 
pervasive developmental disorder, cerebral palsy, specific language impairment, 
at risk for developmental delay, birth asphyxia, prenatal alcohol exposure, small 
for gestational age and premature or low birth weight. This extensive information 
on Bayley III has continued to support its use and it remains one of the most 
widely used assessment tools for early years development.
1.8.3 Neurological assessment: Amiel-Tison
In severe HFMD, many children under the age of 2 years are affected and are at 
risk of motor developmental problems, hence a standardised examination that can 
monitor children under the age of 6 years is appropriate. One of the most long­
standing and established tools is the Amiel-Tison.337, 338 Recent research 
identified that in extreme pre-term infants (<28 weeks gestation), those identified 
by Amiel-Tison evaluation at 9 months corrected age as having a transient 
neurological abnormality (an abnormality which resolved by 12 months corrected 
age) had lower cognitive and academic skills when aged 5 years compared to 
extreme pre-term infants who had normal neurological examinations at 9 
months.339 This highlights the need for complementary neurological and 
neurodevelopmental assessments, particularly in younger infants at risk of motor 
developmental delay.
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Table 1.9 The m andatory and ideal criteria  used for choosing the tool and 
criteria  fu lfilled by Bayley III
Mandatory Bayley III Ideal Bayley III
L o c a l s e n io r  c l in ic ia n  w ith ✓ C a n  m e a s u re  u p  to  7 X
e x p e r ie n c e  o n  th e  to o l o r y e a rs  o f  a g e
p re v io u s  v e rs io n s .
C a n  b e  a d m in is te re d  b y ✓ E a s y  to  t ra in X
p a e d ia t r ic ia n
M u s t g iv e  d e ta i l  o n  2 -3 ✓ C a n  b e  u s e d  to  g iv e ✓
y e a r  o ld  w h e re  h ig h im m e d ia te  fe e d b a c k  to
p re v a le n c e  o f  H F M D c a re r /p a re n t
A s s e s s m e n t  to o l ✓ L o w  c o s t  o f
l ic e n c e s / t ra n s la t io n  fe e
X
C o g n it iv e ,  la n g u a g e  a n d ✓ In te rn a t io n a l ly  r e c o g n is e d ✓
m o to r
E n g a g e s  p a re n ts ✓
D ire c t  te s t ✓
E v id e n c e  o f  h ig h  d e g re e ✓
o f  r e l ia b i l i t y  a n d  v a l id i ty  in
c o u n tr y  o f  c o n s t ru c t
L a rg e  n o rm a t iv e  s a m p le ✓
in  c o u n tr y  o f  o r ig in a l 
c o n s t ru c t  w ith  n o rm e d  
s c o re s  th a t  c a n  c o m p a re  
c h a n g e s  o v e r t im e /g r o u p s
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1.9 Aim s of thesis
Severe HFMD has emerged as a significant threat to the health of young children 
across the Asia Pacific region. Major outbreaks have overwhelmed healthcare 
systems in several resource-limited regions. For example in China, most regions 
have observed a progressive increase in the numbers of cases of HFMD 
annually; in Guangdong province alone there were 48917, 93067, 226622, 
274006, 330621, and 358068 HFMD cases reported each year from 2008 to 
2013.340 Similarly the 2011 outbreak in Vietnam resulted in over 100,000 cases 
being reported across the country, with 166 deaths.91
As reviewed earlier, the age group predominantly affected is children under 5 
years old, with younger age groups (< 24 months) at risk of more severe disease. 
Development of a number of clinical classification systems, together with the 
introduction of management guidelines for supportive care according to the 
disease grade, has undoubtedly improved survival but there are still no reliable 
early predictors of likely disease progression or poor outcome. Evidence based 
therapeutic interventions are also limited, with supportive treatment remaining the 
mainstay of care. Vaccine development appears promising but is still a distant 
prospect for practical application.
The stereotypic involvement of the brainstem seen on MR imaging and at autopsy 
raises significant concerns regarding long-term neurodevelopmental outcomes in 
these children, with the potential for several of the major domains of development 
to be influenced. The current literature suggests that language development is 
most likely to be adversely affected, particularly in children less than 24 months of 
age at illness onset, but methodological issues such as the absence of a suitable 
control group, and/or lack of validation of standardised tests have hindered
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interpretation of study findings to date. Finally most of the focus on outcomes has 
been on cases with virological confirmation of EV-A71 infection. However, in 
clinical practice, virological confirmation is often not feasible, and a broader 
understanding of the spectrum of outcomes associated with severe HFMD, 
irrespective of the specific pathogen causing the disease, should be informative 
for clinicians managing these children and also give a more accurate picture of 
the true burden of severe disease from a public health perspective. A prospective 
observational study is needed to address these questions.
In this thesis I will present the work I have carried out on severe HFMD (Grade 2a, 
2b and >2b as per Vietnamese Ministry of Health classification) in Ho Chi Minh 
City - aiming first to prospectively evaluate the long-term neurological and 
developmental outcomes in a cohort of Vietnamese children with HFMD, and 
second, to identify MRI changes that are prognostic indicators associated with 
poor outcome. To carry out this work I adapted and validated an internationally 
recognised neurodevelopmental tool, the Bayley Scales of Infant and Toddler 
Development, Third Edition (Bayley III), for use in this population of Vietnamese 
children. The specific hypotheses are as follows:
1. Children affected by severe HFMD (grade 2a, 2b and >2b as per Vietnamese 
Ministry of Health classification) under the age of 4 years have lower cognitive, 
language and motor scores than a comparative group of healthy children, as 
measured by internationally recognised adapted tools and measured a week 
post discharge and at 6 months after discharge.
2. Children with severe HFMD and MRI changes during the acute phase of the 
illness predict lower outcome scores at 6 months after discharge compared to 
severe HFMD children with no MRI changes.
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2. Methods
This chapter outlines the study design and procedures. More detailed statistical 
methods are described in the relevant results chapters.
2.1 In troduction
We designed and conducted an observational cohort study to assess 
neurodevelopmental outcomes at discharge and at 6 months after discharge in a 
sample of children aged less than 4 years admitted to the Hospital of Tropical 
Diseases with severe (>grade 2a) HFMD. The neurodevelopmental outcomes 
were compared to a sample of healthy children from District 8, HCMC. Brain MRI 
from a convenience sample of enrolled HFMD cases was carried out during 
hospital admission.
2.2 Study collaborators
2.2.1 OUCRU-VN
The Oxford University Clinical Research Unit (OUCRU-VN) is a large-scale 
clinical and public health research unit with campuses in Ho Chi Minh City and 
Hanoi in Viet Nam. OUCRU-VN is hosted by the Hospital of Tropical Diseases 
(HTD) in Ho Chi Minh City, and the National Hospital for Tropical Diseases 
(NHTD) in Hanoi. As a Wellcome Trust Major Overseas Programme, OUCRU-VN 
has received considerable support from the Wellcome Trust since its 
establishment in 1991.
The work of the unit covers clinical and public health research and includes work
in immunology, host and pathogen genetics, molecular biology, virology,
mathematical modelling, bioinformatics, biostatistics and epidemiology. This work
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is supported by both a Clinical Trials Unit and Data Management Centre 
(compliant with national and international regulations) and a comprehensive 
Management, Finance and Administrative Centre. OUCRU-VN enjoys the support 
of the Vietnamese government, and works closely with the Ministry of Health Viet 
Nam and the Department of Health of Ho Chi Minh City. We have developed 
strong links with more than 20 Vietnamese hospitals and research institutions 
including HTD, NHTD, The National Institute of Hygiene and Epidemiology 
(NIHE), and Hanoi Medical University.
2.2.1.1 Clinical Trials Unit
Our Clinical Trials Unit (CTU) supports governance and operational management 
of all OUCRU-VN research. The CTU is responsible for ensuring that all research 
is conducted efficiently, accurately and in compliance with the applicable 
international and local regulations including the World Medical Association 
Declaration of Helsinki (2008) and the International Conference on Harmonization 
guidelines of Good Clinical Practice (1996) (GCP). The CTU is a multi-disciplinary 
group which functions as a coordinating centre to manage research at dozens of 
national and international research sites. Ethical and regulatory approval, logistics 
and human resources management, control of investigational medicinal products 
and clinical trials monitoring are all activities of focus for the CTU. The CTU works 
to increase the research capacity in all countries which host OUCRU-VN research 
by delivering training in protocol procedures, GCP Guidelines, human subjects 
ethics and research operations.
The Research Ethics Committee of each participating site must approve all clinical 
research before the research is initiated. The Oxford Tropical Research Ethics
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Board additionally reviews OUCRU-VN work internationally. The Ethical 
Committee of the Viet Nam Ministry of Health must also review clinical drug trials. 
The relevant ethics committees before use will approve the study protocol, 
informed consent form, all patient materials and any amendments to these 
documents.
2.2.1.2 Data Management
OUCRU has a Data Management and Information Technology Group (comprised 
of an IT Manager, Data Manager, Data Programmers and Data Entry Team) 
which is responsible for the overall design, implementation, and monitoring of 
clinical databases for clinical trials. In addition, the group provides technical 
support for computer installations, internet connections and communications 
technology. This group is experienced at managing large and complex 
multidisciplinary datasets to international regulatory standards. The core 
application we use for managing databases in clinical trials is the CliRes Data 
Management System. This centralised system was developed at OUCRU and is 
based on international regulatory standards such as ICH Good Clinical Practice 
and FDA regulations. The system supports both paper-based and electronic data 
collection methods. The major supporting tools within the system include multiple 
language interface, data validations, double data entry discrepancy triggers and 
audit trails for data changes.
2.2.1 Hospital for Tropical Diseases
The Hospital for Tropical Diseases, founded in 1862 was originally a private 
hospital built from community funds and donated to the Vietnamese government
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in 1865. It was originally named Cho Quan Hospital after the local village and a 
hospital for the treatment of sick prisoners and patients with venereal diseases. In 
1904 a Psychiatric wing was added and focused on leprosy and neurological 
conditions until it was taken over by the army in 1954 and named the Ngo Quyen 
Institute for Tuberculosis.
Construction of the main hospital block began in 1972 in cooperation with the 
government of South Korea opening in 1974 as the Vietnamese-Korean Medical 
Centre (522 beds) comprising wards for contagious disease, leprosy, psychiatry, 
internal medicine, surgery and paediatrics. In 1975 it was taken over by the 
Military Managing Committee of Saigon and reverted to the name Cho Quan 
Hospital. Following a decision by the Ministry of Health it became the first hospital 
specialising in infectious diseases in Viet Nam and given the responsibility for the 
prevention and treatment of epidemic infectious diseases for Ho Chi Minh City 
and the provinces of the old zone (B2). It was named the Centre for Tropical 
Medicine in 1989 and subsequently named the Hospital for Tropical Diseases 
under the direction of the Health Service of HCMC. It now has approximately 600 
in-patient beds dedicated to infectious diseases, we believe the largest such 
dedicated hospital in the world. The Hospital continues to have responsibility for 
advice on all aspects of infectious diseases for the south of Viet Nam a catchment 
population of over 40 million people.
2.2.2 Children's Hospital 1 (CHI)
Children’s Hospital 1 (CH1) is one of two major paediatric centres in the city. The 
hospital opened in 1956 with 268 beds, but has expanded considerably over the 
years to meet increasing need. It now has 1000 in-patient beds on 17 clinical
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wards and employs over 1200 staff; in excess of 3500 children are seen each day 
in the 35 outpatient clinics on site. Together with Children’s Hospital 2, the 
hospital offers specialist paediatric care to the 10 million children of southern Viet 
Nam, covering the full range of medical and surgical disorders seen in the region, 
as well as providing leadership and training in paediatric diagnosis and 
management throughout the southern provinces via well developed outreach 
programmes. The hospital has a long tradition of involvement in clinical research, 
and over the last 10 years we have developed a very successful series of 
collaborations focused on common and serious local problems such as dengue, 
encephalitis and influenza. The research programme was recently consolidated 
with the opening of a Clinical Trials Unit on site at CH1 enabling the execution of 
major research studies, in particular intervention studies, in the future.
2.2.2.1 Dr Thanh: Retired Head of Psychology department (CH1)
Dr Thanh, a paediatrician and psychologist, set up the Psychology department at 
Children’s Hospital 1. She has collaborated with several international institutions 
in research and also set up a Masters course in Psychology at the Pham Ngoc 
Thach Medical University, HCMC. She has prior experience using the Bayley 
scales of infant development 2nd edition (BSID II) through verbal translation. Dr 
Thanh has led translation and adaptation of other child developmental tests 
including the A Developmental NEuroPSYchological Assessment (NEPSY II). Dr 
Thanh has also translated parental guidance books from French and English into 
Vietnamese. She presents at International Conferences in Thailand on child 
psychology in HIV children. She is widely respected as an expert in the field in 
Vietnam.
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2.2.3 Hung Vuong Maternity Hospital
Hung Vuong Hospital was built in 1900 as a 60 bed maternity hospital, which has 
expanded to 800 bed capacity. It is now the regional tertiary-level referral centre 
for obstetrics with over 200 deliveries a day. It has the highest technical facilities 
for 24 districts in HCMC. It has a history of international collaboration and is a 
centre for postgraduate medical study and specialisation.
2.2.4 District 8 Preventive Medical Centre
The Preventive medical centre (PMC) in District 8, HCMC was set up in 2007 
superseding the previous District 8 Health centre. Its aim is to prevent HIV, 
sexually transmitted diseases, communicable diseases in the community. It 
supports health communication in the community, including schools and 
kindergartens. It is under the control of the People’s Committee of district 8.
2.2.5 Medic MRI centre
Medic centre was established in 1990. Its main focus is on diagnostic imaging 
with X-ray, ultrasound, computerised tomography (CT) scans and MRI machines. 
The Toshiba Access LPT6.0 open MR Imager was installed in 1996 and was the 
first MR Imager installed in Vietnam. The centre carries out approximately 50 MRI 
scans a day with a team of 16 doctors, 5 nurses, 3 technicians and 2 
transportation staff.
2.3 Ethical approval
The Oxford Tropical Research Ethics Committee and the Institutional Review 
Boards of The Hospital for Tropical diseases and Children’s Hospital 1, Ho Chi
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Minh City (HCMC), approved this study. ClinicalTrials.gov Identifier: 
NCT02066714
2.4 P artic ipan ts
2.4.1 Pilot study
Prior to the main study, a pilot study was carried out on a convenience sample of 
42 children whose parents worked at the Oxford University Clinical Research Unit, 
HCMC. This was to evaluate the adaptation of Bayley III as per guidance by the 
International Test commission.341 The parents volunteered and gave consent for a 
video to be recorded during the assessment for training and for reliability 
evaluation. Children were aged <4 years, had no prior known chronic medical 
problems (e.g. congenital heart disease, epilepsy, HIV), had no prior learning 
disability or developmental regression and were believed to be developing 
normally.
2.4.2 HFMD study
Two cohorts were recruited to the main study. The first was the HFMD group and 
the second was the healthy group in HCMC. They were recruited in parallel.
2.4.2.1 HFMD cohort
The HFMD cohort was recruited from the Hospital of Tropical Diseases (HTD). 
Children were HFMD classified (Vietnamese Ministry of Health Guidelines Table
1.4) by the admitting clinician. The children with Grade 2a disease are admitted to 
paediatric ward C and those with Grade 2b or more are admitted to the Paediatric 
Intensive Care Unit (PICU). All children aged less than 4 years were approached
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about the study. Those who were ex-premature (<37 weeks gestation), or had 
previous PICU admission irrespective of ventilation, chronic illness requiring 
medication or repeated hospitalisation (congenital heart disease, epilepsy, HIV), 
or prior learning disability or developmental regression, were excluded from the 
study.
All enrolled HFMD cases were approached about participating in a research 
brain MRI scan. The children had a history of more than day 5 of illness (defined 
from fever onset), judged by the treating physician to be stable for transfer to 
another unit for the MRI and had no known history of complications or reactions 
to sedation.
2A .2.2 Deciding where to recruit Healthy cohort
HTD is a tertiary level referral hospital for infectious diseases for southern 
Vietnam and we needed to identify a suitable population from which we could ask 
volunteers as healthy cohort. HTD routinely collects demographic data on all 
admissions in a centralised database. Due to the high volume of HFMD cases in 
2011, a task force of clinicians was assembled to target schools, kindergartens or 
areas with high numbers of HFMD cases. The task force identified that rapid 
transmission occurred within informal nurseries. These are unregulated child-care 
provisions, usually in a home with high number of children and poor sanitation 
facilities. Most of these were located in District 8, HCMC, close to HTD. Using the 
information from this database, we chose to recruit the healthy cohort from district 
8, where the most frequent admissions to HTD with HFMD occurred.
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2.5 Study sites
2.5.1 Pilot study
The Pilot study recruited volunteers from friends and family who had affiliations 
with OUCRU. Assessments were done following consent at OUCRU.
2.5.2 HFMD cohort
The HFMD cohort was recruited from admissions to the ward or PICU with HFMD 
from July 2013 till December 2014 as per inclusion criteria.
2.5.3 Healthy cohort
2.5.3.1 Kindergartens district 8
The PMC selected 3 kindergartens where the study could be conducted on the 
basis of good relationships with the administrative teams. Two were government- 
run, Tuoi Ngoc and 19 Thang 5, and the third was private, Hoang Mai. Tuoi Ngoc 
is a government school of 700 children from 18 months to 5 years old. 19 thang 5 
kindergarten has 600 children up to the age of 6 years. Hoang Mai kindergarten is 
a private kindergarten with 587 children aged 24 - 60 months. At all three 
kindergartens, volunteers were chosen by the school nurse or principal. 
Assessments took place at the kindergartens, unless the school was closed for 
holidays and then assessments took place at OUCRU.
2.5.3.2 Hung Vuong Hospital Birth Cohort
Oxford University Clinical Research Unit (OUCRU) collaborates with Hung Vuong 
Hospital to enrol mothers delivering and babies born in a birth cohort. The cohort 
inclusion criteria include residing in District 8, HCMC. There are regular study 
visits for blood sampling at 4, 9 and 12 and 18 months after birth plus access to
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study medical care whenever the child is unwell. The birth cohort study records 
sibling data of those enrolled. At the birth cohort study visits, information about the 
neurodevelopmental study was discussed with the parent/guardian. They were 
asked if they were willing to consider for any of their children to participate in the 
neurodevelopmental study. All assessments took place at OUCRU.
2.5.33 District 8 ward clinics
The ward clinics are the government primary care services for the region including 
vaccination. These are run by the Preventive Medical Centre in District 8. The 
PMC selected three ward clinics for us to approach for study participants, based 
on previously working together with OUCRU and having good leadership systems 
that could manage the additional workload of the study. We visited the clinics on 
immunisation days and spoke to parents about the study. Parents who were 
interested wrote down their details to be contacted by the study team. 
Assessments took place at the ward clinic, unless rooms were in use and then 
participants came to OUCRU.
2.6 Outcome measures used in  the study
2.6.1 Bayley Scales of Infant and Toddler Development
The Bayley Scales of Infant and Toddler Development, 3rd Edition (Bayley III) has
6 subtests; cognitive (91 items), receptive language, expressive language, fine
motor and gross motor plus adaptive behaviour (241 items). Each item is scored
as 1 or 0, and the item should be observed by the assessor and not from the
history of the parents. Start points are set according to 14 age categories. These
were calculated from the US standardization sample, where the start item had a
95% pass rate for the age group. This was done to limit extensive testing.336 The
child needs to pass the first three items following the start point to continue,
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otherwise the child goes back to the previous start point and again follows the rule 
of passing the first three items to continue. The child continues till the child fails 5 
consecutive items, which is considered the ceiling of the child’s abilities. Raw 
scores are converted to standard scores based on US norms, which have a mean 
of 10 and standard deviation of 3. The study team translated and adapted the tool 
as per international test commission guidance.341 Cognitive, motor and language 
domains were evaluated at two time points, six months apart.
2.6.2 Amiel-Tison neurological Examination (HFMD cohort)
The Amiel-Tison is a comprehensive neurological examination which evaluates 
the Passive muscle tone, motor activity, primitive reflexes and gross motor skills 
up to the age of 6 years.338 It was designed to evaluate neurological maturation of 
infants from birth and stratify risk of cerebral palsy and hence following a birth or 
prenatal insult. It has been used in research to evaluate premature, low-birth 
weight infants and those with hypoxic ischaemic events.342"344 Even when used for 
research in premature infants, the tool has been modified. Leroux et al. modified 
the tool to evaluate preterm infants and reported: “we have combined some items 
into a single item (i.e. head circumference, anterior fontanels, squamous sutures 
and other sutures were combined into cranial morphology). Moreover, seven 
items were not analysed because they were previously described as poorly 
informative owing to their rarity (ocular signs, seizures, Moro reflex and 
fasciculation of the tongue), lack of relevance in preterm infants (high arched 
palate) or poor interobserver reproducibility (palmar grasp and asymmetric tonic 
neck)”344
This study evaluated children at risk of a motor impairment due to an insult mainly 
after the neonatal period. Hence, the Amiel-Tison was modified to remove items
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more specific to neonatal insults such as head circumference growth, high arched 
palate and ocular signs. The motor milestones included in the Amiel-Tison 
assessment were unnecessary as the Bayley’s motor domain is an objective 
measure.
When researching neurological assessment tools for early childhood, I discussed 
options and experience with Professor Marlow, who led the EPIcure study.333 The 
main concern was finding a detailed tool that could monitor children up to the age 
of 6 years. It was only the Amiel-Tison that had this facility and hence, with 
exclusion of items specific to neonatal insults, the scoring system was the same. 
Table 2.1 compares the original scoring system to the new scoring system, 
highlighting omission of some sections with expansion of objective assessments 
(Tables 2.2-2.4).
I taught the Amiel-Tison to the hospital team and one doctor, interested in 
neurology, carried out the neurological assessments with me.
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5
Table 2.2 Expanded definition of neurological abnormalities age 3-9 months
Sections Score 2 Score 1 Score 0
A) Passive muscle tone
Lower limbs
• Adductors No resistance Age dependent angles Age dependent
• popliteal angle 
right
No resistance Age dependent angles Age dependent
• popliteal angle 
left
No resistance Age dependent angles Age dependent
Slow angle
• Dorsiflexion of 
foot right
>=110 90-100 =<80
• Dorsiflexion of 
foot left >=110 90-100 =<80
Rapid angle
• Dorsiflexion of 
foot right
Tonic stretch Phasic stretch Identical
• Dorsiflexion of 
foot left
Tonic stretch Phasic stretch Identical
Upper limbs
• Hand right
Inactive 
thumb/constantly 
closed hand
Finger movements 
present
• Hand left Inactive 
thumb/constantly 
closed hand
Finger movements 
present
• Scarf sign right Positionl (age>6m) 
No resistance
Positionl (age3-6m)- Position 2/3
• Scarf sign left Positionl (age>6m) 
No resistance
Positionl (age3-6m)- Position 2/3
B) Comparison of left right side /left side 
more tonic
none
and right side
C) Body axis
• Dorsal 
extension
excessive Moderate/minimal
• Ventral flexion excessive absent Moderate
• Comparison of 
curvatures
rag doll flexion<extension extension=<flexion
D) Diffuse rigidity Lead pipe 
resistance
none
E) Motor activity
• Face - insufficient Varied and symmetrical
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Sections Score 2 Score 1 Score 0
Facial paralysis Present - Absent
• Fasciculation of 
tongue
Present Absent
• Limbs
• Spontaneous 
movements
Barely present or 
uncoordinated
Insufficient or 
uncoordinated
Coordinated and varied
• Involuntary 
movements
Present Absent
• Dystonia Present - Absent
F) Deep tendon and 
cutaneous reflexes
• Bicipital reflex 
(R/L)
Absent/clonus Very brisk Normal
• Knee reflex Absent/clonus Very brisk Normal
G) Primitive reflexes:
• Asymmetric 
tonic neck reflex
Present (>6m) Absent
• sucking Absent or 
inadequate
Insufficient present
• Moro reflex Present (>6m) - Absent
• grasping reflex Present (>6m) - Absent
• automatic 
walking reflex
Present (>6m) Absent
H) Gross motor 
function
• Sitting position - Falls backwards (>6m) No abnormality
• Standing 
position
Excessive extension No abnormality
• Lower limb 
deformities
Scissoring of legs No abnormality
Total 8 sections of which score 2 exists in 7 sections and score 1 in 7 sections.
Severe deficit: score of 2 in at least 3 of 7 sections
Moderate deficit: score of 1 in at least 3 of 7 sections and up to two 2 in any section.
Mild abnormality: a score of 1 in at least 2 of 7 sections
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Table 2.3 Definition of neurological abnormalities age 10-24 months
Sections Score 2 Score 1 Score 0
A) Passive muscle tone
Lower limbs
• Adductors =<70 80-100 >=110
• popliteal angle 
right
=<80 90-100 >=110
• popliteal angle 
left
=<80 90-100 >=110
Slow angle
• Dorsiflexion of 
foot right
>=110 90-100 =<80
• Dorsiflexion of 
foot left >=110 90-100 =<80
Rapid angle
Dorsiflexion of 
foot right
Tonic stretch Phasic stretch Identical
• Dorsiflexion of 
foot left
Tonic stretch Phasic stretch Identical
Upper limbs
• Hand right Inactive 
thumb/constantly 
closed hand
Finger movements 
present
Hand left Inactive 
thumb/constantly 
closed hand
Finger movements 
present
• Scarf sign right Position 1 - Position 2/3
Scarf sign left Positionl - Position 2/3
B) Comparison of left
right side /left side 
more tonic
none
and right side
C) Body axis
• Dorsal 
extension
excessive Moderate/minimal
Ventral flexion excessive - Moderate/minimal
• Comparison of 
curvatures
rag doll flexion<extension extension=<flexion
D) Diffuse rigidity Lead pipe 
resistance
none
E) Motor activity
• Face - insufficient Varied and symmetrical
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Sections Score 2 Score 1 Score 0
• Drooling - Present Absent
• Facial paralysis Present - Absent
• Fasciculations 
of tongue
Present Absent
• Limbs
• Spontaneous 
movements
Barely present or 
uncoordinated
Insufficient or 
uncoordinated
Coordinated and varied
• Involuntary 
movements
Present Absent
• Dystonia Present - Absent
F) Deep tendon and 
cutaneous reflexes
• Bicipital reflex 
(R/L)
Absent/clonus Very brisk Normal
Knee reflex Absent/clonus Very brisk Normal
• Cutaneous 
reflex
Extension (after 12 
months)
flexion
G) Primitive reflexes: 
Asymmetric tonic neck 
reflex
Present Absent
H) Postural Reactions
• Lateral propping Absent Incomplete Present
Parachute
reaction
Absent/incomplete Present
1) Gross motor function
• Sitting position Falls
forward/backwards
No abnormality
• Standing 
position
Excessive extension No abnormality
• Lower limb 
deformities
Scissoring of legs No abnormality
Total 9 sections of which score 2 exists in 8 section and score 1 in 7 sections.
Severe deficit: score of 2 in at least 4of 8 sections
Moderate deficit: score of 1 in at least 3 of 7 sections and up to two 2 in any section.
Mild abnormality: a score of 1 in at least 2 of 7 sections
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Table 2.4 Definition of neurological abnormalities age 24-60 months
Sections Score 2 Score 1 Score 0
A) Passive muscle tone
Lower limbs
• Adductors =<30 or no 
resistance
40-90 >100
• popliteal angle 
right
=<90 or no 
resistance
90-100 120-160
• popliteal angle 
left
•
=<90 or no 
resistance
90-100 120-160
Slow angle
• Dorsiflexion of 
foot right
>=110 90-100 =<80
• Dorsiflexion of 
foot left >=110 90-100 =<80
Rapid angle
Dorsiflexion of 
foot right
Tonic stretch Phasic stretch Identical
• Dorsiflexion of 
foot left
Tonic stretch Phasic stretch Identical
Upper limbs
Hand right Inactive 
thumb/constantly 
closed hand
Finger movements 
present
• Hand left Inactive 
thumb/constantly 
closed hand
Finger movements 
present
• Scarf sign right No resistance Positionl Position 2/3
• Scarf sign left No resistance Positionl Position 2/3
B) Comparison of left right side /left side 
more tonic
none
and right side
C) Body axis
Dorsal
extension
excessive Moderate/minimal
• Ventral flexion excessive - Moderate/minimal
• Comparison of 
curvatures
rag doll flexion<extension extension=<flexion
D) Diffuse rigidity Lead pipe 
resistance
none
E) Motor activity
Face
• Facial
expressions
insufficient Varied and symmetrical
• Drooling Present - Absent
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Sections Score 2 Score 1 Score 0
• Facial paralysis Present - Absent
• Fasciculations 
of tongue
Present Absent
Limbs
• Spontaneous 
movements
Barely present or 
uncoordinated
Insufficient or 
uncoordinated
Coordinated and varied
• Involuntary 
movements
Present Absent
• Dystonia Present - Absent
F) Deep tendon and 
cutaneous reflexes
• Bicipital reflex 
(R/L)
Absent/clonus Very brisk Normal
• Knee reflex Absent/clonus Very brisk Normal
Cutaneous
reflex
Extension (after 12 
months)
flexion
G) Primitive reflexes: 
Asymmetric tonic neck 
reflex
Present evident Present elicited 
(> 5years)
Absent
H) Postural Reactions
• Lateral propping Absent Incomplete Present
• Parachute 
reaction
Absent/incomplete Present
1) Gross motor function
• Holding head 
behind the axis
Abnormality present Abnormality absent
• Poorly
maintained head 
control due to 
fatigue
Abnormality present Abnormality absent
Sitting position Falls
forward/backwards
No abnormality
• Standing 
position
Excessive extension No abnormality
• Lower limb 
deformities
Scissoring of legs No abnormality
Total 9 sections of which score 2 exists in 8 section and score 1 in 7 sections.
Severe deficit: score of 2 in at least 4 of 8 sections
Moderate deficit: score of 1 in at least 3 of 7 sections and up to two 2 in any section.
Mild abnormality: a score of 1 in at least 2 of 7 sections
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2.6.3 Brain MRI scans (HFMD cohort)
The MRI centre was 5km from the hospital. Each child had a 1.5 Tesla MRI with 
as much of the following sequence which was feasible: Sagittal T1WI, Axial T2 
Wl, Axial T2 FLAIR and Axial diffusion weighted scans. Cuts were made at 5- 
5.5mm/1.5mm.
2.6.4 Virological samples (HFMD cohort)
Throat and rectal swabs were collected in viral transport medium, divided into 
three aliquots and stored at -80 °C until analysis. Thanh et al. describe primers 
and probes for enterovirus (EV) and enterovirus-A71 (EV-A71).345 140 pi of 
culture supernatant/throat/rectal swabs in viral transport medium was mixed with 
20 pi of EAV (a non-human internal control virus) and total nucleic acid was 
extracted using the QIAamp Viral RNA Mini Kit (QIAgen GmbH, Hilden, 
Germany), eluted in 100 pi elution buffer and stored at -80 °C.
Real-time RT-PCR was done using the SuperScriptR III One-Step qRT-PCR 
system with PlatinumR Taq DNA Polymerase (Invitrogen, Carlsbad, CA, USA) and 
was performed in a LightCycler 480 II machine (Roche Diagnostics GmbH, 
Mannheim, Germany). 345
To maximise yield of detection, throat swabs were initially screened for EVs/EV- 
A71 and only the cases with a negative throat swab had the rectal swab tested.
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2.7 Procedures
2.7.1 HFMD cohort
Children who met the Vietnamese Ministry of Health Grade 2 criteria were 
admitted to hospital. Grade 2a were admitted to Children’s Ward C (Nhi C) for 
observation. If they progressed to features of Grade 2b then they were transferred 
to the Paediatric Intensive care unit (PICU).
In ward C, standard of care consists of 4-hourly observations of heart-rate, 
respiratory rate and temperature. Day of illness is defined as from start of fever. 
Children were observed for up to day 7 of illness.
If the disease severity of a child was grade 2b or higher, children were admitted to 
PICU. The children received intravenous phenobarbital daily (dose: 10mg/kg) and 
had continuous non-invasive monitoring of heart rate, respiratory rate and 
continuous pulse oximetry monitoring oxygen saturations. Arterial lines are 
inserted according to guidance on normal and abnormal manual blood pressure 
measurements and clinical concern of disease progression.
Grade 2b cases receive one or two doses of intravenous immunoglobulin if the 
child has one or more of the following; irregular breathing pattern, hypertension, 
cranial nerve palsies, limb weakness, sustained observed myoclonus.
Grade 3 and 4 children receive supportive care as necessary, including; 
intravenous milrinone with or without intravenous magnesium sulphate (as part of 
an on-going intervention trial) to treat hypertension, nasal continuous positive 
airway pressure or mechanical ventilation for apnoea or respiratory insufficiency, 
or haemofiltration for persistent hyperpyrexia or hypertension unresponsive to first 
line medication (milrinone and magnesium sulphate).
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2.7.1.1 Approaching participants: recruitment by ward doctors during normal working 
hours
Grade 2a and 2b participants were approached as soon as possible after 
admission. Grade 3 and 4 cases are approached during recovery phase. This is 
the most appropriate time for the doctors to discuss long-term follow-up of these 
cases.
2.7.1.2 Consent fo r HFMD participants
HFMD participants enrolled consented to virology rectal and throat swabs, 
completion of the neurological examination and neurodevelopment schedule. 
Participating in the MRI sub-study was optional.
2.7.1.3 Virology samples
Throat and rectal swabs for EV and EV-A71 RT-PCR345 were collected in 1ml viral 
transport medium (VTM) on the day of enrolment from all participants as part of 
the study. Both swabs were analysed as described previously in section 2.5.4. If 
either throat or rectal swab was virus positive, the child was classified as positive 
for the specific virus identified. All EV positive samples were further characterised 
and typed byVP1 and/or whole genome sequencing.346 Routine clinical 
diagnostic EV and EV-A71 RT-PCR is carried out on all cases >Grade 2b as part 
of standard of care. These results were also collected in the case record form 
(CRF). Patients with grade 3 and 4 disease were enrolled to the study when they 
were in stable condition, often more than a week after admission. Both research 
RT-PCR results and hospital RT-PCR were taken into account for final
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aetiological diagnosis and discrepant results were independently scored by two 
senior researchers.
2.7.1 A  M RI o f HFMD participants
This aspect of the study was additional and optional. Scans were carried out 
when the responsible clinician deemed the patient at very low risk of progression 
of disease (> day 5 illness). There is no MRI scanner at HTD. The nearest private 
facility is 5 km away.
PICU doctors trained in paediatric resuscitation and a nurse accompanied up to 
two children to the MRI centre in an ambulance. I organised a resuscitation kit for 
transportation and the child was monitored en route to scan and back with a small 
portable oxygen saturation and heart rate monitor.
The doctor at the MRI centre currently uses the following intravenous regimes to 
sedate patients:
• <3 year: Thiopental sodium (dose up to 5mg/kg)
• >3 year: Propofol (2mg/kg of 0.5%)
• Consider midazolam (dose 0.1 mg/kg) as necessary
The patient was attached to a non-invasive saturation monitor and a clinician 
trained in resuscitation observes the patient during the scan.
The child was monitored by clinical observation and an MRI compatible pulse 
oximeter. If the child was not cooperative, the scan was abandoned and not 
repeated. After the scan the child was observed for 30 minutes to 1 hour as
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needed before being transferred back to the hospital by ambulance, 
accompanied by the doctor and nurse.
2.7.1.4.1 Interpretation of brain MRI scans
The Medic centre has radiologists which report scans immediately. These results 
were fed back to parents and clinically acted upon as appropriate. For the study, 
a consultant paediatric neuroradiologist, Dr Kling Chong at Great Ormond Street 
Hospital in the United Kingdom, reviewed the scans. Dr. Chong was informed of 
the age of the child but was not aware of the severity of the child’s illness. A 
proforma (Table 2.2), which included specific regions listed according to the 
literature, was used to document MRI changes.
Table 2.5 Proform a to document Brain MRI changes
Regions with abnormality
MRI sequence
T1W T2W FLAIR DWI
Posterior aspect of medulla oblongata,
dorsal/caudal, left or right
Posterior aspect of pons
Ventricle dilatation or abnormality
Periventricular region
Midbrain: specify location
dentate nuclei of cerebellum
Globus pallidus
Anterior commissure
Hypothalamus
Thalamus
Putamen
Cervical spinal cord 
Deep White Matter changes 
Subcortical white matter 
Diffuse changes 
Other comments
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2.7.1.5 Case record form for HFMD participants
A case record form (CRF) (Appendix 1) recorded clinical and demographic data of 
the enrolled child from enrolment, daily observation and neurological review and 
discharge. The HFMD grade was determined by the admitting clinician (Table
1.4). The CRF does not specify the criteria from Table 1.4 for the clinician to 
allocate the grade, to avoid retrospective bias of interpreting documentation from 
clinical notes. The clinical features listed on the CRF are from enrolment. The day 
of enrolment may not be the day of admission and features identified on 
admission may not persist till enrolment.
Daily neurological examination included evaluation of consciousness using the 
Blantyre coma scale. Blantyre coma scale is a modification of the Glasgow coma 
scale and is suitable to use in preverbal children. The scale uses motor and crying 
responses to pain and includes the ability to watch. It was developed for children 
with cerebral malaria in Malawi.347 (Table 2.6) It has been used in assessing and 
monitoring coma in children due to meningitis and encephalitis in LMICs.348"350
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Table 2.6 Blantyre Coma Scale
Response Findings Scores
Best motor Localises painful stimulus (pressure with blunt end of pencil 2
response on sternum or supraorbital ridge)
Withdraws limb from painful stimulus (pressure with 1
horizontal pencil on nail bed of finger or toe)
No response or inappropriate response 0
Best verbal Cries appropriately with painful stimulus or if verbal speaks 2
response
Moan or abnormal cry with painful stimulus 1
No vocal response to painful stimulus 0
Eye movement Watches or follows (e.g. mother's face) 1
Fails to watch or follow 0
The study nurse completed the socioeconomic aspects of the CRF. Further 
details of data collected are described in 2.7.2.5.
2.7.1.6: First follow-up at 7-10 days post discharge
Patients were requested to come back for the first review 7-10 days after 
discharge. This period after discharge was to ensure the effect of phenobarbital 
(half-life 20-80 hours depending on the age)351 does not affect performance on 
the neurodevelopmental examination.
The neurological examination and neurodevelopmental assessments were carried 
out in a research clinic held above the PICU (Figure 2.1). The room had blinds for
privacy, in a quiet area and had child friendly table and chairs. There were stairs
and space outside to evaluate gross motor skills.
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Figure 2.1 Picture of assessment room in clinic above PICU
2.7.1.7 Six month follow-up visits
Six month follow-up appointments were arranged with a dedicated study nurse 
who also supported families regarding general health advice and concerns about 
their child. Neurodevelopmental and neurological examinations were carried out 
at the 6 month visit.
Parents or carers were present during the assessment. Allied health workers were 
not informed of the results but the parents were informed of areas of strength and 
weakness. Children with concerns were reviewed by a Vietnamese paediatrician 
and psychologist, and referred to available resources as necessary.
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2.7.2 Healthy cohort
2.7.2.1 Kindergartens
The study team carried out talks to all parents and teachers at the kindergartens. 
Leaflets about the study were handed out (Appendix 2). The principal and nurse 
at each school collected a list of names of volunteers and passed the contact 
details to the study team. Assessments were carried out in a private room at each 
kindergarten.
2.7.2.2 Hung Vuong hospital
Birth cohort study nurses approached participants, informing them of the 
neurodevelopmental study. The study nurses asked mothers whether they would 
be willing to be contacted for further information about participation in this second 
study. If they agreed, the details of the child, parents’ contact details and any 
siblings’ details under 4 years were passed weekly to the neurodevelopmental 
study team. Hung Vuong participants came to OUCRU for assessments.
2.7.2.3 Ward clinics
The ward clinics staff both phoned the parent, or hand delivered letters to the 
home to inform of the study and arranged a meeting of invited parents with the 
study team at the clinic. This meeting gave the study team time to discuss the 
project and answer questions and distribute leaflets. Any one who agreed to 
participate was approached about the study.
2.7.2.4 Consent fo r Healthy participants
Healthy participants enrolled consented to completion of the neurodevelopment 
schedule and demographic and socioeconomic information in the CRF.
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2.7.2.5 Case Record Form fo r Healthy participants
A case record form (CRF) recorded demographic data of the enrolled child from 
enrolment. The study nurse completed the socioeconomic aspects of the CRF, 
which included maternal education levels. Johnson et al. highlight higher 
socioeconomic status is known to improve academic attainment in infants in 
western studies.352 Hillemeier et al. found low maternal education was a strong 
predictor of developmental delay in 7,200 US infants between 24-48 months.353 
Walker et al. review the evidence of the positive effects of higher maternal 
education in low and middle income countries.354
2.7.2.6 First assessment a t enrolment
The neurodevelopmental assessments were carried out in a room at OUCRU for 
the Hung Vuong cohort, at a private room at the ward clinics or kindergartens. 
There was space outside to evaluate gross motor skills.
2.7.2.7 Six month follow-up visits
Six month follow-up appointments were arranged with a dedicated study nurse 
who also supported families regarding general health advice and concerns about 
their child. Neurodevelopmental assessments were carried out at the 6 month 
visit.
Parents or carers were present during the assessment. Teachers and allied health 
workers were not informed of the results but the parents were informed of areas of 
strength and weakness. Children with concerns were reviewed by a Vietnamese 
paediatrician and psychologist, and referred to available resources as necessary.
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2.8 Sample size calculations
Calculation of sample sizes required estimation of the prevalence of severe 
HFMD grades and the rates of disease progression. Prospective epidemiological 
data on the prevalence and age ranges from a recent outbreak in Vietnam was 
used86.
Sample size was determined based on feasibility considerations and the power 
calculations outlined below. The ideal sample size to ensure the significance and 
sample sizes stratified across severity groups described below was up to 250 
grade 2a and 2b participants and up to 100 grade 3 and 4 participants recruited.
2.8.1 MRI findings in HFMD
There are limited published data on MRI findings in EV-A71 HFMD. One previous 
retrospective study of MRI scans in 24 patients, found changes in 13 cases who 
clinically presented with myoclonus. The equivalent clinical grading would be 
Grade 2b.355 This gives a plausible range of 30-70% MRI abnormalities in the 
population of grade 2b children (95% confidence interval for observed proportion 
24/13 (54%) in a population of 24 is 32%-74%). The data from Children’s Hospital 
1 showed that amongst patients who reached Grade 2b, 25% subsequently 
progressed to Grade 3 or 4.86
A sample size of 100 children with Grade 2a and 100 children with Grade 2b with 
MRI scans provides 80% power to detect a difference between the proportion of 
children with abnormal MRI in grade 2a vs. grade 2b of 14% vs. 30% (the lower 
estimated range of Grade 2b’s with MRI changes) or of 50% vs. 70% (the higher
132
estimated range of Grade 2b’s with MRI changes).
2.8.2 Neurodevelopment
We aimed to include up to 350 children with HFMD grade 2a, 2b, >2b, and 350 
healthy children (age range similar to Grade 2a) and follow them up at enrolment 
and 6 months follow-up.
The Bayley scoring system has a mean score of 100 with a standard deviation 
(SD) of 15 in healthy children from the US. Based on this, we assumed an SD of 
approximately 15 in all 5 study populations. As little is known about within-child 
longitudinal changes in Bayley scores over time, power considerations were 
based on pair-wise comparisons between groups at each time point separately. 
With the sample sizes given, there would be 80% power at the two-sided 5% 
significance level to detect differences in mean scores of - 7.4 or larger between 
grade 2a or 2b children compared to grade >2b.
2.9 D ata analysis
2.9.1 Data management
All participants had allocated study codes and data entered in a dedicated case 
record form (CRF). This was double data entry into an online secure system 
standard at OUCRU. The assessor entered Bayley III data into a secure online 
data entry system. I entered the neurological examinations into the online data 
management system.
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2.9.2 General statistical methods
Standard data summaries such as median (inter-quartile range) for continuous 
variables and frequency (%) for categorical variable together with graphical 
summaries (histograms, boxplots and scatterplots) were used for descriptive 
analyses in all studies. Analysis was undertaken using R version 3.0.1.356 For 
binary data, Fisher’s exact test was used. For categorical and non-parametric 
data, the Wilcoxon rank-sum test was used. Results were significant at a level of 
p<0.05.
2.9.3 Analysis plan of Bayley adaption 
2.9.3.1 Reliability
The seven trained assessors independently scored 18 videos from the pilot study 
for evaluation of inter-observer reliability.
Test and retest was carried out in a convenience sample from the main study.
Parents recruited in the healthy cohort were asked after the first assessment if
they were willing to return within two weeks for a repeat assessment. Since the
Bayley III can take up to 90 minutes, in order to limit fatigue and boredom at the
re-test, only 2 or 3 of the domains were repeated. As a result to get a minimum of
20 children for each domain, a minimum of 40 children were required to
participate. There is no clear guidance for the required sample size to calculate
test-retest reliability but the study was limited by the feasibility of parents willing to
attend twice, the shortage of available room space for testing and cost. In order to
accommodate parents to come at weekends for the re-test, the children were not
seen for the re-test by the same examiner and not in the same testing
environment as the original, hence not optimal test re-test conditions.
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R package ICC357, was used to calculate the ICC estimates and 95%CI, which are 
based on mean squares obtained by applying analysis of variance models to the 
data.356
2 .9 3 .2  Validity
Comparison of a test to a local gold standard evaluates concurrent validity. As a 
local gold standard may not exist in many LMIC, researchers have looked at 
relationships with known variables that influence child neurodevelopment, such as 
maternal education and stunting, (<2 standard deviations length for age z 
(standardised to the mean) score measurements using WHO growth 
standards).320,358,359 Univariate and multi-variate regressions using raw scores 
were used to evaluate the relationship between maternal education and stunting 
independently on subtest scores.
Structural equational modelling and confirmatory factor analysis were carried out 
to evaluate whether the test items were measuring the hypothesised underlying 
traits in the infants assessed. The details are within the relevant results sections.
2.9.3.3 Comparison to US publically available Bayley III data
The mean raw score for each age category from the US Bayley manual was 
plotted with locally weighted scatterplot smoothing (LOESS) of study data raw 
scores for each domain. The Vietnam study data was split into 13 age groups (<6 
months and then 3 monthly age groups). The mean and 95%CI were calculated 
for each age group with the mean US raw score for the age groups overlaid. This
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was to evaluate whether there is similarity between the US and Vietnam data. 
Further comparative analysis was limited without full US datasets.
2.9.4 MRI in HFMD
Dr. Kling Chong at Great Ormond Street Hospital reported all MRI scans. Dr. 
Chong was not aware of the severity of the HFMD cases. The proportions of 
abnormal MRI’s between different grades were compared based on a Fisher’s 
exact test. Regression analysis of subtest scores was performed to see if an 
abnormality on MRI was an independent risk factor for outcome.
2.9.5 Neurological examination
The proportions of abnormal neurological examinations between different grades 
were compared based on a Fisher’s exact test.
2.9.6 Neurodevelopment
The literature suggests that important covariates such as level of maternal
education and stunting influence neurodevelopment.358 The healthy group was
recruited concurrently within the appropriate age range of HFMD cases and hence
there is overlap in age and sex distribution between the two groups. The
resources needed to generate 1:1 matching for every grade 2a HFMD case
concurrently would mean potential wasting of healthy cases and would have been
an inefficient use of resources and time. However, the healthy group may not
have similar distribution on the covariates of stunting and maternal education, and
regression analysis may increase bias of estimated effect when the relationship
between the outcome scores to covariates is non-linear, especially if the means
and variance of covariates between the groups is large.360, 361 To ‘balance’
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covariates between the HFMD and healthy cohorts we analysed the scores by 
adjusting for covariates based on a propensity score weight in the final outcome 
model.362 This method has been shown to be more robust when there are scarce 
outcomes.363
Martens and colleagues used a simulated population to compare regression and 
propensity score methods and concluded:364 “
The differences between propensity score methods and linear/logistic regression 
analysis are systematic and can be substantial, especially when the number of 
prognostic factors is more than five, the treatment effect is larger than an OR of 
1.25 (or smaller than 0.8) or the incidence proportion is between 0.05 and 0.95. 
This difference is frequently overlooked by analysts in the literature. With respect 
to the objective to adjust for the imbalance of covariate distributions between 
treatment groups, we illustrated that the estimate of propensity score methods is 
in general closer to the true marginal treatment effect (the effect that would be 
found when both treatment groups had similar distributions of prognostic 
indicator) than the estimate of linear/logistic regression analysis.”
Hence I carried out a) linear regression to compare all HFMD grades to the 
healthy group and b) propensity score balance to calculate the average treatment 
effect on the treated (ATT) of having HFMD grade 2a (compare balanced healthy 
and grade 2a), and having more severe HFMD (comparing grade 2a to 2b and 
>2b).
2.10 Ethical considerations
The Bayley III is not a diagnostic test in Vietnam. Despite the inclusion and 
exclusion criteria, if a child was felt by an assessor to have more difficulties than
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expected on items, they were offered a review by the lead Vietnamese 
psychologist. It was explained to the parents that the review was offered as a 
second opportunity for the child to demonstrate skills, as children were very shy 
and not cooperative until well into the testing process.
2.11 Sum m ary
The prospective study adapted an appropriate child development tool to assess 
cognitive, language and motor domains and neurological function in Vietnamese 
children with severe HFMD at two time points over 6 months. Additionally MRI 
scans were carried out during the acute admission to evaluate clinical and 
possible prognostic indicators of outcome.
The following results chapters describe firstly the reliability and validity of the 
adapted Bayley III for Vietnam, secondly, the adjusted regression and propensity 
score analysis of Bayley III scores by HFMD severity compared to the healthy 
group and lastly the descriptive changes in brain MRI in relation to Bayley III 
scores.
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3. Adaptation and validation of Bayley III for Vietnam
There is no internationally recognised valid child developmental assessment tool 
in use in Vietnam. For the purpose of this and future studies in Vietnam we 
adapted the Bayley III. The adaptation process had to be robust enough to ensure 
accurate and reliable group comparisons to compare data between different 
studies in the same or different countries and to evaluate children longitudinally as 
they use different tests over time. In this study, I compared two groups from the 
same setting. I deconstructed the Bayley III to the underlying traits that it is 
designed to measure and looked at whether these traits are also measured in the 
Vietnamese adaptation. This is an important prerequisite in order to interpret 
differences between the Bayley III scores of children from US and Vietnam.
This chapter presents data which:
a) Assesses the psychometric properties of the Vietnam Bayley III by evaluating 
reliability and validity in a healthy sample of urban Vietnamese children
b) Compares study data to US publically available data to evaluate whether US 
scaled scores are appropriate for Vietnamese children.
Additionally we hypothesised:
i) that the same underlying structure of traits or latent factors evaluated by 
the original Bayley is the best-fit model for the Vietnamese sample
ii) that the tool was evaluating the same underlying traits in males and 
females in the Vietnamese sample.
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3.1 T ra in in g  and  ad a p ta tio n
3.1.1 Training on original Bayley III
Dr. Thanh, the local lead psychologist and myself attended training on Bayley III 
by an official trainer, Betty Hutchson. Ambiguous items were clarified by Betty 
Hutchson or Gloria Maccow, both of whom are experts on Bayley III employed by 
the publisher, Pearsons.
3.1.2 Adaptation procedures
Adaptation of the cognitive, language and motor domains followed the guidance 
from the international test commission and additional publications in reducing 
cultural bias.341,365'367 An initial direct translation of the Bayley III record form was 
closely scrutinised by local psychologists for ambiguity. Pilot testing while training 
psychologists on Bayley III, was used to modify items in addition to language 
advice from a post-doctoral language expert based at the University of Hawaii.368. 
None of the manuals were translated so study assessors needed to have a good 
standard of reading and understanding English.
An independent postdoctoral scientist carried out back translation. Discrepancies 
were reviewed and amended by two further independent post-doctoral scientists, 
with children and with experience living in the US. During piloting, further 
adaptations were made to make items less ambiguous and ensure language was 
appropriate for the target audience.
After several revisions, a version was then back translated to English. 
Discrepancies were reviewed by a second team consisting of two postdoctoral 
Vietnamese scientists, with children who had spent more than 2 years with their
children residing and working in the US. Items were clarified and a consensus 
reached with the psychological team about changes. This led to the final version 
used in the study population.
The socio-emotional and adaptive domains were not adapted, as too many items 
were not easily adaptable. These include items reporting “playing make-believe 
where the story makes sense”, discriminating this from “imitates familiar make- 
believe” and “describes his or her feelings to explain why he or she is doing 
something”, “makes plurals by adding an -s ”, “states time and day of favourite 
television shows”, “uses wall switch to turn on and off lights”, “puts own dirty cup 
or plate in the sink or dishwasher”. Many items focus on independent tasks by 
young children are not necessarily encouraged in Vietnamese society and so 
children may receive incorrectly low scores on an adaptation of the socio- 
emotional-adaptive domains. Changing many items on the test would alter the 
fundamental structure of the test.
If a child was not cooperative or shy we gave the child time to settle and used 
toys not included in the Bayley kit for the child to play with. During this time, no 
scoring was done. Children also started on the fine motor domain before 
progressing to cognitive. However, the receptive language was always tested 
before expressive language. Modifications are listed in Table 3.1.
The tonal Vietnamese language has regional dialects, split to north, middle and 
south. Hence separate minor modifications are needed for application regionally. 
The study sample may not be demographically representative of Vietnam and 
further sampling would be ideal.
141
Table 3.1 Modifications to Bayley III.
Domain Item No English version Vietnamese version
Cognitive 59
Cognitive
Cognitive
Receptive
84
69-71
24
Expressive 27
Expressive 31-35-37
Expressive 46-47-48
Translation of language 
during instruction 
During assessm ent, 
flex ib ility  as several d iffe rent 
w ords used with young 
children fo r the fo llow ing 
items.
Introduce dog’s name
This was not 
mentioned.
Spinning top 
picture
If the child feared d 
This was not 
mentioned. 
Discriminate be 
In English:
Ear = tai 
Hand=tay
Let’s say: The dog’s 
name is Clifford 
before telling story 
Ask the child: Look, 
tell me What is this? 
And Using the 
child’s answer, 
oil and bear 
Get 0 score
ween “tai” and “tay” 
Tai and tay have 
similar sound in 
Vietnamese, so we 
need to say: “ lo tai”. 
“ban tay”
Difference language
This was not 
mentioned.
Picture Washing 
by machine/ 
Vacuuming 
replaced with 
hand wash and 
sweeping 
Picture page 165 
(snow image but 
is one of several 
pictures that can 
be used) 
Block
Apple
If the child can 
understand 
assessor’s question, 
but they answer 
correct by other 
language such as: 
Chinese, English. 
Get 1 score
t
Not Using as 
children not familiar
Block = khoi, cue.. 
So, ask parent use 
khoi, cue or any other 
synonym word at 
home.
Apple = tao, bom. 
So, ask parent use 
tao, bom or synonym 
word at home
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Domain Item No English version Vietnamese version
Big Big= to, Ion, bu. 
So, ask parent use 
to, Ion, bu or any 
other synonym word 
at home
Small Small= nho, be 
So, ask parent use 
nho, be or any other 
synonym word at 
home
Cup Cup= ly, tach 
So, ask parent use 
ly, tach or any other 
synonym word at 
home
Ball Ball= bong, banh 
So, ask parent use 
bong, banh or any 
other synonym word 
at home
3.1.3 Training on Vietnamese Bayley III
Child development and infant psychology are not established as a specialty in 
Vietnam. I ran an introductory course on child development, which included an 
overview of the Bayley III. Psychologists, special educators and paediatricians 
were invited to participate. Seven assessors who had either a degree in 
psychology or special education were recruited. They underwent 6 months of 
intensive training with practice on volunteers, which was recorded on video 
followed by constructive feedback in video training sessions. Items that were not 
clear or a source of confusion were queried with the publisher’s assessment 
training consultant. Ongoing video training occurs during the study to maintain 
consistency of scoring.
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3.2 Sample characteristics
3.2.1 Comparison to census data
There were 267 healthy control children aged less than 43 months enrolled in the 
study. 191 (72%), 54 (20%), 22 (8%) were recruited from Hung Vuong Hospital 
birth cohort, kindergartens and ward clinics respectively (Table 4.14). Each child 
underwent one assessment and 206 children had two assessments and 3 had 
three assessments over a six-month period, resulting in a total of 476 
assessments.
We compared the latest publically available census data from 2011 with the study 
cohort. (Table 3.2 and 3.3)
Applying Fisher’s exact test, there were significant differences in proportions of 
stunted children (OR 0.66, 95%CI 0.48-0.99, p-value = 0.037) and levels of 
maternal education (No school /primary OR 0.24, 95%CI 0.0029-0.89, p-value < 
2.2e-16, secondary OR 0.64, 95%CI 0.5-0.83, p-value < 2.2e-16 and higher OR 
2.62, 95%CI 2-3.43, p-value = 4.263e-12) between the study and census data. 
There were also significant differences in proportions of families owning 
refrigerators (OR 49.3, 95%CI 19.06-182.62, p-value < 2.2e-16), using air- 
conditioning (OR 10.5, 95%CI 8.12-13.72, p-value < 2.2e-16), owning a motorbike 
(OR 17.97, 95%CI 6.08-87.6, p-value <2.2e-16) and having access to better 
quality water (OR 1.52, 95%CI 1.15-2.01, p-value 0.002) and sanitation facilities 
(OR 7.36 95%CI 3.12-22.17, p-value 6.271e-10) compared to 2009 census data. 
The study sample was not designed to be representative of the general 
population, but that of urban Vietnam. There are no directly comparable 
population level data for urban population within Vietnam in the last 5 years.
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Table 3.2 Characteristics o f the va lida tion  sample and the M u ltip le  Ind ica to r 
C luster Survey 2011, w h ich  sampled 11,614 households across the six regions 
o f V ie t Nam .369
Healthy Cohort Study Population Multiple Cluster Survey 2011
National Prevalence 
stunting N=3678
Urban:
N=983
Study N= 267 Male n=147 Female
n=120
Both sexes 
n=267
Male
N=1821
Female
N=1751
Both
sexes
N=3678
Both
Sexes
N=112
Age at 
enrolment in 
months 
Median (IQR)
15.87
(16 .16 )
15.97
(12 .16 )
Z scores: 
length for age 
(all data) 
Mean (SD)
-0 .93 (1 .45 ) -0 .76  (1 .44 )
Stunted (<- 
2SD z scores: 
length for age 
according to 
WHO 
guidelines)
30 (2 0 % ) 13 (1 1 % ) 43 (1 6 % ) 432
(2 3 .7 % )
378
(2 1 .6 % )
835
(2 2 .7 % )
112
(1 1 .4 % )
Maternal Education
Rural and urban both sexes N=3678
No School or 
Primary
21 (1 4 % ) 2 2 ( 1 8 % ) 43 (1 6 % ) 865 (2 3 .5 % )
Secondary
School
71 (4 8 % ) 55 (4 6 % ) 126 (4 7 % ) 2149  (5 8 .4 % )
Higher
Education
55 (3 7 % ) 43 (3 6 % ) 98 (3 7 % ) 664 (1 8 .1 % )
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Table 3.3 Household Assets compared to 2009 Vietnam Census370
Urban Households Study n=267 Urban Census 2009
Refrigerator use 263 (99%) 3,986,771 (57.4%)
A ir conditioner use 178 (67%) 1,125,186 (16.2%)
Motorcycle use 267 (99%) 5,778,734(83.2%)
Drinking water
Piped 193 (72%) 4,410,452 (63.5%)
Borehole 0 2,111,460 (30.4%)
Rain 0 166,694(2.4%)
Natural Spring 0 256,987 (3.7%)
Bottle 74(28%) NA
Sanitation
Sanitary toilet 263 (98%) 6,098,231 (87.8%)
Urban population in 2009: 25,374,262 
Urban households in 2009: 6,945,594
3.3 R e lia b ility  o f Vietnamese Bayley I I I
3.3.1 Internal consistency of subtest items
Internal consistency (how well related items are measuring the same underlying 
trait) of the subsets with all ages combined was very good with Cronbach’s alpha 
0.95 to 0.97.319 When this was split into four age groups, the fine motor domain at 
age group 18-24 months and receptive language aged less than 12 months had a 
Cronbach’s alpha of <0.7, below the acceptable cut-off described by Cicchetti.319 
(Table 3.4)
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Table 3.4 In ternal consistency: Cronbach's alpha by age group and all ages 
com bined
Ages in Months according to Bayley entry___________ All ages
=<12 >12 =<18 >18 =<24 >24 =<43
Domains
N 119 113 95 149 476
Cognitive 0.91 0.82 0.77 0.90 0.97
Receptive 0.62 0.85 0.88 0.90 0.96
Expressive 0.79 0.87 0.92 0.89 0.97
Fine Motor 0.89 0.73 0.58 0.83 0.95
Gross 0.93 0.86 0.72 0.85 0.97
Motor
3.3.2 Inter-observer reliability
Seven raters scored up to 20 videos for each domain. Intra-class-correlation (ICC) 
and 95% confidence interval were calculated for agreement within these specific 
raters using the raw scores. ICC were very good (>0.90) in all domains (Table
3.5).319
Table 3.5 In te ro b serv er reliability: 7 assessors
Domain Cognitive Receptive Expressive Fine Gross
N=20 N=21 N=18 Motor=19 Motor=20
IC C 0.99 0.978 0.97 0.99 0.99
C l 0.99-0.99 0.96-0.99 0.94-0.99 0.98-0.99 0.97-0.99
3.3.3 Test-retest reliability
Test-retest reliability was evaluated in up to 29 children using Pearson’s 
correlation. Correlations on raw scores were high in all domains (Table 3.6).
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Table 3.6 Test-retest: raw scores
Domain Median (Range) Days 
difference between Testing
Pearson correlation
Cognitive N=29 
Receptive Language N=28 
{ Expressive Language N=27 
Fine motor N=29 
Gross motor N=25
9 (2.1 to 31.2) 
9(2.1 to 30.0) 
9 (3 to 30) 
9(2.1 to 31.2) 
8.1 (3 to 16.8)
0.97 (0.94-0.99)** 
0.96 (0.95-0.99)** 
0.97 (0.94-0.99)** 
0.97 (0.96-0.99)** 
0.96 (0.91-0.98)**
**p value<0.01
3.4 Distribution o f raw  scores
To evaluate relationships between subtests, the raw scores need to be 
standardised as the raw score subtests are effectively of different metrics. The 
sample was split into 13 age groups consisting of 19 to 70 children. The youngest 
infant was 4.6 months, hence the groups started at <6 months and then at 3 
monthly intervals (Table 3.7). Z scores (standardised scores in relation to mean 
score for the age group) were calculated for each subtest within these age 
groups. The Z scores were used in the correlation analysis and factor analysis. 
Standardising the score in this manner allows a more stable measure of the 
underlying constructs or factors being measured by the observed test scores.371
The raw scores were not normally distributed for any domain. (Figure 3.1, 3.2). 
Distribution improved with calculation of Z scores. (Table 3.7, Figure 3.3).
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Figure 3.1 Histogram of subset raw scores
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Figure 3.2 Q-Q plot of subtest raw scores:
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Table 3.7 Mean and standard deviation of raw  scores per age group
Age group 
in months
N
476
CS
mean
CS
SD
RC
mea
n
RC
SD
EC
mean
EC
SD
FM
mean
FM
SD
GM
mean
GM
SD
<6 30 24.0 4.3 8.0 1.5 6.8 1.9 16.4 3.4 19.5 3.8
6-9 19 28.6 3.7 9.3 1.1 8.6 2.2 20.2 2.5 25.8 5.3
9-12 70 37.9 3.1 10.9 1.5 11.4 2.4 26.8 2.0 36.8 3.3
12-15 47 42.4 4.3 11.8 2.5 12.6 3.0 29.2 2.3 42.3 4.1
15-18 66 48.6 4.0 16.0 4.4 16.6 4.8 32.8 2.2 48.2 3.1
18-21 53 52.2 3.5 18.9 4.7 21.3 5.7 34.6 1.8 51.0 2.2
21-24 42 57.3 3.6 23.5 3.4 27.7 6.0 37.4 2.0 53.2 3.1
24-27 31 60.1 4.0 26.1 4.1 30.8 4.2 39.4 2.4 56.8 2.4
27-30 30 66.4 4.8 30.3 4.1 33.5 5.3 42.2 3.4 58.6 3.2
30-33 20 67.7 3.9 33.4 4.7 36.4 3.2 45.6 3.4 61.3 2.5
33-36 20 70.0 3.4 36.5 2.8 38.4 4.9 48.3 3.7 61.7 2.8
36-39 23 71.9 4.0 37.4 3.8 38.3 2.9 51.5 4.7 63.8 2.4
39-43 25 74.8 4.3 38.3 3.4 39.8 3.9 53.6 4.0 63.8 3.2
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Figure 3.3 Q-Q plot of subtest z scores
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3.5 Validity
3.5.1 Relationship with known risk factors for poor child development 
In all domains, scores increased with age. Male sex was predictive of lower 
cognitive, receptive and expressive scores after adjusting for age. Higher 
maternal education predicted better scores in all domains in univariate 
analysis, but only improved scores in cognitive and receptive scores following 
adjustment for age and sex. Stunting was not predictive of scores following 
adjustment for age and sex (Table 3.8).
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3.5.2 Convergent and discriminant validity
Correlations between subtests were evaluated for convergent and divergent 
validity. It is expected that the two motor subtests correlate higher to each other 
than with other subtests and similarly with the two language subtests.
The study data using Z scores correlations ranged from 0.3 (RC and FM) to 0.5 
(RC and EC, FM and GM). This is similar to the original US correlation between 
subsets, 0.36 (EC and GM) to 0.53 (RC and EC). Additionally, the correlation 
between the fine motor and cognitive subtest was high at 0.5, similar to the US 
manual: 0.51. (Figure 3.4)
Figure 3.4 Correlation m atrix  between domains using Z scores from  13 age 
groups.3 (476  assessments)
CS R L E L F M G M
CS
R L 0.44
E L 0.43 0.5
F M 0.5 0.3 0.38
G M 0.42 0.32 0.3 0.43
aAII correlations were significant at p<0.05
CS: cognitive, RL: receptive language, EL: expressive language, FM: fine motor, GM: gross motor 
3.5.3 Construct validity
Structural equation modelling (SEM) is a statistical method, used to evaluate 
theoretical models using observed data372. The theoretical model identifies the 
relationship between the observed data, e.g. test scores and the underlying latent 
trait (factor) being assessed e.g. language. Confirmatory factor analysis (CFA) is
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one SEM method which tests specific hypotheses about the structure of the factor 
loadings (how much the observed variable contributes to the underlying factor), 
and uses path analysis diagrams to describe these relationships.373 The factor 
structure was based on an a priori hypothesis that the best-fit structure would be 
the same as the original US Bayley III, i.e. a 3-factor model (fine and gross motor 
subtests on the first factor, receptive and expressive language on the second, and 
cognitive on the third). Deciding adequate sample size for factor analysis, Comrey 
and Lee are often quoted stating a sample size of “50 is very poor, 100 is poor, 
200 is fair, 300 is good, 500 is very good, and 1,000 is excellent.”374 In practice 
there are several recommendations on adequate sample size for factor analysis, 
depending on the number of indicators (observed variables) to factors, and the 
variance of the indicator explained by the factor (communalities). However it is an 
area of on-going debate.374
Several measures of overall model fit are used. Non-significant Chi square 
statistics at 0.05 level and Root Mean Square Error of Approximation (RMSEA) < 
0.05 indicate good fit.375,376 The RMSEA also permits a confidence interval (Cl) 
calculation, whereby a good fit has an upper limit of Cl <0.08. The Comparative 
Fit Index (CFI) has acceptable fit at 0.95, and good fit at >0.97.375,376 A criterion p- 
value of 0.05 was used for all analyses (SEM in R using Psych and Lavaan 
packages).356,377,378
3.5.3.1 Confirmatory factor analysis
The study followed the procedure of construct validity as described in the original 
US Bayley III technical manual.336 The following models were evaluated for 
goodness of fit. Null model (no common factors), one factor model; (5 subtests on
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a general factor), two factor model; (fine and gross motor subtests on first factor 
(Motor scale) and receptive and expressive language and cognitive on second 
factor) and three factor model; (fine and gross motor subtests on the first factor, 
expressive and receptive language on the second and the cognitive on the third). 
All models assumed that factors are free to intercorrelate and errors are 
uncorrelated. The best model fit was 3 factors, the same best fit construct 
structure as US Bayley. There were no modification indices >10 (ML and WLS) 
and all standardised residuals <2.58 (ML) suggesting no small areas of ill-fit in the 
model. (Table 3.9)
It is assumed that subtests loading on the same factors have only the underlying
construct to explain their relationship and since underlying factors can correlate,
any relationship between subtests of different factors are explained by the factor
relationship. Standardised solutions define the metric of the latent variables by
fixing the variance of one factor to 1.0. (Figure 3.5-3.7).379
Table 3.9 Goodness-of Fit Statistics for Confirm atory Factor Analysis of 
subtests.
N5 X2 Df p-value CFI TLI RMSEA (Cl)
Model 1 
Estimator 
: ML
476 41.59 5 <0.01 0.935 0.871 0.124(0.091 -  
0.160)
Model 2 
Estimator 
: ML
476 31.18 4 <0.01 0.952 0.880 0.119(0.083-0.160)
Model 3 
Estimator 
: ML
476 5.98 3 0.11 0.995 0.982 0.046(0.0-0.099)
Model 3 
Estimator 
: WLS
476 6.20 3 0.10 0.983 0.944 0.047(0.0-0.101)
M L : Maximum Likelihood, WLS: Weighted Least Squares, X2:chi-square, Df: degrees of freedom, 
CFI: Comparative Fit Index, RMSEA: Root Mean Square of Approximation, TLI: Tucker-Lewis 
Index, Cl: 95% Confidence Interval. 5 Sample includes some children tested twice from test-retest 
group
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3.5.3.2 Average variance extracted
The average amount of variance in measured variables that a construct is 
managed to explain should be higher than the shared variance with any other 
construct, determining that discriminant validity is supported i.e. the items are 
specific to the construct of interest and the other constructs are sufficiently 
different. An average variance extracted (AVE) greater than 0.50 suggests that 
both the validity of the construct and the individual subtests are good.380 As far as 
we could determine from the literature, the AVE of Bayley III has never been 
evaluated before. In this sample, the AVEs for each construct was lower than their 
shared variance with the other constructs, which demonstrated poor convergent 
and discriminant construct validity for the Vietnamese Bayley III. (Table 3.10).
Table 3.10 The square roots of AVEs and correlations among la ten t constructs
M L C
M (0.66)
L 0.685** (0.7)
C 0.694** 0.616** (1.00)
AVE 0.44 0.5 1.000
The square roots of AVE on the diagonal in brackets, correlation coefficients on the anti-diagonal. 
M: Motor 
L: language 
C: Cognition 
**p-value <0.01
3.5.3.3 Measurement invariance
SEM can additionally evaluate measurement invariance (Ml) to determine 
whether group differences in scores are due to the differences in underlying ability 
or due to bias or unreliability of the test.373 Although the Bayley has been used as 
the “gold standard” for outcome research worldwide, there is no published data on 
measurement invariance between gender or within different age groups. The 
major limitation is the requirement of having sufficient sample size to evaluate
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factor analysis and hence Ml. In this study we evaluated whether there is gender 
Ml.
Ml is carried out in a hierarchical process with nested models of “configural”, 
“weak”, “strong” and “strict” Ml.381 Configural evaluates whether the number of 
factors and pattern of loading is similar between groups, indicating participants 
from different groups conceptualise the constructs in the same way and hence 
respond to the test in the same way. Weak invariance evaluates whether the 
magnitude of factor loading is similar between groups (different groups respond to 
items in the same way) so that a change in one on the test is the same change in 
unit on the underlying factor for both groups compared. If one unit change in the 
item score does not result in the same change in the factor score across groups, 
the regression lines are slopes are unequal; as illustrated in Figure 3.9. Strong or 
scalar invariance additionally evaluates whether the intercepts are similar 
between groups (observed scores are related to the latent constructs in the same 
way irrespective of group membership). If there is no strong invariance, the item- 
factor relationship is dependent on the group membership as illustrated in figure 
3.10-3.11, whereby the same item score gives a higher factor score to females. 
Strict invariance evaluating the residual variances (same level of systematic 
measurement error per item for each group) can result in the shift of the item- 
factor regression lines away from the ideal position (Figure 3.12).379 In practice, 
these nested models are evaluated by showing a non-improvement in fit between 
models.382 Figures 3.8-3.12 are based on figures from Wu et al.382
Strong invariance (or scalar invariance) is required in order to meaningfully 
compare the means of latent variables across different groups.383 Wu et al. advise 
strict invariance to be met before means can be compared.382 A significant drop in
model fit suggests that the constructs are not measured similarly in the two 
groups. Changes in the comparative fit index (CFI) >0.01 is commonly used to 
define whether a more constrained model has a significant decrease in model fit 
compared to the previous model with fewer constraints.381
The analyses were run by means of maximum likelihood (ML) estimation. The use 
of ML estimation can cause problems when using non-normal data.375 Other 
estimation methods for non-normal data include asymptotic distribution free (ADF) 
(or weighted least squares, WLS). However, Ory et al. identified more consistency 
between ML and ADF with non-normal data with the ADF estimation providing an 
overall better goodness-of-fit than ML.384 For the best-fit model identified by ML, 
the WLS method was also used to evaluate the potential effect of sample non­
normality.
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3.5.3.3.1 Gender measurement invariance (Ml)
We tested the hypothesis that a change in the underlying latent factor would result 
in the same change in Z scores irrespective of gender, by evaluating model 
invariances with restrictions imposed on the model.385 The goodness of fit indices 
for male and female subsets suggests that the 3 factor model was a good fit for 
the observed data at baseline. Factor loadings were significant for both sexes. As 
restrictions were imposed on the model, goodness of fit indices remained 
adequate, suggesting the Z scores of the subtests are measuring the same 
underlying constructs in both males and females. (Tables 3.11, 3.12, Figures 
3.13-3.14)
Table 3.11 Evaluating M easurem ent invariances according to gender.
Estimator:
M L
N X2 df P-
value
C F I T L I R M SEA (C l)
Model 3 476 2.686 3 0.443 1.000 1.000 0(0.0-0.074)
Male 256 6.347 3 0.096 0.988 0.962 0.066(1.0-0.139)
Female 220 3.290 3 0.349 0.999 0.996 0.021 (0.0-0.118)
ML: Maximum Likelihood, WLS: Weighted Least Squares 
X2:chi-square, Df: degrees of freedom
CFI: Comparative Fit Index, RMSEA: Root Mean Square of Approximation 
TLI: Tucker-Lewis Index, Cl: 95% Confidence Interval
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Table 3.12 Measurement invariance by gender: imposing model restrictions
Df Chisq Chisq
d iff
D f d iff P value CFI ACFI
Baseline Configural 
Invariance (equal 
number of factors)
6 9.637 0.141 0.993
Metric Invariance 
(equal loadings)
8 9.806 0.1694 2 0.279 0.997 0.004
Scalar Invariance (equal 
loadings and intercepts)
10 10.711 0.9050 2 0.380 0.999 0.002
Strict Invariance 
(equal loadings, 
intercepts and residuals)
14 17.925 7.2143 4 0.210 0.993 0.006
Strict Invariance +equal 
means
17 34.05 16.1288 3 0.008 0.969 0.024
C o m p a r is o n  b e tw e e n  p ro g re s s iv e ly  re s tr ic tiv e  m o d e ls  in d ic a te d  th a t s o m e  a s p e c ts  
o f th e  s tr ic t in v a r ia n c e  a s s u m p tio n  w e re  m e t w h ic h  s u g g e s te d  th a t b e in g  m a le  o r 
fe m a le  d id  n o t a lte r  th e  re s p o n s e  to  th e  te s t ite m s . H o w e v e r, th e re  w a s  a 
d if fe re n c e  in m e a n s  o f th e  la te n t v a r ia b le  b e tw e e n  m a le s  and  fe m a le s , w h ic h  
s u p p o rts  th e  n eed  to  a d ju s t s c o re s  fo r  g e n d e r.
3.5.4 C om parison to  pub lished  US Bayley III data
T h e  m e a n  ra w  s c o re  fo r  e a c h  a g e  c a te g o ry  fro m  th e  U S  B a y le y  m a n u a l w a s  
p lo tte d  w ith  lo c a lly  w e ig h te d  s c a tte rp lo t s m o o th in g  (L O E S S ) o f  s tu d y  d a ta  ra w  
s c o re s  fo r  e a ch  d o m a in . T h e  V ie tn a m  s tu d y  d a ta  w a s  s p lit in to  13 a g e  g ro u p s . 
T h e  m e a n  and  9 5 % C I w a s  c a lc u la te d  fo r  e a ch  a g e  g ro u p  w ith  th e  m e a n  U S  ra w  
s c o re  fo r  th e  a g e  g ro u p s  o v e rla id  (ra w  s c o re s  e q u iv a le n t a t s c a le  s c o re  10 fro m  
th e  a d m in is tra t io n  m a n u a l). T h is  w a s  to  e v a lu a te  w h e th e r  th e re  is s im ila r ity  
b e tw e e n  th e  U S  and  V ie tn a m  d a ta . F u r th e r  c o m p a ra tiv e  a n a ly s is  w a s  lim ite d  
w ith o u t fu ll U S  d a ta s e ts . (F ig u re s  3 .15 , 3 .1 7 , 3 .1 9 , 3 .2 1 , 3 .2 3 )
T h e  m e a n s  and  9 5 %  c o n fid e n c e  in te rv a ls  o f th e  ra w  s c o re s  fo r  13 a g e  g ro u p s  
w e re  p lo tte d . (F ig u re s  3 .1 6 , 3 .18 , 3 .20 , 3 .2 2 , 3 .2 4 ).
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3.6 Sum m ary
T h e  re s u lts  d e m o n s tra te  th a t th e  V ie tn a m e s e  a d a p ta tio n  o f  B a y le y  III is re lia b le  
a n d  v a lid  on  th e  o r ig in a l p ro p e rt ie s  th a t w e re  p u b lis h e d  b y  th e  a u th o r  o f  B a y le y  III. 
A d d it io n a lly  w e  lo o k e d  a t m e a s u re m e n t in v a r ia n c e  a n d  fo u n d  s o m e  d iffe re n c e s  in 
th e  u n d e r ly in g  a b ilit ie s  m e a s u re d  b y  th e  V ie tn a m e s e  B a y le y  III b e tw e e n  th e  
s e x e s . T h is  h a s  n o t b e e n  e v a lu a te d  p re v io u s ly  u s in g  B a y le y  III. T h e  p ro c e s s  o f  
p ilo t s tu d y , tra n s la tio n  a n d  b a c k - tra n s la tio n  in v o lv in g  d if fe re n t te a m s  o f  p e o p le  
fro m  a v a r ie ty  o f  b a c k g ro u n d s  ( lin g u is ts , s c ie n tis ts  a n d  s o c ia l s c ie n tis ts )  has  
re s u lte d  in th is  s u c c e s s fu l a d a p ta tio n .
3.7 Discussion
T h is  c h a p te r  d e m o n s tra te s  p s y c h o m e tr ic  m e th o d s  o f  te s tin g  th a t a re  n o t u s u a lly  
c a rr ie d  o u t fo r  ch ild  d e v e lo p m e n t to o ls . T h e s e  m e th o d s  a re , h o w e v e r, re c o g n is e d  
as  im p o rta n t fo r  p a tie n t re p o rte d  o u tc o m e  m e a s u re s , a n d  o u tc o m e  m e a s u re s  in 
h e a lth  a n d  a llie d  s p e c ia lt ie s  su c h  as  p h y s io th e ra p y  m e a s u re s .386 D e s p ite  th e  
te c h n ic a l d iff ic u lt ie s , th e  u se  o f  fre e  s o ftw a re  fo r  a n a ly s is  s h o u ld  e n c o u ra g e  a ll 
g ro u p s  w o rk in g  in ch ild  d e v e lo p m e n t to  e x p lo re  th e  u n d e r ly in g  s tru c tu re  o f  th e  
o u tc o m e  m e a s u re  a n d  u n d e rs ta n d  p s y c h o m e tr ic  v a lid ity .
O u r p o p u la tio n  d iffe rs  fro m  th e  la te s t p u b lic ly  a v a ila b le  c e n s u s  d a ta  fro m  2 0 0 9  
an d  2 0 1 1 , w ith  h ig h e r le v e ls  o f m a te rn a l e d u c a tio n  a n d  a s s e ts , th o u g h  
c o m p a ra b le  le v e ls  o f  s tu n tin g . T h e  M IC S  2011  d a ta  id e n tif ie d  s tu n tin g  p re v a le n t in 
a ll le v e ls  o f  m a te rn a l e d u c a tio n  b u t in v e rs e ly  re la te d , s u g g e s tin g  m a te rn a l 
e d u c a tio n  m a y  be  p ro te c tiv e . 369 S tu n tin g  is a m e a s u re  o f  in a d e q u a te  lin e a r  
g ro w th  in b o th  th e  a n te n a ta l a n d  p o s tn a ta l p e rio d , w h ic h  is c o m p o u n d e d  b y  
in fe c tio u s  d is e a s e s  a n d  p o o r e n v iro n m e n t.387 S e v e ra l s tu d ie s  h a v e  fo u n d
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c o n s is te n t a s s o c ia t io n s  b e tw e e n  s tu n tin g  a t 2 to  3 y e a rs  a n d  p o o re r lo n g  te rm  
e d u c a tio n a l and  c o g n it iv e  o u tc o m e s  c o m p a re d  to  c h ild re n  w ith  n o rm a l g ro w th , 
d e s p ite  a d ju s tm e n t fo r  s o c io e c o n o m ic  c o n fo u n d e rs  in L M IC s .388'390 L o n g itu d in a l 
s tu d ie s  a ls o  s u g g e s t p o o re r  s o c ia l in te ra c tio n  a t s c h o o l a g e  and  a tte n tio n  
d if f ic u lt ie s .391, 392 T h e  re la t io n s h ip  b e tw e e n  s tu n tin g  and  p a re n ta l e d u c a tio n  is 
c o m p le x , a n d  d iffe re n t in d if fe re n t s e tt in g s . S tu d ie s  in B a n g la d e s h  fo u n d  lo w e r 
p a te rn a l e d u c a tio n  to  be  a s tro n g e r  p re d ic to r  o f  s tu n tin g  b u t th is  w a s  n o t th e  ca se  
in In d o n e s ia .393 In In d o n e s ia , lo w e r m a te rn a l e d u c a tio n  w a s  a s tro n g  p re d ic to r  o f 
s tu n tin g  e ve n  w h e n  a d ju s te d  fo r  p a te rn a l e d u c a tio n , g e n d e r, a g e  a n d  w e e k ly  p e r 
h e a d  h o u s e h o ld  e x p e n d itu re .393 H ig h e r m a te rn a l e d u c a tio n  m a y  in c re a s e  
k n o w le d g e  a b o u t h e a lth  is s u e s , in c re a s e  c o n s u m p tio n  o f h e a lth y  fo o d s , c h a n g e  
tra d it io n a l a tt itu d e s  to w a rd s  n u tr it io n  w h ils t  in d ire c tly  c h a lle n g in g  g e n d e r  ro le s .394 
R e s e a rc h  in u rb a n  a n d  ru ra l s ite s  in H a n o i, V ie tn a m  fro m  o v e r  1 0 0 0  c h ild re n  
id e n tif ie d  th a t o n ly  12%  g ro w th  in le n g th  w a s  e x p la in e d  b y  v a r ia b le s  in m a te rn a l 
e d u c a tio n  a n d  h o u s e h o ld  w e a lth , w ith  m o re  th a n  8 0 %  o f  v a r ia t io n  le ft 
u n e x p la in e d .395 O u r d a ta  d o e s  n o t d e m o n s tra te  s tu n tin g  a s  a p re d ic to r  o f  lo w e r  
s c o re s , b u t th e  p ro p o rtio n  o f  m o th e rs  w h o  d id  n o t a tte n d  s c h o o l o r  had  o n ly  u p  to  
p r im a ry  e d u c a tio n  p a re n ts  w a s  s m a ll, a n d  th e  a d v e rs e  c o n s e q u e n c e s  o f  s tu n tin g  
m a y  h a v e  b e e n  m e d ia te d  b y  fa c to rs  a s s o c ia te d  w ith  h ig h e r  le v e ls  o f  m a te rn a l 
e d u c a tio n .
In th is  s tu d y , th e  a s s e s s o rs  had  to  be  fa m ilia r  w ith  a ll ite m s  o f  th e  B a y le y  III a s  th e  
h e a lth y  p o p u la tio n  w a s  e n ro lle d  a t a n y  a g e . T h is  re q u ire d  in v e s tm e n t in tra in in g  
a n d  m o n ito r in g  d u r in g  th e  s tu d y  p e rio d . W e  d e m o n s tra te d  th a t a d a p ta tio n  a n d  
a p p lic a tio n  o f  B a y le y  III in  V ie tn a m  is fe a s ib le  a n d  in v e s tm e n t in th is  le v e l o f  
tra in in g  led  to  g o o d  to  e x c e lle n t in te r -o b s e rv e r  re lia b ility .
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T e s t- re te s t re lia b ility  w a s  n o t d o n e  u n d e r  id e a l c o n d it io n s  (su ch  as  sa m e  
e n v iro n m e n t), y e t re lia b ility  w a s  e x c e lle n t. M e a n  s c o re s  im p ro v e d  in th e  re te s t 
(d a ta  n o t s h o w n ) as  e x p e c te d  d u e  to  s o m e  fa m ilia r ity  w ith  ite m s . V ie tn a m  is a filia l 
s o c ie ty  a n d  m o s t c h ild re n  a re  e x p o s e d  to  th e ir  m a in  c a re g iv e r  a n d  im m e d ia te  
fa m ily  o n ly .396 T h e y  h a ve  lim ite d  c o n ta c t w ith  u n fa m ilia r  a d u lts  a n d  p la y in g  w ith  
a d u lts  b e fo re  s c h o o l a g e  is u n c o m m o n . T h e  a s s e s s o rs  fo u n d  s ig n if ic a n t d if f ic u lty  
in g e ttin g  c h ild re n  to  e x p lo re  u n fa m ilia r  to y s , to  be re la xe d  a n d  c o m fo rta b le  to  
s p e a k  a n d  c o o p e ra te . S in c e  th e  c o g n it iv e  d o m a in  is th e  f irs t  s u b te s t to  be  
a d m in is te re d , th e  a s s e s s o rs  b e lie v e d  p e r fo rm a n c e  on  th is  d o m a in  w a s  le ss  g o o d  
th a n  th e  p e r fo rm a n c e  on  o th e r  d o m a in s  th a t w e re  a d m in is te re d  la te r  w h e n  th e  
c h ild  w a s  m o re  fa m ilia r  to  th e  s itu a tio n .
In fa n ts  d id  n o t c o o p e ra te  w e ll w ith  ite m s  s u c h  as  s u s ta in e d  p la y  w ith  a n  u n fa m ilia r  
o b je c t, a n d  had  h ig h  le v e ls  o f  s tra n g e r  a w a re n e s s  w ith  s o m e  b e in g  u n fa m ilia r  w ith  
w e s te rn  g a m e s  su c h  as  “ p e e k -a -b o o ” w ith  p a re n ts . Id e n tify in g  p a rts  o f  th e  b o d y  o r  
c lo th in g  in o ld e r  in fa n ts  s e e m s  to  be u n iv e rs a lly  a sk ill p a re n ts  te a c h , a n d  c h ild re n  
w e re  fa m ilia r  b e in g  a s k e d  a b o u t. In th e  o ld e r  a g e  g ro u p s , n o u n s  a n d  p ro n o u n s  
s tru c tu re s  a re  m o re  c o m p le x  a n d  d e p e n d  on  re la t io n s h ip  o f  th e  c h ild  to  th e  p e rs o n  
o r  o b je c t, so  th e s e  ite m s  a re  d iff ic u lt  to  tra n s la te , a n d  a c tu a lly  n o t a g e  a p p ro p r ia te  
a t th e  a g e  te s te d  in B a y le y  III. D e s p ite  th e  c h a lle n g e  in d if fe re n t s tru c tu re  in 
la n g u a g e  a n d  o b v io u s  lim ita t io n s  in tra n s la t io n  fo r  s o m e  ite m s  w h e re  p lu ra ls  o r  
v e rb  e n d in g s  in E n g lish  a re  n o t tra n s la ta b le  in th e  e x a c t fo rm a t, re lia b ility  a n d  
v a lid ity  o f  th e  to o l has  b e e n  d e m o n s tra te d  as  a p p ro p r ia te  fo r  re s e a rc h  s e tt in g s .
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W e  u se d  C F A  to  e v a lu a te  w h e th e r  th e  a d a p ta tio n  had  th e  s a m e  c o n s tru c t 
s tru c tu re  a s  th e  o r ig in a l B a y le y  III. O f n o te , th e  c o n s tru c t c o n v e rg e n t and  
d is c r im in a n t v a lid ity  w a s  n o t m e t and  th is  m a y  be  d u e  to  th e  la rg e  o v e r la p  a n d  
h ig h  c o rre la t io n s  b e tw e e n  s u b te s t s c o re s . T h is  is n o t u n e x p e c te d  in v ie w  o f  kn o w n  
o v e r la p  o f  c o g n it iv e  a n d  la n g u a g e  d o m a in s  in e a r ly  c h ild h o o d ,336 a n d  th e  
re la tio n s h ip  b e tw e e n  f in e  m o to r  a n d  c o g n it iv e  s k ills .397 R e c e n t w o rk  s u g g e s ts  it is 
th e  v is u o s p a tia l c o o rd in a tio n  (e .g . c o p y in g  a p ic tu re ) ra th e r  th a n  v is u a l-m o to r  
c o o rd in a tio n  (e .g . tra c in g  o v e r  a p ic tu re )  th a t re la te  to  c o g n it iv e  fu n c t io n .398 W ith in  
B a y le y , c h ild re n  w ith  f in e  m o to r  d e la y  m a y  be  d is a d v a n ta g e d  in s c o r in g  
a d e q u a te ly  on  c o g n it iv e  ite m s  re q u ir in g  f in e  m o to r  c o n tro l, e s p e c ia lly  w ith in  t im e d  
ta s k s  (e .g . c o m p le tin g  a p u zz le , p e g s  in h o le ). T h e  B a y le y  s ta r t a n d  e n d  p o in t 
s y s te m  a v o id s  to o  m a n y  s im ila r  ite m s  b e in g  g ro u p e d  to g e th e r, s o  a ch ild  w ith  f in e  
m o to r  d if f ic u lt ie s  w ill n o t be  g iv e n  f in e  m o to r  re la te d  a c tiv it ie s  c o n s e c u tiv e ly . 
H o w e v e r, fro m  a c lin ic a l p e rs p e c tiv e  it is u s e fu l to  n o te  w h e n  e x a m in in g  c h ild re n , 
to  d if fe re n tia te  w h ic h  f in e  m o to r  a s p e c ts  a c h ild  f in d s  c h a lle n g in g , in o rd e r  to  
ta rg e t in te rv e n tio n .
M u ltiv a r ia te  a n a ly s is  id e n tif ie d  th a t fe m a le  g e n d e r  had  im p ro v e d  c o g n it iv e , 
re c e p tiv e  a n d  e x p re s s iv e  la n g u a g e  s k ills  c o m p a re d  to  m a le s . In v ie w  o f  g e n d e r  
m e a s u re m e n t in v a r ia n c e , th is  ca n  be  in te rp re te d  as  a tru e  d if fe re n c e  in th e  la te n t 
a b ility  b e in g  m e a s u re d  b y  th e  te s t. A d d it io n a lly , w e  lo o k e d  a t g e n d e r  M l a n d  fo u n d  
in v a r ia n c e  is  he ld  ir re s p e c tiv e  o f g e n d e r, i.e . th e  la te n t c o n s tru c t o r  fa c to r  is 
m e a s u re d  in th e  s a m e  w a y  b e tw e e n  g ir ls  a n d  b o y s  b u t th e re  is a g e n d e r  
d if fe re n c e  in la te n t m e a n s . T h is  is in a g re e m e n t w ith  th e  m u lt iv a r ia te  re g re s s io n  
a n a ly s is  on  ra w  s c o re s . G e n d e r d if fe re n c e s  in th e s e  d o m a in s  a re  w e ll 
d o c u m e n te d  in th e  lite ra tu re  in e a r ly  c h ild h o o d  (a s  re v ie w e d  b y  A rd ila  e t a l. 
(2 0 1 1 )),399'401 w ith  in c o n c lu s iv e  e v id e n c e  w h e th e r  e a r ly  g e n d e r  d if fe re n c e s  a re
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s u s ta in e d  o r  d im in is h  w ith  a g e .401 In v ie w  o f th e s e  f in d in g s , g e n d e r  is an  im p o rta n t 
c o v a r ia te  to  a d ju s t fo r  in p o p u la tio n  o r  g ro u p  d iffe re n c e s  a n a ly s is .
P lo ts  o f  ra w  s c o re s  a n d  m e a n s  fo r  V ie tn a m  a n d  U S  s h o w  th e re  a re  d is c re p a n c ie s , 
w h e re  th e  U S  m e a n  v a lu e s  d o  n o t c o n s is te n tly  lie  w ith in  th e  V ie tn a m e s e  9 5 %  C l 
p e r  a g e  g ro u p . T h is  s u g g e s ts  th e  U S  s c a le d  s c o re s  m a y  n o t be  a p p ro p r ia te  fo r  
re s e a rc h  o r  c lin ic a l use . T h is  w a s  a ls o  th e  c a s e  in a M a la w ia n  s ta n d a rd iz a tio n  
s tu d y  402
T h e  a im  o f  d e v e lo p in g  an  a d a p te d  in te rn a tio n a lly  re c o g n is e d  c h ild  d e v e lo p m e n t 
to o l w a s  re a lis e d , s u p p o rte d  b y  g o o d  p s y c h o m e tr ic  p ro p e rtie s  a n d  a te a m  o f  
a s s e s s o rs  w h o  c o u ld  re lia b ly  a n d  c o n s is te n tly  a s s e s s  c h ild re n . T h e  B a y le y  ll l-V N  
d e m o n s tra te s  th e  c lo s e s t ra w  s c o re  p a tte rn  to  th e  U S  fro m  w h a t ca n  be  a c c e s s e d  
p u b lic a lly  a n d  b y  c re a tin g  lo ca l Z  s c o re s  fro m  th e  h e a lth y  p o p u la tio n , w e  h a ve  
u s e fu l d a ta  fo r  c o lle a g u e s  w o rk in g  in th e  fie ld  a s s e s s in g  c h ild re n  in L M IC s .
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4 .  O u t c o m e s  f o l l o w i n g  s e v e r e  H F M D
T h is  c h a p te r  p re s e n ts  th e  B a y le y  III a n d  n e u ro lo g ic a l e x a m in a tio n  s c o re s  fo r  
H F M D  c a s e s  a d m itte d  to  H T D  o v e r  6 m o n th s . T h e s e  s c o re s  w e re  c o m p a re d  to  a 
h e a lth y  c o h o rt o f  c h ild re n  o v e r  th e  s a m e  t im e  p e rio d . T w o  m e th o d s ; lin e a r  
re g re s s io n  and  p ro p e n s ity  s c o r in g , w e re  u se d  to  e v a lu a te  d iffe re n c e s  in s c o re s  
b e tw e e n  th e  tw o  g ro u p s  in o rd e r  to  d e te rm in e  s ix -m o n th  o u tc o m e s  fo llo w in g  
s e v e re  H F M D  in V ie tn a m .
4.1 R ecru itm en t
R e c ru itm e n t fro m  H T D  and  th e  c o m m u n ity  s ta rte d  J u n e  2 0 1 3  a n d  w a s  c o m p le te d  
by  D e c e m b e r 2 0 1 4 . T w o  h u n d re d  a n d  fo r ty  tw o  H F M D  c a s e s  a n d  291 h e a lth y  
c h ild re n  w e re  e n ro lle d  in th e  s tu d y . P r io r  to  th e  f irs t  n e u ro d e v e lo p m e n ta l 
a s s e s s m e n t, 2 1 (9 % ) H F M D  c a s e s  w ith d re w , 13/21 (6 1 % ) o f  th e s e  w e re  g ra d e  2 a  
ca s e s . A  fu r th e r  2 0 /2 4 2  (9 % ) w ith d re w  p r io r  to  th e  s e c o n d  a s s e s s m e n t a t 6 
m o n th s . O v e ra ll, 2 2 1 /2 4 2  (9 1 % ) o f  e n ro lle d  H F M D  c a s e s  a tte n d e d  th e  f irs t  
a s s e s s m e n t a n d  2 0 1 /2 4 2  (8 3 % ) a tte n d e d  th e  s e c o n d  a s s e s s m e n t. (F ig u re  4.1 
illu s tra te s  th e  e n ro lle d  H F M D  a n d  th e  w ith d ra w a ls .)
T h e  h e a lth y  c o m p a r is o n  g ro u p  had  2 /291  (< 1 % ) w ith d ra w a ls  p r io r  to  th e  f irs t  
a s s e s s m e n t a n d  4 3 /2 9 1  (1 5 % ) b e fo re  th e  s e c o n d . O v e ra ll 2 8 9 /2 9 1  (9 9 % ) o f  
e n ro lle d  h e a lth y  g ro u p  a tte n d e d  th e  f irs t  n e u ro d e v e lo p m e n ta l a s s e s s m e n t a n d  
248 /2 9 1  (8 4 % ) o f  e n ro lle d  h e a lth y  g ro u p  a tte n d e d  th e  s e c o n d  a s s e s s m e n t.
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4.2 Clinical features of H FM D
T h e  H F M D  g ra d e  on  a d m is s io n  w a s  re c o rd e d  in th e  C R F . H o w e ve r, c lin ica l 
fe a tu re s  w e re  o n ly  d e te rm in e d  p ro s p e c tiv e ly  fro m  e n ro lm e n t. T h is  w a s  d o n e  to  
a vo id  re tro s p e c tiv e  b ia s  o f in te rp re tin g  d o c u m e n ta tio n  fro m  c lin ic a l n o te s . T h e  
d is c h a rg e  g ra d e  o f  H F M D , (the  m o s t s e v e re  g ra d e  re a ch e d  d u r in g  a d m is s io n ) 
w a s  u se d  fo r  d e s c r ip t iv e  a n a ly s is  (T a b le  4 .1 , 4 .2 ). T h e re  w e re  no  s ig n if ic a n t 
d if fe re n c e s  in a g e  d is tr ib u tio n , g e n d e r and  p ro p o rtio n s  b e in g  ca re d  a t h o m e , 
k in d e rg a rte n  o r d a y  ca re  b e tw e e n  s e v e r ity  g ra d e s . M o s t o f th e  c h ild re n  in a ll 
g ra d e s  w e re  b e in g  lo o ke d  a fte r  a t h o m e . T h e re  w e re  s ig n if ic a n t d if fe re n c e s  in tim e  
to  e n ro lm e n t w ith  la te r  e n ro lm e n t t im e s  fo r  m o re  s e v e re  c h ild re n . L o n g e r d u ra tio n  
o f h o s p ita liz a tio n  and  s m a lle r  p ro p o rtio n s  o f c h ild re n  fro m  H C M C  w e re  a m o n g  th e  
m o re  s e v e re  d is e a s e  g ra d e s . 3 /7  (4 3 % ) o f g ra d e  4 w e re  fro m  H C M C  and  
p ro p o rtio n s  o f H C M C  c a s e s  fro m  d is tr ic t 8 w e re  42 /191  (2 2 % ). H T D  is a re g io n a l 
re fe rra l h o sp ita l and  e x p e c te d  to  re c e iv e  m o re  s e v e re  c a s e s  fro m  o u ts id e  H C M C .
Table 4.1 Demographic o f HFMD cases (includes those who w ith d re w  p r io r  to 
f irs t  assessment)
D ISC H AR G E G R AD ES OF HFMD
T o ta l g ra d e  2a g rade g rade g ra d e C o m p a r is o n
2b 3 4 E s tim a te  
(95% C I); p - 
va lu e
N 242 147 58 30 7
D e m o g ra p h ic s
G e n d e r (m ale) 142 (59%) 84 (57%) 36 (62%) 19 (63%) 3 (43%) 0.7078^
A g e  a t 
e n ro lm e n t 
(m o n th s ,
16.2 (10.0) 15.1 (8.7) 17.1(10.2)
19.7
(16.1)
18.7
(17.2)
KW = 4.22, df = 
3, p-value = 
0.24
m e d ia n , IQR)
HCM C o r ig in 191 (79%) 122 (83%) 42 (72%) 24 (80%) 3 (43%) 0.043 ^ *
D is tr ic t  8 42 (22%) 29 (24%) 6 (14%) 7 (29%) 0
Illn e s s  d a y  on 
a d m is s io n  
(days ) (m e d ia n ,
1(1) 1(1) 1(1) 1.5(1) 1(1.5)
KW = 4.91, df = 
3, p-value = 
0.18
IQR)
Illn e s s  d a y  on 3(2) 2(2) 4(2) 5(2) 5(5.5) KW = 107.89, df
184
DISCHARGE GRADES OF HFMD
T o ta l g ra d e  2a g rade
2b
g rade
3
g rade
4
C o m p a ris o n  
E s tim a te  
(95% C I); p- 
va lu e
e n ro lm e n t = 3, p-value <
(days) (m ed ian , 
IQR)
2.2e-167**
D u ra tio n  o f KW = 18.90 df =
h o s p ita l s ta y  
(days) (m e d ia n , 
IQR)
5(2) 5(2.5) 6(2) 6(2) 7(9.5) 3, p-value = 0.00029**
A tte n d s
d a yca re
35 (14%) 22 (15%) 11 (19%) 2 (7%) 0
A tte n d s
K in d e rg a rte n
34 (14%) 21 (14%) 7 (12%) 4 (13%) 2 (29%) 0.62^
L o o ke d  a fte r  a t 
hom e
173 (71%) 104 (71%) 40 (69%) 24 (80%) 5 (71%)
H7 Fisher's exact test, KW: Kruskal-Wallis chi-squared, *p-value<0.05 
T h e re  w e re  1 7 1 /2 4 2  (7 1 % ) H F M D  c a s e s  w ith  g ra d e  2a  e n ro lle d , a n d  o f  th e s e  16 
(9 % ) p ro g re s s e d  to  g ra d e  2 b  a n d  19 (1 1 % ) to  g ra d e  3 o r 4 . O f th e  5 5 /2 4 2  (2 3 % ) 
H F M D  c a s e s  e n ro lle d  w ith  g ra d e  2b , 13 (2 4 % ) p ro g re s s e d  to  g ra d e  3 o r 4 . N o 
ca s e s  w e re  a d m itte d  a t g ra d e  4. (T a b le  4 .2 ).
Table 4.2 Adm ission, E nro lm ent and Discharge HFMD Grades
D IS C H A R G E  G R A D E S  O F  H F M D
Total grade 2a grade 2b grade 3 grade 4
N u m b e r o f  cases 242 147 58 30 7
g ra d e  on  a d m is s io n
g ra d e  1 7 4 (3%) 0 3 (10%) 0
g rade  2a 171 136 (93%) 16 (28%) 14 (47%) 5 (71%)
g rade  2b 55 1 (1%) 41 (71%) 12 (40%) 1 (14%)
g rade  3 2 0 0 1 (3%) 1 (14%)
g ra d e  4 0 0 0 0 0
N o t kn o w n 7 6 (4%) 1 (2%) 0 0
g rade  on  E n ro lm e n t
g rade  1 0 0 0 0 0
g rade  2a 146 146 (99%) 0 0 0
g rade  2b 61 1 (1%) 58 2 (7%) 0
g rade  3 33 0 0 28 (93%) 5 (71%)
grade  4 2 0 0 0 2 (29%)
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4.2.1 Clinical characteristics of HFMD cohort at Enrolment
T h e  m e d ia n  d a y  o f e n ro lm e n t w a s  3 d a y s  a fte r  a d m is s io n  (T a b le  4 .1 ). T h e  
c lin ic ia n  fo llo w in g  V ie tn a m e s e  g u id e lin e s  re c o rd e d  g ra d in g  o f  s e v e r ity . T h e  C R F  
d id  n o t re q u e s t s p e c if ic a tio n  o f  w h y  th e  g ra d in g  w a s  c h o s e n  a n d  re c o rd e d  th e  
in itia l c la s s if ic a tio n  fro m  th e  n o te s . S in c e  c lin ic a l fe a tu re s  w e re  o n ly  d e te rm in e d  
p ro s p e c tiv e ly  fro m  e n ro lm e n t, s o m e  c lin ic a l fe a tu re s  m a y  h a ve  re s o lv e d  fro m  
a d m is s io n  b u t th e  g ra d in g  d o e s  n o t c h a n g e  fro m  th e  m o s t s e v e re  g ra d in g  d u r in g  
th e  il ln e s s  e p is o d e .
T h e re  w e re  s ig n if ic a n t d if fe re n c e s  b e tw e e n  s e v e r ity  g ra d e s  in th e  re p o rtin g  o f 
fe v e r, irr ita b ility , m y o c lo n u s  a n d  tre m o r  a t e n ro lm e n t. C h ild re n  w ith  g ra d e  2 a  had  
h ig h e r p ro p o rtio n s  o f  fe v e r  o n  e n ro lm e n t w h e re a s  th e  c h ild re n  w ith  g ra d e  > 2 b  had  
h ig h e r p ro p o rt io n s  o f  irr ita b ility , m y o c lo n u s  a n d  tre m o r. (T a b le  4 .3 )  T h e re  w a s  a 
s ig n if ic a n t d if fe re n c e  in p ro p o rt io n s  o f  c h ild re n  w ith  a rash , w ith  h ig h e r  n u m b e rs  o f 
c h ild re n  w ith  le ss  s e v e re  g ra d e s  p re s e n tin g  w ith  a ra sh  a t e n ro lm e n t, b u t c h ild re n  
w ith  m o re  s e v e re  g ra d e s  p re s e n tin g  w ith  a v e s ic u la r  ra th e r  th a n  a m a c u la r  ra sh  a t 
e n ro lm e n t. A d d it io n a lly , th e re  w e re  s ig n if ic a n t ly  h ig h e r p ro p o rt io n s  o f  c h ild re n  w ith  
le ss  s e v e re  g ra d e s  p re s e n tin g  w ith  m o u th  u lc e rs  a t e n ro lm e n t. (T a b le  4 .4 )
A ll c a s e s  had  n o rm a l B la n ty re  c o m a  s c a le  s c o re  on  e n ro lm e n t, e x c e p t o n e  ch ild  
w ith  g ra d e  4  d is e a s e . A n o th e r  ch ild  w ith  g ra d e  2 b  had  c ra n ia l n e rv e  p a ls y  (n o t 
s p e c if ie d  a n d  o n ly  on  a d m is s io n  d a y )  a n d  a n o th e r  c h ild  w ith  g ra d e  2 b  p re s e n te d  
w ith  tre m o r. O n e  g ra d e  4  ch ild  had  le ft 6 th a n d  7 th lo w e r m o to r  n e u ro n  c ra n ia l 
n e rve  p a ls y  a n d  r ig h t lo w e r lim b  w e a k n e s s . O n e  c h ild  e n ro lle d  a t g ra d e  4  h a d  a 
p e rs is te n t tre m o r  (T a b le  4 .5 ). A s  e x p e c te d , c h ild re n  w ith  m o re  s e v e re  g ra d e s  had  
m o re  in te rv e n tio n s  a n d  th e  tw o  c h ild re n  w ith  g ra d e  4  re q u ire d  v e n t ila t io n  (T a b le  
4 .6 ). A ll c h ild re n  w e re  re c o rd e d  as  fu lly  re c o v e re d  b y  d is c h a rg e  e x c e p t tw o
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c h ild re n  w ith  g ra d e  4  d is e a s e . T h e s e  tw o  c h ild re n  w h o  d id  n o t fu lly  re c o v e r  a t 
d is c h a rg e  w e re  a 3 5  m o n th  o ld  g ir l fro m  D a k  N o n g  w h o  had  p e rs is te n t c ra n ia l 
n e rv e  p a ls y  a n d  a 2 6  m o n th  o ld  b o y  fro m  B in h  D in h  w h o  had  tre m o r  a t d is c h a rg e . 
T h e  g ir l w a s  e n te ro v iru s  A71 (E V -A 7 1 ) p o s it iv e  on  R T -P C R  a n d  th e  b o y  had  a 
n e g a tiv e  R T -P C R  re su lt. E V -A 71  w a s  a s s o c ia te d  w ith  m o re  s e v e re  g ra d e s  a n d  
c o x s a c k ie v iru s  A 6  (C V A 6 ) w ith  le ss  s e v e re  g ra d e s .
T h e  d if fe re n c e  in t im e  b e tw e e n  a d m is s io n  a n d  e n ro lm e n t m e a n t s o m e  fe a tu re s  
th a t had  re s u lte d  in th e  in it ia lly  c la s s if ic a tio n  o f  H F M D  m a y  h a v e  re s o lv e d  b y  
e n ro lm e n t. H o w e v e r, th e  c h ild ’s H F M D  g ra d e  d o e s  n o t a lte r  d e s p ite  no  lo n g e r  
c o n tin u in g  to  f i t  th e  c r ite r ia , e .g . re s o lu tio n  o f  m y o c lo n u s  by  e n ro lm e n t.
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4.3  N eurology a ssessed  w ith th e  Amiel-Tison tool
87/147 (59%) children at grade 2a and 34/58 (59%) grade 2b, 34/37 (92%) grade 
>2b had an Amiel-Tison examination a week after discharge. 73/147 (50%) 
children at grade 2a, 25/58 (43%) grade 2b, 23/37 (62%) grade >2b had 
neurology examination at 6 months follow-up. 47/147 (32%) children at grade 2a, 
17/58 (29%) grade 2b, 17/37 (46%) grade >2b had both the first examination one 
week post discharge and the second at 6 months. (Figure 4.2).
The modified scoring of Amiel-Tison (Table 2.2-2.4) classified 21/160 
assessments (13%) of grade 2a children with an abnormal examination in at least 
one section resulting in 4/113 (4%) children classified with mild abnormality and 
3/113 (3%) with moderate abnormalities. 13/58 (22%) assessments of grade 2b 
children had an abnormality in at least one section resulting in 1/58 (2%) child 
classified as mild abnormality. 7/37 (19%) assessments of >grade 2b children had 
an abnormal examination in at least one section resulting in 1/37 (3%) classified 
with moderate abnormality. The classification is different depending on age 
groups. All 17 children assessed age 3-9 months had a normal examination. 
7/136 (5%) of 10-24 month olds had an abnormal classification. 4/79 (5%) of 24- 
48 month old children had an abnormal classification (Tables 4.8-4.10). There 
were 24 children who had the first assessment at 10-24 months and the second at 
24-48 months and there were 11 children who had the first assessment at 3-9 
months and the second at 10-24 months. There was only one child (code 01) who 
had persistent abnormal classifications between two assessments (Table 4.10). 
Child code 01 had grade 4 HFMD and had a persistent lower motor 7th cranial 
nerve palsy, development of restrictive jaw movements and reported clumsiness 
when walking and was unable to run. Using the modified criteria, she had
195
restricted passive movement and abnormal motor activity but could walk, so was 
classified as moderate abnormality. Three children had mild abnormalities at the 
first assessment but were classified as normal 6 months later. Two children had 
moderate abnormalities at the first assessment but were classified as normal 6 
months later, and one child (code 586) was classified as normal at the first 
assessment but had moderate abnormality at the second assessment (Table 
4.11). The children who were classified as normal 6 months later may have had 
difficulty assessing all sections as noted in child 607 who was not co-operative 
(Table 4.9).
In summary there was no significant difference in prevalence of abnormality 
between Grades HFMD (Table 4.12).
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Figure 4.2 HFMD Discharge Grade cases with Amiel-Tison per visit
Grade 2a
(113/147)
1st assessment /  B o th \ 2nd assessment
47
Grade 2b
(42/58)
1st assessment /  B o tn \ 2nd assessment
Grade >2b
(37/37)
1st assessment /  B o tn \ 2nd assessment
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2
4.4 D istribution of covariates for Bayley I I I  score analysis
4.4.1 HFMD cohort
The numbers of children enrolled at grade 3 and 4 were small and for analysis 
were combined to form group >2b. Despite the loss to follow-up, there was no 
significant difference in age distribution, stunting, gender or maternal education 
between total HFMD cases at enrolment, 1st assessment and 2nd assessment. 
(Table 4.13).
At enrolment, there were no significant differences in age between HFMD grades 
(Kruskal-Wallis chi-squared = 4.22, df = 3, p-value = 0.24), gender (p-value = 
0.71), stunting (p-value = 0.21) and maternal education levels (p-value = 0.93). 
There was no significant difference in proportions of severity of HFMD at each 
assessment (X-squared = 0.69, df = 6, p-value = 0.99).
203
4.4.2 Healthy cohort and grade 2a HFMD
The age range from the healthy comparison group was limited to same range as 
the HFMD cases (4.5 months to 42 months) hence 23 healthy cases were 
excluded. Table 4.14 shows the distribution of covariates for the included healthy 
comparison group.
There were no significant differences in age between the children enrolled at 
grade 2a HFMD and the healthy comparison group (Kruskal-Wallis chi-squared = 
0.65, df = 1, p-value = 0.42), gender (p-value=0.7476) and stunting (p-value = 
0.8528). However, there was a significant differences in the levels of maternal 
education (p-value < 2.2e-16), with the higher proportions of secondary and 
higher education in the healthy comparison group compared to grade 2a HFMD.
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4 .4 .3  Age distribution at first a ssessm en t and second  a ssessm en t
The validation of Bayley in Chapter 3 identified the large influence of age on 
scores. To adjust for this, Z scores were created by splitting the healthy cohort 
into 13 age-groups to calculate mean and standard deviation (SD) of raw scores, 
and from these calculate Z scores of the HFMD children. Further linear regression 
adjustment was done using the healthy comparison group data. The following 
plots show the different groups’ means and medians of age distribution. (Figure 
4.3)
Using the Z scores, further age adjustment by linear regression was carried out. 
This was to adjust for the fact that there were no significant difference in age 
distribution between groups (Healthy, grade 2a, grade 2b, and grade >2b) at the 
first assessment (Kruskal-Wallis chi-squared = 2.1616, df = 3, p-value = 0.5396) 
but there was a significant difference in age distribution between groups at the 
second (Kruskal-Wallis chi-squared = 9.6513, df = 3, p-value = 0.02178).
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Figure 4.3 Age distributions density plots with medians at assessment by group
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4.5 Bayley I I I  scores by domain
4.5.1 Missing Bayley III scores
In total, 201 children with HFMD remained in the study at 6 months follow up. 
However, despite attending appointments, some children did not cooperate or had 
incomplete assessments and did not agree to return again to complete 
assessments. At 6 months, 119/146 (82%) children with grade 2a, 45/61 (74%) 
grade 2b, 34/37 (92%) >grade 2b (grade 3 and 4) had returned and completed 
assessments. Two children in grade 4 were ventilated during their admission. The 
more severe child was in hospital for 42 days. She is from an ethnic minority 
group that doesn’t use Vietnamese as their first language so the language 
domains could not be assessed. She was too weak to cooperate with the first 
assessment after discharge. After 6 months she completed the cognitive, fine and 
gross motor domains only.
Tables 4.15-4.18 evaluate differences in covariates between the children who had 
an assessment and those who did not for each grade of HFMD and for the 
healthy cohort.
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The data suggest missing Bayley scores were random for the HFMD group but 
not for the healthy group. The methods for regression analysis and propensity 
scores require minimal missing covariate data, which the study data satisfy. 
Dealing with non random missing outcomes in one subset of a dataset requires 
complex modelling and there is debate whether this process improves precision or 
bias.403 For this reason, no imputation for missing outcomes was carried out. 
Since the HFMD data has missing data at random outcome scores, comparisons 
between grades, with grade 2a as baseline using the propensity score is useful to 
determine whether a difference between the more severe groups and the healthy 
group are biased by limited outcome scores from children from families with lower 
maternal education and stunted children.
4.5.2 Bayley III score descriptive analysis
Unadjusted median Z scores were lower than healthy group with increasing grade 
of HFMD for all domains at the first assessment. Median cognitive scores were 
lower than the healthy group at the second assessment for all grades. There was 
improvement in receptive and expressive median Z scores between assessments 
in grade 3 and 4. Grade 3 had improvement in fine and gross motor median Z 
scores between assessments, while median Z scores of grade 4 got worse. Plots 
of Z scores by group at each assessment time and changes in Z scores between 
assessments were similar for all groups. (Table 4.19 and Figure 4.4)
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4.5.3 Linear Regression
Univariate and multiple linear regression were used to adjust the Z scores for age, 
gender, maternal education and stunting. (Table 4.24) A reduced cognitive Z 
score at the second assessment was associated with grade 2a and >2b on 
univariate linear regression alone. A reduced expressive Z score associated with 
grade 2b and >2b persisted after adjustment for the first assessment but not the 
second assessment. Grade 2b and >2b were associated with lower fine motor Z 
scores at the first assessment but not the second. At the first assessment grade 
2b were associated with lower gross motor Z scores, but on the second 
assessment lower Z scores were associated with grade 2a and >2b. There was a 
positive change in receptive Z scores associated with grade 2b between the two 
assessments. Linear regression is limited by the assumption that the covariates 
operate in a linear fashion.
4.5.4 Propensity score analysis
Propensity score matching is a statistical technique where each control is 
weighted based on the probability of having the same covariate distribution as a 
HFMD case, i.e. “conditional probability of receiving the treatment rather than 
being part of the control group given the observed covariates.”404 It is a way of 
replicating a randomised control experiment with regards to covariate distribution. 
The healthy child is weighted on a propensity score in relation to the probability of 
having the same covariates as a HFMD child prior to knowing outcomes. This 
method assumes the covariates are not dependent on the group selection i.e. 
HFMD or healthy.405 For each healthy propensity weighted outcome score, the 
difference in means in the outcome variable between the HFMD and control gives 
an estimate of the mean effect of HFMD on the outcome at that propensity score
222
value (average treatment effect on the treated (ATT)), which results in an 
unbiased estimate. Using the propensity weighted data to do further covariate 
adjustment will reduce bias in estimates, as long as certain criteria are fulfilled.405 
Propensity weighting can be done multiple times till the best balance on 
covariates are achieved.361
I used the “Toolkit for weighting and analysis of nonequivalent groups 
(TWANG)”406 for propensity score weighting between healthy and grade 2a, and 
between grade 2a, 2b and >2b. The weighted healthy sample was used to 
evaluate the effect of grade 2a HFMD cases on scores at enrolment, at 6 months 
and differences in scores between the two assessments. Then the grade 2a 
sample was used to evaluate the effect of grade 2b, and >2b HFMD on scores at 
enrolment and six months later. This was done to evaluate whether >grade 2a 
HFMD affected scores. No assumptions about outcome were made for children 
lost to follow-up.
As discussed in section 2.10.6, the benefits of modelling using adjusted 
propensity weighting over modelling using adjusted linear regression is that the 
covariates are better matched, reducing bias, particularly if there is poor overlap 
between covariates on some of the covariates.407 In this study, more differences 
between groups were identified with maternal education: an important covariate 
from the literature of neurodevelopmental outcomes.
4.5.4.1 Balancing covariates
The covariates (age, maternal education, sex, stunting) of the children in the 
healthy comparison group were weighted to the children in grade 2a and balance
223
distributions were evaluated 408
Balance was achieved with all Kolmogorov-Smirnov distances (KS) <0.06, where 
0 suggests the distributions between the weighted healthy covariates, and the 
grade 2a covariates are the same. (Tables 4.20-4.23) Once balanced, the weights 
allocated to the healthy children were used to calculate the average affect of 
HFMD (i.e. average treatment effect on the treated: ATT) on grade 2a children 
and then, using weights on grade 2a children to match either grade 2b or >2b, the 
average effect of more severe HFMD on grade 2b and >grade 2b was calculated.
Table 4.20 Balance of covariates in children w ith  grade 2a HFMD and children  
in healthy group: 270 Healthy children covariates weighted to 133 grade 2a
Mean of grade 
2a
Mean of 
weighted  
Healthy group
KS Pre-weighted  
Mean of Healthy  
Group
Statistical notation E(Y1$|$t=1) E(Y0$|$t=1) E(Y0$|$t=0)
Age 17.34 17.08 0.04 17.89
Maternal 
Education: 
No School/ 
Primary
0.35 0.34 0.02 0.16
Secondary 0.53 0.54 0.01 0.47
Higher 0.11 0.12 0.01 0.37
Male 0.59 0.55 0.04 0.54
Female 0.41 0.45 0.04 0.47
Not Stunted 0.84 0.82 0.02 0.83
Stunt 0.16 0.18 0.02 0.17
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Table 4.21 Balance of the grade 2a and grade 2b, grade 2a and >grade 2b: 133 
grade 2a covariates weighted to 50 grade 2b, 133 grade 2a covariates weighted  
to 36 grade >2b
Mean grade 
2b
Mean of 
weighted 
grade 2a
KS Pre-weighted 
Mean grade 
2a
Statistical
notation
E(Y1$|$t=1) E(Y0$|$t=1) E(Y0$|$t=0)
Age 18.77 18.48 0.05 17.34
Maternal 0.38 0.34 0.04 0.35
Education:
No School/
Primary
Secondary 0.48 0.52 0.04 0.53
Higher 0.14 0.14 0.00 0.11
Male 0.64 0.59 0.05 0.59
Female 0.36 0.41 0.05 0.41
Not Stunted 0.80 0.81 0.01 0.84
Stunt 0.18 0.19 0.01 0.16
Missing Stunt 0.02 0.00 0.02 0.00
grade >2b age limit was 36 months and this limit was applied to grade 2a hence different pre- 
weighted mean values______________________________________________________________
Mean grade 
>2b
Mean of 
weighted 
grade 2a
KS Pre-weighted 
Mean grade 
2a
Statistical
notation
E(Y1$|$t=1) E(Y0$|$t=1) E(Y0$|$t=0)
Age 19.48 19.33 0.06 17.03
Maternal 0.33 0.30 0.03 0.34
Education:
No School/
Primary
Secondary 0.56 0.58 0.03 0.54
Higher 0.11 0.11 0.00 0.12
Male 0.61 0.62 0.01 0.59
Female 0.39 0.38 0.01 0.41
Not Stunted 0.97 0.96 0.01 0.84
Stunt 0.03 0.04 0.01 0.16
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Table 4.22 Second assessment: 205 healthy covariates balanced to 119 grade 
2a covariates
Mean of 
grade 2a
Mean of 
weighted 
matched 
Healthy 
group
KS Pre-weighted 
Mean of 
Healthy 
Group
Statistical
notation
E(Y1$|$t=1) E(Y0$|$t=1) E(Y0$|$t=0)
Age 17.53 17.37 0.06 16.38
Maternal 0.33 0.29 0.04 0.14
Education: 
No School/ 
Primary
Secondary 0.55 0.56 0.02 0.47
Higher 0.13 0.15 0.02 0.39
Male 0.58 0.53 0.05 0.51
Female 0.42 0.47 0.05 0.49
Not Stunted 0.85 0.84 0.00 0.84
Stunt 0.15 0.15 0.00 0.16
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Table 4.23 Balance of the grade 2a and grade 2b, grade 2a and >grade 2b: 119  
grade 2a covariates weighted to 42 grade 2b, 118 (age-lim ited to match grade 
>2b) grade 2a covariates weighted to 35 grade >2b
Mean grade 
2b
Mean of 
weighted 
grade 2a
KS Pre-weighted 
Mean grade 
2a
Statistical
notation
E(Y1$|$t=1) E(Y0$|$t=1) E(Y0$|$t=0)
Age 17.76 17.62 0.06 17.53
Maternal 0.41 0.35 0.06 0.33
Education:
No School/
Primary
Secondary 0.45 0.51 0.06 0.55
Higher 0.14 0.15 0.00 0.13
Male 0.64 0.59 0.05 0.58
Female 0.36 0.41 0.05 0.42
Not Stunted 0.83 0.85 0.01 0.85
Stunt 0.14 0.15 0.01 0.15
Missing stunt 0.02 0.00 0.02 0.00
Age limits of grade 2a was limited to match grade >2b age range
Mean grade 
>2b
Mean of 
weighted 
grade 2a
KS Pre-weighted 
Mean grade 
2a
Statistical
notation
E(Y1$|$t=1) E(Y0$|$t=1) E(Y0$|$t=0)
Age 19.79 19.95 0.06 17.37
Maternal
Education:
No
School/Primary
0.34 0.31 0.04 0.32
Secondary 0.54 0.59 0.04 0.55
Higher 0.11 0.11 0.01 0.13
Male 0.60 0.63 0.03 0.58
Female 0.40 0.37 0.03 0.41
Not Stunted 0.97 0.97 0.00 0.85
Stunt 0.03 0.03 0.00 0.15
Results of propensity score weighted analysis and presented in Table 4.24
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2
4.5.5 Results of linear regression and propensity score analysis
4.5.5.1 Cognitive scores 
1st A s s e s s m e n t
C o m p a re d  to  h e a l th y  g ro u p  a n d  following a d ju s tm e n t ,  g r a d e  2 a  h a d  low er  Z 
s c o r e s  up  to  -0 .3 4  a n d  -0 .4 4  by 9 5 %  Cl limits l inea r  r e g re s s io n  (LG) a n d  
p ro p en s i ty  w e ig h te d  s c o r e  (P W S )  respec tive ly .  G r a d e  2b , h a d  low er  Z  s c o r e s  up  
to  -0.61 c o m p a r e d  to  h e a l th y  (LR) a n d  -0 .6  c o m p a r e d  to g r a d e  2 a  (P W S ). G r a d e  
> 2b  h a d  low er Z  s c o r e s  u p  to -0 .6 0  c o m p a r e d  to  h e a l th y  (LR) a n d  -0 .52  c o m p a r e d  
to  g r a d e  2 a  (P W S ).
2 nd A s s e s s m e n t
C o m p a re d  to  h e a l th y  g ro u p  a n d  following a d ju s tm e n t ,  g r a d e  2 a  h a d  low er  Z  
s c o r e s  u p  to -0 .4 3  a n d  -0.51 by LG a n d  P W S  re spec tive ly .  G r a d e  2b , h a d  low er  Z 
s c o r e s  u p  to  -0 .4 9  c o m p a r e d  to he a l th y  (LR) a n d  -0 .5 4  c o m p a r e d  to g r a d e  2 a  
(P W S ). G r a d e  > 2 b  h a d  low er  Z  s c o r e s  up  to  -0 .71 c o m p a r e d  to  h e a l th y  (LR) a n d  
m arg inally  positive  coeff ic ien ts  with Z  s c o r e s  u p  to  0 .5 6  c o m p a r e d  to g r a d e  2 a  
(PW S ).
D i f f e r e n c e  in C o g n i t i v e  s c o r e s
C o m p a re d  to h e a l th y  g ro u p  a n d  following a d ju s tm e n t ,  g r a d e  2 a  h a d  n e g a t iv e  
c h a n g e  in Z  s c o r e s  up  to  -0 .3 8  by LG a n d  P W S . G r a d e  2b , h a d  n e g a t iv e  c h a n g e  
in Z  s c o r e s  u p  to -0 .4 3  c o m p a r e d  to  h e a l th y  (LR) a n d  m arg inally  posit ive  
coeff ic ien ts  with c h a n g e  in Z  s c o r e  up  to  0 .4 9  c o m p a r e d  to  g r a d e  2 a  (P W S ).  
G r a d e  > 2 b  h a d  n e g a t iv e  c h a n g e  in Z  s c o r e s  u p  to -0 .5 4  c o m p a r e d  to  h e a l th y  (LR) 
a n d  pos itive  coeff ic ien ts  with c h a n g e  in Z  s c o r e  u p  to  0 .7 3  c o m p a r e d  to  g r a d e  2 a  
(PW S ).
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4.5.5.2 Receptive language scores 
1st A s s e s s m e n t
C o m p a re d  to h e a l th y  g ro u p  a n d  following a d ju s tm e n t ,  g r a d e  2 a  h a d  low er  Z 
s c o r e s  up  to -0 .3 9  a n d  -0 .3 7  by LG a n d  P W S  re spec tive ly .  G r a d e  2b , h a d  
significantly  low er Z  s c o r e s  u p  to -0 .8 2  c o m p a r e d  to h e a l th y  (LR) a n d  -0 .75  
c o m p a r e d  to g r a d e  2 a  (P W S ). G r a d e  > 2 b  h a d  significantly  low er  Z  s c o r e s  u p  to  - 
0 .9 2  c o m p a r e d  to h e a l th y  (LR) a n d  -0 .7 6  c o m p a r e d  to g r a d e  2 a  (P W S ),  w hich  
w a s  no t significant.
2 nd A s s e s s m e n t
C o m p a re d  to  he a l th y  g ro u p  a n d  following a d ju s tm e n t ,  g r a d e  2 a  h a d  low er  Z 
s c o r e s  u p  to  -0.51 by LG a n d  P W S . G r a d e  2b , h a d  low er Z  s c o r e s  u p  to -0 .5 6  
c o m p a r e d  to  he a l th y  (LR) a n d  -0 .5 8  c o m p a r e d  to g r a d e  2 a  (P W S ).  G r a d e  > 2 b  h a d  
positive  coeff ic ien t with Z  s c o r e s  u p  to  0 .4 3  c o m p a r e d  to  h e a l th y  (LR) a n d  0 .9 3  
c o m p a r e d  to  g r a d e  2 a  (P W S ).
D i f f e r e n c e  in R e c e p t i v e  l a n g u a g e  s c o r e s
C o m p a re d  to h e a l th y  g ro u p  a n d  following a d ju s tm e n t ,  g r a d e  2 a  h a d  n e g a t iv e  
c h a n g e  in Z  s c o r e s  u p  to  -0 .3 4  a n d  -0 .3 3  by LG a n d  P W S  resp e c t iv e ly .  G r a d e  2b, 
h a d  positive  coeff ic ien ts  with c h a n g e  in Z  s c o r e s  up  to  0 .6 4  c o m p a r e d  to  h e a l th y  
(LR) a n d  0 .5 4  c o m p a r e d  to  g r a d e  2 a  (P W S ). G r a d e  > 2 b  h a d  s ignificantly  
im proved  c h a n g e  in Z  s c o r e s  up  to 1 .0 6 6  c o m p a r e d  to h e a l th y  (LR) a n d  1 .30  
c o m p a r e d  to  g r a d e  2 a  (P W S ).
4.5.5.3 Expressive language scores 
1st A s s e s s m e n t
C o m p a re d  to he a l th y  g ro u p  a n d  following a d ju s tm e n t ,  g r a d e  2 a  h a d  lo w er  Z 
s c o r e s  u p  to  -0 .4 6  by LG a n d  significantly  low er  Z  s c o r e s  by -0 .4 9  u s in g  P W S .
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G r a d e  2b , h a d  significantly  low er Z  s c o r e s  up  to -0.71 c o m p a r e d  to  h e a l th y  (LR) 
a n d  -0 .47  c o m p a r e d  to g r a d e  2 a  (P W S ), w hich  w a s  no t significant, g r a d e  > 2b  h a d  
significantly  low er  Z  s c o r e s  u p  to  -0 .7 8  c o m p a r e d  to  h e a l th y  (LR) a n d  -0 .46  
c o m p a r e d  to  g r a d e  2 a  (P W S ), w hich  w a s  no t significant.
2 nd A s s e s s m e n t
C o m p a re d  to  h e a l th y  g ro u p  a n d  following a d ju s tm e n t ,  g r a d e  2 a  h a d  low er  Z 
s c o r e s  u p  to  -0 .4 6  a n d  -0 .4 8  by LG a n d  P W S  respec tive ly .  G r a d e  2b , h a d  low er  Z 
s c o r e s  up  to  -0 .4 6  c o m p a r e d  to h e a l th y  (LR) a n d  -0 .4 0  c o m p a r e d  to  g r a d e  2 a  
(P W S ). G r a d e  > 2b  h a d  low er  Z  s c o r e s  u p  to  -0 .4 0  c o m p a r e d  to  h e a l th y  (LR) a n d  
a  positive  coeff ic ien t with Z  s c o r e s  up  to 0 .8 4  c o m p a r e d  to  g r a d e  2 a  (P W S ).  
D i f f e r e n c e  in E x p r e s s i v e  l a n g u a g e  s c o r e s
C o m p a re d  to h e a l th y  g ro u p  a n d  following a d ju s tm e n t ,  g r a d e  2 a  h a d  n e g a t iv e  
c h a n g e  in Z  s c o r e s  u p  to  -0 .2 9  a n d  -0 .3 3  by LG a n d  P W S  resp e c t iv e ly .  G r a d e  2b , 
h a d  positive  c h a n g e  in Z  s c o r e s  u p  to  0 .5 2  c o m p a r e d  to  h e a l th y  (LR) a n d  0 .4  
c o m p a r e d  to  g r a d e  2 a  (P W S ). G r a d e  > 2 b  h a d  positive  c h a n g e  in Z  s c o r e s  u p  to 
0 .7 7  c o m p a r e d  to  h e a l th y  (LR) a n d  0 .8 3  c o m p a r e d  to g r a d e  2 a  (P W S ).
4.5 .5A  Fine motor scores 
1st A s s e s s m e n t
C o m p a re d  to  h e a l th y  g ro u p  a n d  following a d ju s tm e n t ,  g r a d e  2 a  h a d  lo w er  Z  
s c o r e s  u p  to  -0 .4 4  by  LG a n d  significantly  low er  Z  s c o r e s  by -0 .5 0  u s in g  P W S . 
G r a d e  2b , h a d  low er Z  s c o r e s  up  to -0 .5 0  c o m p a r e d  to  h e a l th y  (LR) a n d  a  pos it ive  
coeff ic ien t with h ig h e r  Z  s c o r e s  up  to  0 .4 7  c o m p a r e d  to  g r a d e  2 a  (P W S ).  G r a d e  
> 2 b  h a d  significantly  low er  Z  s c o r e s  u p  to  -0 .8 9  c o m p a r e d  to  h e a l th y  (LR) a n d  - 
0 .7 9  c o m p a r e d  to  g r a d e  2 a  (PW S ), w hich  w a s  no t  significant.
235
2nd Assessment
C o m p a re d  to  h e a l th y  g ro u p  a n d  following a d ju s tm e n t ,  g r a d e  2 a  h a d  n e g a t iv e  
c h a n g e  in Z  s c o r e s  u p  to  -0 .3 6  a n d  -0 .4 0  by LG a n d  P W S  re spec tive ly .  G r a d e  2b , 
h a d  n e g a t iv e  c h a n g e  in Z  s c o r e s  up  to -0 .52  c o m p a r e d  to  h e a l th y  (LR) a n d  -0 .4 5  
c o m p a r e d  to  g r a d e  2 a  (P W S ). G r a d e  > 2b  h a d  n e g a t iv e  c h a n g e  in Z  s c o r e s  up  to  - 
0 .5 0  c o m p a r e d  to  h e a l th y  (LR) bu t positive  c h a n g e  in Z  s c o r e s  up  to  0 .5 7  
c o m p a r e d  to g r a d e  2 a  (P W S ).
D i f f e r e n c e  in F in e  M o to r  s c o r e s
C o m p a re d  to  h e a l th y  g ro u p  a n d  following a d ju s tm e n t ,  g r a d e  2 a  h a d  a  posit ive  
c h a n g e  in Z  s c o r e s  u p  to -0 .1 9  a n d  -0 .1 5  by LG a n d  P W S  resp ec tiv e ly ,  g r a d e  2b , 
h a d  w o r s e n e d  Z  s c o r e s  u p  to  -0 .5 2  c o m p a r e d  to he a l th y  (LR) a n d  -0 .6 8  c o m p a r e d  
to g r a d e  2 a  (P W S ). g r a d e  > 2 b  h a d  positive  c h a n g e  in Z  s c o r e s  u p  to  0 .8 9  
c o m p a r e d  to  h e a l th y  (LR) a n d  significantly  im proved  Z s c o r e  u p  to  1 .0 4 3  
c o m p a r e d  to  g r a d e  2 a  (P W S ).
4.5.6.5 Gross M otor scores 
1st A s s e s s m e n t
C o m p a re d  to  h e a l th y  g ro u p  a n d  following a d ju s tm e n t ,  g r a d e  2 a  h a d  lo w er  Z 
s c o r e s  u p  to  -0 .4 8  by  LG a n d  significantly  low er  Z  s c o r e s  by -0 .5 8  u s in g  P W S . 
G r a d e  2b , h a d  significantly  low er Z  s c o r e s  up  to  -0 .9 5  c o m p a r e d  to  h e a l th y  (LR) 
a n d  -0 .8 7  c o m p a r e d  to  g r a d e  2 a  (P W S ), bu t  w a s  no t significant. G r a d e  > 2 b  h a d  
significantly  low er Z  s c o r e s  up  to  -0 .8 0  c o m p a r e d  to  h e a l th y  (LR) a n d  -0 .6 6  
c o m p a r e d  to g r a d e  2 a  (P W S ), w hich  w a s  no t significant.
2 nd A s s e s s m e n t
C o m p a re d  to h e a l th y  g ro u p  a n d  following a d ju s tm e n t ,  g r a d e  2 a  h a d  s ignif icantly  
low er Z  s c o r e s  up  to  -0 .5 9  a n d  -0 .6 7  by LG a n d  P W S  re spec tive ly .  G r a d e  2b , h a d
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low er Z  s c o r e s  up  to -0 .5 6  c o m p a r e d  to  h e a l th y  (LR) bu t posit ive  coeff ic ien t  with Z 
s c o r e s  u p  to 0 .4  h ig h e r  c o m p a r e d  to g r a d e  2 a  (P W S ). G r a d e  > 2b  h a d  significantly  
low er  Z  s c o r e s  up  to  -0 .6 7  c o m p a r e d  to  he a l th y  (LR) bu t im proved  Z s c o r e s  up  to 
0 .5 8  c o m p a r e d  to  g r a d e  2 a  (P W S ),  w hich  w a s  no t significant.
D i f f e r e n c e  in G r o s s  M o to r  s c o r e s
C o m p a re d  to h e a l th y  g ro u p  a n d  following a d ju s tm e n t ,  g r a d e  2 a  h a d  n e g a t iv e  
c h a n g e  in Z  s c o r e s  up  to  -0.41 a n d  -0 .4 5  by LG a n d  P W S  resp e c t iv e ly .  G r a d e  2b, 
h a d  pos itive  c h a n g e  in Z  s c o r e s  u p  to  0 .7 3  c o m p a r e d  to h e a l th y  (LR) a n d  0 .8 4  
c o m p a r e d  to  g r a d e  2 a  (P W S ). G r a d e  > 2 b  h a d  positive  c h a n g e  in Z  s c o r e s  u p  to 
0 .6 2  c o m p a r e d  to  h e a l th y  (LR) a n d  0 .8  c o m p a r e d  to  g r a d e  2 a  (P W S ).
4.6 Bayley I I I  scores by E V -A 71
T h e  B ay ley  III s c o r e s  w e r e  r e g r e s s e d  by  R T -P C R  resu l t  to d e te r m in e  in f lu en ce  by 
EV-A71. (F igure  4  a n d  T a b le  17). 19%  of c a s e s  w e r e  EV-A71 posit ive  o n  R T -P C R  
but th e  n u m b e r  of s e v e r e  c a s e s  g r a d e  4  w a s  sm all  (7 /242 , 3% ). U nfo r tuna te ly ,  
o n e  of  th e  tw o ch ild ren  w h o  did p r o g r e s s  cou ld  no t s p e a k  V ie tn a m e s e ,  w hich  
limited h e r  l a n g u a g e  a n d  cogn it ive  s c o r e s .  S h e  did c o o p e r a te  a t  th e  s e c o n d  
a s s e s s m e n t  a n d  h e r  cognitive , fine m o to r  a n d  g r o s s  m o to r  Z  s c o r e s  r a n g e d  from  -
1.1 to  -1 .9 . T h e r e  w e r e  no  s ignif icant d i f fe ren ce  in s c o r e s  b e tw e e n  EV-A71 c a s e s  
a n d  non  EV-A71 c a s e s  following a d ju s tm e n t  for all d o m a in s ,  a l th o u g h  th e r e  w e r e  
s ign if icant im p ro v e m e n ts  in r ec e p tiv e  s c o r e  a n d  g r o s s  m o to r  s c o r e s  b e tw e e n  first 
a n d  s e c o n d  a s s e s s m e n t  with coeff ic ien ts  of 0 .4 9  a n d  0 .5 3  for r e c e p t iv e  a n d  g r o s s  
m o to r  respec tive ly .  (F igu re  4 .5  a n d  T a b le  4 .2 5 )
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4.7 Summary
Two methods were used to analyse cognitive, language and motor Bayley III 
scores at two assessments and change in scores between assessments. The first 
method compared all severities (grade 2a, 2b >2b) to a healthy control group. 
However, since the missing outcome scores were not missing at random for the 
healthy group, but were missing at random within the HFMD groups, comparisons 
between grades of HFMD severity were made using propensity score weighting 
matching methods and further adjustment for covariates (age, gender, maternal 
education and stunting). The level of significance was interpreted with caution in 
view of the small sample sizes. We did not recruit the sample size for which the 
study was powered to determine differences between groups, hence the focus on 
the limits of the 95%CI. The results are summarised in Table 4.26.
Table 4.26 summarises the direction of coefficients and lim it of 95%  
confidence intervals of Z score or Z score change.
Negative coefficient with lower limit of 95% Cl up to -0.5 Z score
Negative coefficient with lower limit of 95% Cl between -0.5 and -1 Z 
score
0
t
Positive coefficient with upper limit of 95% Cl up to 0.5 Z score
Positive coefficient with upper limit of 95% Cl between 0.5 and 1 Z 
score
Positive coefficient with upper limit of 95% Cl between 1 and 1.5 Z 
score
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Cognitive Multivariate linear regression Propensity score balanced to 
grade 2a with adjustm ent
Comparative
group
Healthy 2a
1st 2nd Difference 1st 2nd Difference
Grade 2a
a
Grade 2b
I I t t
Grade >2b
1 I i t
Propensity score balanced to 
grade 2a with adjustm ent
Receptive Multivariate linear regression
Comparative
group
Healthy
Difference Difference2nd 2nd
Grade 2a
Grade 2b
Grade >2b
Expressive Multivariate linear regression Propensity score balanced to 
grade 2a with adjustm ent
Comparative  
group_______
Healthy
2nd Difference Difference2nd
>2b
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Fine motor Multivariate linear regression Propensity score balanced to 
grade 2a with adjustm ent
Comparative
group
Healthy 2a
1st 2nd Difference 1st 2nd Difference
2a
I I I f
2b
{J 1 I u I
>2b
i i t 1 t t
Gross motor Multivariate linear regression Propensity score balanced to 
grade 2a with adjustm ent
Com parative
group
Healthy 2a
1st 2nd Difference 1st 2nd Difference
2a
u I
•kie
a
2b
I
★ ★
1 t 1 D t
>2b
I I
*
t I i t
*p<0.05 ** p<0.01
At both assessments, for cognitive, expressive language, fine and gross motor 
domains, all grades of HFMD had negative Z score coefficients and lower Z score 
limits compared to healthy group. In addition, the 95% Cl limits were lower with 
increasing severity of HFMD compared to the healthy group. This pattern was not 
seen in receptive language where grade >2b had a positive coefficient in Z score 
compared to healthy group.
Compared to changes in Z score over the six months for the healthy group, there 
was a negative change in Z score for cognitive scale for all grades of HFMD.
246
T h e r e  w a s  m o re  variability in th e  o th e r  d o m a in s  bu t c o n s is ten t ly  positive  c h a n g e s  
in Z  s c o r e s  for g r a d e  > 2 b  in rec e p tiv e  la n g u a g e ,  fine a n d  g r o s s  m o to r  d o m a in s .
Looking b e tw e e n  g r a d e s  of HFMD, g r a d e  2 b  a n d  > 2 b  h a d  low er Z  s c o r e s  th a n  
g r a d e  2 a  a t  th e  first a s s e s s m e n t .  T h is  w a s  no t c o n s i s t e n t  a t  th e  s e c o n d  
a s s e s s m e n t  with g r a d e  2 b  hav ing  h ig h e r  Z  s c o r e  limits in cogn it ive  a n d  g r o s s  
m o to r  d o m a in s ,  a n d  > 2 b  hav ing  h ig h e r  Z  s c o r e  limits in re c e p t iv e  a n d  e x p r e s s iv e  
l a n g u a g e ,  a n d  fine a n d  g r o s s  m otor. T h e  b ig g e s t  c h a n g e  in Z  s c o r e s  w a s  s e e n  in 
g r a d e  > 2 b  in all d o m a in s .
4.8 Discussion 
Amiel-Tison
M odification o f  th e  tool w a s  requ ired ,  a s  s o m e  s e c t io n s  w e r e  irre levan t  for th is
popu la tion  ( h e a d  c irc u m fe re n c e ,  g r o s s  m o to r  m ile s to n e s ) ,  a s  th e y  w e r e  a l s o
hav ing  ob jec t ive  d e v e lo p m e n ta l  t e s t s ,  avo id ing  b ia s  from  re p o r te d  abilities . T h e
s e c t io n s  c o v e re d  by ob jec t ive  a s s e s s m e n t  ( p a s s iv e  to n e ,  c o m p a r i s o n  b e tw e e n
s id e s ,  rigidity, m o to r  activity, primitive re f lexes ,  pos tu ra l  re f lexes ,  g r o s s  m oto r)  a r e
re le v a n t  for th is  popu la tion . H ow ever ,  th e  tool is limited to primarily d e t e c t  c e re b r a l
pa lsy , sp a s t ic i ty  a n d  to  p red ic t  t h o s e  w h o  m a y  no t walk. It w ould  b e  u se fu l  to
modify th e  tool fu r th e r  to  look a t  quality  of gait, runn ing , h o p p ing  o r  ju m p in g .  T h e
sco r in g  s y s te m  will h a v e  to b e  m odified a g a in  a f te r  trials o n  no rm a l c h ild ren  a n d
ch ild ren  with know n m o to r  d i s o rd e r s  to  d e te r m in e  w hich  a r e a s  m a y  b e  m o re
spec if ic  for c e r ta in  m ilder m o to r  a b n o rm a li t ie s  a n d  s h o u ld  ca rry  m o re  w e ig h t  w h e n
sco ring . T h e r e  w a s  s o m e  variability in sc o r ing , with a b n o rm a l i t ie s  im prov ing
b e tw e e n  a s s e s s m e n t s  or  b e c o m in g  a p p a r e n t .  M ore s t ru c tu re d  reliability
a s s e s s m e n t s  b e tw e e n  a s s e s s o r s  m a y  h a v e  b e e n  a b le  to  d is t ingu ish  w h e t h e r  t h e
c h a n g e s  w e r e  real o r  d u e  to  e x a m in e r  b ias ,  particularly  w h e n  c h ild ren  w e r e
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u n c o o p e ra t iv e .  D e sp i te  t h e s e  limitations, e x p a n s io n  on  th e  m odified criteria  did 
d is t ingu ish  m o d e r a te  a n d  mild ab n o rm a li t ie s ,  bu t  t h e s e  w e r e  no t significantly  
d ifferen t in p ro p o rt io n s  b e tw e e n  g r a d e s  of HFMD, in fluenced  by th e  sm all  s a m p le  
s ize .
Bayley III
This  is th e  first s tu d y  to  c o m p a r e  n e u ro d e v e lo p m e n ta l  o u t c o m e s  of HFM D c a s e s  
to a  h e a l th y  c o m p a r is o n  g ro u p  a n d  add itionally  c o m p a r e  d i f fe re n c e s  b e tw e e n  
g r a d e s  by b a la n c in g  re le v a n t  c o v a r ia te s .
T h ro u g h  bo th  m e th o d s ,  th e  lo w e s t  95% C I limit in Z  s c o r e s  w a s  within m in u s  o n e  Z 
s c o re ,  i.e. 1 s ta n d a r d  dev ia t ion  o f  th e  c o m p a ra t iv e  g ro u p  m e a n .  T h is  w a s  a l s o  th e  
limit w h e n  c o m p a r in g  EV-A71 c a s e s  to  non  EV-A71 c a s e s .  In r e s e a r c h ,  la rg e  
s tu d ie s  following p re te rm  infants  h a v e  o p te d  to  u s e d  < 2 S D  of th e  m e a n  of  a  
c o m p a ra t iv e  g ro u p  to  d e te rm in e  im p a irm en t .352 Following th is  th re s h o ld ,  n o  g ro u p  
p e rfo rm e d  significantly  w o r s e  th a n  th e  h e a l th y  o r  g r a d e  2 a  c o m p a ra t iv e  g ro u p .  
P o s t  d i s c h a rg e ,  th e  m o re  s e v e r e  HFM D g r a d e s  p e rfo rm e d  w o r s e  th a n  th e  h e a l th y  
g ro u p  a n d  th is  p e r s i s te d  for all d o m a in s  e x c e p t  rec e p tiv e  l a n g u a g e  a t  t h e  s e c o n d  
a s s e s s m e n t .  In terestingly , th e r e  w e r e  la rg e r  posit ive  c h a n g e s  in Z  s c o r e s  b e tw e e n  
a s s e s s m e n t s  for th e  g r a d e  > 2b  ch ildren , d e s p i t e  n e g a t iv e  coe ff ic ien ts  o f  Z  s c o r e s  
a t  th e  s e c o n d  a s s e s s m e n t  c o m p a r e d  to  h e a l th y  g ro u p s .  B e tw e e n  g r a d e s  of  
HFMD, th e  m o re  s e v e r e  g r a d e s  h a d  low er  Z  s c o r e s  a t  th e  first a s s e s s m e n t  
c o m p a r e d  to g r a d e  2 a  bu t this did no t  p e r s i s t  a t  th e  s e c o n d  a s s e s s m e n t .  T h e r e  is 
a  non-sign ifican t reduc t ion  in Z  s c o r e s  a t  th e  first a s s e s s m e n t  b e tw e e n  h e a l th y  
a n d  all HFMD g r a d e s  w hich  p e r s i s t s  for m o s t  d o m a in s  a t  six m o n th s .  H o w e v e r  th e  
Z  s c o r e s  b e tw e e n  th e  g r a d e s  of HFM D a p p e a r s  to n a rro w  a n d  o v e r la p  by  th e  six 
m o n th  a s s e s s m e n t ,  with m o s t  Z  s c o r e  im p ro v e m e n ts  s e e n  in g r a d e  2 b  a n d  > 2b .
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T h e  variability within o n e  Z s c o r e  m a y  r e p r e s e n t  variability in p e r fo rm a n c e  on  th e  
d a y  of a s s e s s m e n t  r a th e r  th a n  ac tu a l  c h a n g e  in ability, o r  th e  im p ro v e m e n t  m a y  
reflect be ing  p a r t  of a  s tu d y  in te re s te d  in n e u ro d e v e lo p m e n t  th a t  e n g a g e s  th e  
p a re n t s  in th e  a s s e s s m e n t .  P a r e n t s  a r e  a w a r e  of s o m e  of the ir  child’s  lim itations 
a t  th e  first a s s e s s m e n t  a n d  m a y  ac tively  w ork  on  t h e s e  a r e a s  prior to  th e  s e c o n d  
a s s e s s m e n t .
R e s u l ts  from  o n e  a s s e s s m e n t  m a y  h a v e  g iven  b ia s e d  v iew  of  p ro g n o s is  following 
s e v e r e  HFMD. D e sp i te  low er  Z  s c o r e s  for HFM D c o m p a r e d  to  h ea lthy , t h e r e  h a v e  
b e e n  im p ro v e m e n ts  in Z  s c o r e s  for th e  m o re  s e v e r e  g r a d e s .  E nco u rag in g ly ,  all 
low er limits of 9 5 %  Cl w e r e  within 1 s t a n d a r d  dev ia tion  of th e  h e a l th y  c o m p a r is o n  
g ro u p ,  w hich  is d e e m e d  to b e  within no rm al d e v e lo p m e n ta l  variability.409
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5. Brain MR! findings in severe HFMD
5.1 Introduction
T h e r e  a r e  differing o p in io n s  on  th e  clinical e v a lu a t io n  a n d  p ro g n o s t ic  v a lu e  of MRI 
in HFM D en c ep h a l i t is .  Z e n g  e t  al. c o n c lu d e d  from  ex am in in g  MRI s c a n s  o n  4 2  
EV-A71 positive  HFMD b ra in s te m  e n c e p h a l i t i s  c a s e s ,  th a t  MRI c h a n g e s  w e r e  
relatively spec if ic  a n d  cou ld  con tr ibu te  to  clinical e v a lu a tio n  a n d  m a n a g e m e n t .235 
L e e  e t  al. w e r e  m o re  c a u t io u s  w h e n  d e sc r ib in g  the ir  f ind ings  from  2 2  EV-A71 
HFM D C N S  c a s e s ,  c o m m e n tin g ,  “clinical f e a tu r e s  w e r e  no t a lw a y s  c o n s i s t e n t  with 
MRI f ind ings .”242
A s  p rev ious ly  rev iew ed  in c h a p te r  1 (T ab le  1.5), typical MRI f ind ings  in EV-A71 
HFM D c o n s is t  of le s io n s  in th e  d o rsa l  p o n s ,  d o rsa l  m edu lla ,  m idbra in , d e n ta t e  
nuclei, h y p o th a la m u s  a n d  cerv ica l co rd .  P r e v a l e n c e  o f  MRI c h a n g e s  in EV-A71 
HFM D r a n g e  from  4 6 %  in c a s e s  with m y o c lo n u s /a ta x ia / t re m o r  to  1 0 0 %  in c a s e s  
with c ran ia l  n e rv e  invo lvem en t  a n d  c a rd io p u lm o n a ry  c o m p r o m is e .126 H o w ev er ,  
EV-A71 d e te c t io n  c a n  va ry  from  3 0 %  to m o re  th a n  9 0 %  of s a m p l e d  c a s e s  of 
HFMD, d e p e n d in g  on  clinical sever i ty .  (T ab le  1.2) O u tb r e a k s  in C h in a  b e tw e e n  
2 0 0 8 -1 4  h a v e  s h o w n  fluc tuation  in d e te c t io n  r a t e s  of EV -A 7180 a n d  it is im p o r ta n t  
to identify th a t  o th e r  p a th o g e n s  m a y  h a v e  a  s im ilar clinical p r e s e n ta t io n  a n d  
p ro p e n s i ty  to s e v e r e  d i s e a s e  a s  E V -A 71.
T a b le  1 .5  in c h a p te r  1 rev iew ed  MRI f ind ings  in th e  HFM D litera tu re  a n d  fo u n d  
s te re o ty p ica l  f ind ings in EV-A71 in fec ted  c o m p l ic a te d  c a s e s  with C N S  
m a n ife s ta t io n s ,  bu t  s tu d ie s  did no t c o n s is ten t ly  s t a t e  w h e n ,  in th e  i l lness  o r  
r e c o v e ry  p h a s e ,  th e  s c a n s  w e r e  t a k e n  n o r  d o  th e y  d e s c r ib e  th e  o u t c o m e  for th e
children  w h o  h a d  s c a n s .  T h is  p ro sp e c t iv e  s tu d y  a im s  to identify w h e th e r  MRI 
c h a n g e s  a r e  e x c lu s iv e  to  s e v e r e  HFMD c a s e s  a s s o c i a te d  with EV-A71, a n d  
c o m m e n ts  o n  o u tc o m e  d a ta  a s  m e a s u r e d  by  s ta n d a r d is e d  tools .
5.2 M R I  Scans
T h e  s tu d y  o ffe red  r e s e a r c h  MRI s c a n s  to  all en ro l led  HFMD c a s e s  with p a re n ta l  
c o n s e n t  w h e n  th e  child w a s  d e e m e d  clinically unlikely to p r o g r e s s  to  m o re  s e v e r e  
d i s e a s e .  T h e  s c a n s  w e r e  ca rr ied  o u t  a t  a  p r iva te  MRI facility 5 km from  th e  
hospita l.  A c o n s u l ta n t  p a e d ia tr ic  neu ro rad io log is t :  Dr. Kling C h o n g  a t  G r e a t  
O rm o n d  S t r e e t  H ospita l in th e  United  K ingdom , rev iew ed  th e  s c a n s .  Dr. C h o n g  
w a s  in form ed  of  th e  a g e  o f  th e  child bu t w a s  no t a w a r e  o f  th e  s e v e r i ty  of  th e  
child’s  i llness. A p ro fo rm a  (T ab le  2 .5 )  th a t  inc luded  spec if ic  r e g io n s  lis ted  
a c c o rd in g  to  th e  l itera ture  w a s  u s e d  to  d o c u m e n t  MRI c h a n g e s .
5.3 Results
5.3.1 Clinical characteristics of sample scanned
A total o f  8 7 /2 4 2  (36% ) HFMD c a s e s  h a d  MRI brain  s c a n s :  3 2 /1 4 7  (2 2 % )  G r a d e  
2 a ,  2 6 /5 8  (45% ) G r a d e  2 b  a n d  2 9 /3 7  (78% ) g r a d e  > 2 b  c a s e s .  T h e  m e d ia n  d a y  of  
illness  for th e  s c a n  w a s  d a y  5, with a  r a n g e  o f  4  to  4 2  d a y s .  T a b l e s  5 .1 -  5 .3  
c o m p a r e  th e  c h a ra c te r is t ic s  o f  th e  ch ild ren  w h o  h a d  MRI c o m p a r e d  to  t h o s e  w h o  
did not, by HFMD g r a d e .  Sm all  s a m p le  s i z e s  led to  th e  w ide  9 5 %  c o n f id e n c e  
in tervals ,  w hich  limit interpretability. H ow ever ,  th e  re s u l ts  s u g g e s t  n o  s ign if ican t  
d i f f e re n c e s  in a g e ,  g e n d e r ,  level o f  m a te rn a l  e d u c a t io n ,  s tu n t in g  a n d  viral 
a e t io lo g y  b e tw e e n  t h o s e  w h o  h a d  MRI a n d  t h o s e  w h o  did not, within g r a d e s .
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There were no significant differences in ages, in the proportion of male sex, level 
of maternal education, stunting and in the proportion of MRI changes between 
severity groups (Table 5.4). There was a significant difference in the timing of 
scan with the more severe cases having scans later after illness onset. All grade 
2a and 2b cases and 98% of grade >2b cases recovered by discharge. One 35- 
month female patient with grade 4 EV71 disease had a persistent 6th and 7th 
nerve left facial palsy, and a 26-month old male patient with grade 4 disease (EV- 
A71 PCR-negative) had a tremor at discharge.
Table 5.1 Characteristics of the sample that had MRI out of total cases enrolled  
grade 2a
Discharge Grade 2a Had MRI Total Cases 
enrolled
Odds Ratio (95%CI); 
p-valuea
Number 32 147
Age at enrolm ent (median, IQR) 17.6 (13.2-21.8) 15.1 (11.5- 
20.2)
p-value = 0.1315
Gender (male) 22 (69%) 84 (57%) 1.65 (0.78-inf); 0.16
Maternal education
Primary 6 (19%) 50 (34%) 0.45 (0.17-inf); 0.98
Secondary 22 (69%) 82 (56%) 1.74 (0.82-inf); 0.12
Higher 4 (12%) 15 (10%) 1.26 (0.36-inf); 0.45
Stunted 3 (9%) 22 (15%) 0.59 (0.14-inf); 0.87
Duration in hospital (median, 
IQR)
6 (5-7) 5 (4-6.5) p-value = 0.20 ^
Recovery at discharge 32 (100%) 147 (100%)
PCR
CV-A10 4 (12%) 16 (11%) 1.17 (0.34-Inf); 0.50
CV-A16 2 (6%) 6 (4%) 1.56 (0.22-Inf); 0.44
EV-71 3 (9%) 13 (9%) 1.07 (0.24-Inf); 0.57
CV-A6 5 (16%) 32 (22%) 0.67 (0.23-Inf); 0.85
EV 10(31%) 38 (26%) 1.30 (0.58-Inf); 0.34
Negative PCR 8 (25%) 42 (29%) 0.85 (0.36-Inf); 0.72
9 Fisher’s exact test 
p Kruskal-Waliis chi-squared
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Table 5.2 Sample had MRI out of total cases enrolled grade 2b
Discharge Grade 2b Had MRI Total Cases 
enrolled
Odds Ratio (95%CI); 
p-value a
Number 26 58
Age at enrolm ent (median, IQR) 16.2 (12.6- 
21.3)
17.1 (12.6- 
22.9)
p-value = 0 .9 2 1
Gender (male) 15 (58%) 36 (62%) 0.83 (0.34-Inf); 0.73
Maternal education
Primary 9 (35%) 23 (40%) 0.91 (0.35-inf); 0.66
Secondary 11 (42%) 28 (48%) 0.79 (0.32-inf); 0.77
Higher 6 (23%) 7 (12%) 1.67 (0.51-inf); 0.29
Stunted 2 (8%) 10 (18%) 1.20 (0.53-inf); 0.43
Duration in hospital (median, 
IQR)
7 (5-8) 6 (5-7) p-value = 0.68 ^
Recovery at discharge 26 (100%) 58 (100%)
PCR
CV-A10 2 (8%) 10 (17%) 0.40 (0.059-Inf); 0.94
CV-A16 0 1 (2%) NS
EV-71 3 (12%) 10 (17%) 0.63 (0.14- Inf); 0.84
CV-A6 8 (31%) 12 (21%) 1.90 (0.68- Inf); 0.18
EV 3 (1 2% ) 12 (21%) 0.50 (0.11-Inf); 0.91
Negative PCR 6 (23%) 13 (22%) 1.04 (0.34-Inf); 0.58
Table 5.3 Sample had MRI ou t o f to ta l cases enro lled  grade >2b
Discharge Grade >2b Had MRI Total Cases 
enrolled
Odds Ratio (95%CI); 
p-value 9
Number 29 37
Age at enrolm ent (median, IQR) 21.0 (12.3- 
29.1)
19.6 (10.5- 
26.9)
p-value = 0 .6 0 13
Gender (male) 18 (62%) 22 (59%) 1.11 (0.43-Inf); 0.52
Maternal education
Primary 9 (3 1% ) 13 (35%) 0.83 (0.30-inf); 0.73
Secondary 17 (59%) 20 (54%) 1.20 (0.47-inf); 0.45
Higher 3 (10%) 4 (11%) 0.95 (0.17-inf); 0.67
Stunted 2 (7%) 2 (5%) 1.29 (0.13-inf); 0.60
Duration in hospital (median, 
IQR, range)
6 (5 -7 )(5 -4 2 ) 6 (5-7)(4-42) p-value = 0.84 ^
Recovery at discharge 27 (93%) 35(95%) 0.77 (0.080- Inf); 0.78
PCR
CV-A10 1 (3%) 1 (3%) 1.28 (0.032- Inf); 0.69
CV-A16 0 0
EV-71 17 (59%) 22 (59%) 0.97 (0.38-Inf); 0.63
CV-A6 0 0
EV 4 (1 4% ) 5 (14%) 1.02 (0.24-Inf); 0.62
Negative PCR 7 (24%) 9 (24%) 0.99 (0.32-Inf); 0.62
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Table 5.4 Characteristics of cases that had Brain MRI
Discharge Grade Grade 2a Grade 2b Grade >2b p-value v
Number 32 26 29
Age at enrolm ent 17.6 (13.2- 16.2 (12.6- 21.0 (12.3- 0.51 *
(median, IQR) 21.8) 21.3) 29.1)
Gender (male) 22 (69%) 15(58% ) 18 (62%) 0.64
Maternal education
Primary 6 (19%) 9 (35%) 9 (31%) 0.41
Secondary 22 (69%) 11 (42%) 17 (59%) 0.14
Higher 4 (12%) 6 (23%) 3 (10%) 0.40
Stunted 3 (9%) 2 (8%) 2 (7%) 1.00
Day illness scan 
(median, IQR, range)
6 (5 -7 ) (4-16) 7 (6-8) (4-15) 8 (6-8) (5-42) 0.0033** ^
Acute abnorm alities  
MRI
5 (16% ) 6 (23%) 12 (41%) 0.068
Recovery at discharge  
in those with MRI
5 (100%) 6 (100%) 9 (82%) 0.39
abnormalities
d F is h e r ’s e x a c t  te s t  
p K ru s k a l-W a l l is  c h i- s q u a re d
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5.3.2 MRI changes
Table 5.5 com pares the clinical characteristics and severities between the MRI 
scans with abnorm alities and those with none. There were no significant 
differences in the age of enrolment, gender, level o f maternal education, stunting, 
median duration of hospitalization, median day o f illness o f scan and proportion 
w ith grade 2a and grade 2b classification between the groups. There were 
significantly more grade >2b cases in the group with MRI abnorm alities. There 
were no significant differences in the proportion o f patients with fever, vom iting, 
m yoclonus, ataxia, cranial nerve abnorm alities, rash, ulcer and irritability between 
groups. There was a trend to MRI abnorm alities in the EV-A71 positive cases but 
this was not significant (p value = 0.098). There were sign ificantly more MRI 
abnorm alities in the CV-A10 positive cases, yet the highest proportion o f CV-A10 
positive cases were grade 2a (12%).
Table 5.5 Comparison between MRI scans w ith  abnorm a lities  and those 
w ithou t.
MRI No MRI Odds Ratio (95%CI);
abnormalities abnormalities p-value 9
Number of cases 23 (26%) 64 (74%)
Grade 2a 5 (16%) 27 (84%) 0.38 (0.122-Inf); 0.97
Grade 2b 6 (23%) 20 (77%) 0.78 (0.26- inf); 0.76
Grade >2b 12 (41%) 17 (27%) 2.97 (1.16-Inf) ;0.026*
Age at enrolm ent in months (median, 19.7 (15.0- 17.6 (12.3- p-value = 0 .1 8 13
IQR) 25.9) 22.8)
Gender (male) 17 (74%) 38 (59%) 1.92 (0.72-Inf); 0.16
Maternal education
Primary 7 (30%) 17 (27%) 1.21 (0.43-inf); 0.46
Secondary 13(57% ) 37 (58%) 0.48 (0.21-inf); 0.97
Higher 3 (13%) 10(16% ) 0.81 (0.17-inf); 0.73
Stunted 2 (9%) 5 (8%) 1.12 (0.15-inf); 0.60
Day illness scan (median, IQR, range) 7 (6-8) (4-42) 7 (5 -8 )(4 -1 6 ) p-value = 0.50
Clinical features on admission
Fever 10 (43%) 33 (52%) 0.73; (0.29-Inf); 0.82
Vomiting 0 5 (8%) 0 (0-inf); 1
Rash 9 (39%) 39 (61%) 0.42 (0.18-Inf); 0.98
Ulcer 16 (70%) 54 (86%) 0.43 (0.15-Inf); 0.96,
Myoclonus 4 (17%) 7 (11%) 1.70 (0.42-Inf); 0.32,
Irritability 1 (4%) 7 (11%) 0.37 (0.016-Inf); 0.92
Trem or 1 (5%) 3 (5%) 0.93 (0.034-Inf); 0.72
Cranial N abnorm ality 1 (5%) 0
Ataxia 0 1 (2%)
Nystagmus 1 (4%) 0
Limb weakness 0 0
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Duration in hospital 6(2) 6(2 ) p-value = 0.58 ^
PCR
CV-A10 5 (22%) 2 (3%) 8.34 (1.39-Inf); 0.013*
CV-A16 1 (4%) 1 (2%) 2.82 (0.07-Inf); 0.46
EV-A71 9 (39%) 14 (22%) 2.27 (0.84-Inf); 0.093
CV-A6 1 (4%) 12 (19%) 0.20 (0.009-Inf); 0.99
EV 1 (4%) 20 (31%) 0.10 (0.0050-Inf); 0.99
Negative PCR 6 (26%) 15(23% ) 1.15 (0.38-Inf); 0.50
* Fisher’s exact te s tp Kruskal-Wallis chi-squared
Acute abnorm alities in T2W I and FLAIR consisted o f hyperintense lesions in the 
pons, dentate nuclei o f cerebellum  and white m atter o f the brain (Table 5.6). 
There was no significant difference in location of lesion between grades of 
severity. There were significantly more EV-A71 positive PCR cases w ith MRI 
changes at grade >2b, reflecting more than 50% of grade >2b cases were EV- 
A71 positive.
Table 5.6 Acute MRI abnorm a lities  by HFMD grade at discharge and PCR
Discharge Grade Grade 2a Grade 2b Grade >2b p-value*
Num ber scanned 32 26 29
Number with 5 (16%) 6 (23%) 12 (41%) 0.064
abnormalities
Posterior aspect of pons 0 0 3 (10%) 0.059
Periventricular region 1 (3%) 0 0 1
Dentate nuclei of 
cerebellum
1 (3%) 5 (19%) 8 (28%) 0.020*
Deep W hite Matter 5 (16%) 4 (15%) 5 (17%) 1
changes
Subcortical white m atter 0 0 2 (7%) 0.20
PCR
CV-A10 3 (9%) 2 (8%) 0 0.27
CV-A16 1 (3%) 0 0 1
EV-71 1 (3%) 0 8 (28%) 0.00075**
CV-A6 0 1 (4%) 0 0.30
EV 0 0 1 (3%) 0.63
Negative PCR 0 3 (12%) 3 (10%) 0.11
a Fisher’s exact test
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7
5.3.3 MRI and neurodevelopmental outcomes
The numbers of cases scanned within each grade was small, limiting the strength 
of this analysis. Nonetheless, looking at scores within each grade, adjusted for 
age, suggests that acute MRI changes are associated with worse cognitive, fine 
and gross motor scores at the second neurocognitive assessment for children 
with grade 2b disease (Figures 5.1-5.5). Surprisingly, after adjusting for age, 
gender, maternal education and stunting, between the two assessments there 
were significantly improved cognitive Z scores from the grade 2a with acute MRI 
changes, but significantly worse Z scores for fine and gross motor domains at the 
second assessment for those with grade 2b disease. (Table 5.8)
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5.3.4 Case Studies
Four case studies are described with MRI images o f changes identified.
Figure 5.6 MRI Case 10.
Male, 34 month old child, grade >2b, EV-A71 PCR positive. Scan at day 7 of 
illness. Presented at day 3 o f illness with rash and ulcers in the mouth. He 
developed hypertension and was treated with a course o f im m unoglobulin, 
intravenous m ilrinone for 2 days and m agnesium  sulphate for 3 days. D ischarged 
after 5 days in hospital with com plete recovery, (a) Axial FLAIR showed 
hyperintense signal at the dentates, also visible on (b) sagittal T2W I.
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Figure 5.7 MRI Case 18.
Male, 6 month old child, grade >2b, EV-A71 PCR positive. Scan at day 21 of 
illness. No rash at presentation, day 3 of illness. He developed hypertension and 
respiratory distress. He was treated with a course o f im m unoglobulin, ventilated 
for 6 days and adm inistered intravenous m ilrinone for 2 days and m agnesium  
sulphate for 3 days. D ischarged after 19 days in hospital with com plete recovery. 
Hypointense lesion ponto-m edullary junction (a) sagittal and (b) axial T2W I.
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Figure 5.8 MRI Case 43.
Male, 22 month old child, grade >2b, negative PCR. Scan at day 6 of illness. 
Fever, cough, m yoclonus on day 1 o f illness. He was treated w ith a course of 
im m unoglobulin. D ischarged after 6 days in hospital with com plete recovery. 
Hyperintense lesion (a) dentates Axial FLAIR and (b) + (c) axial T1W I.
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Figure 5.9 MRI Case 79.
Male, 15 month old child, grade >2b, EV-A71 PCR positive. Scan at day 8 of 
illness. Fever, cough, runny nose, vesicu lar rash, mouth ulcers and m yoclonus on 
day 3 o f illness. He was treated with a course o f im m unoglobulin. D ischarged after 
11 days in hospital with com plete recovery. Normal appearance o f dentate nuclei 
for age, scattered hyperintense foci on axial FLAIR.
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Figure 5.10 MRI Case 01.
Female, 35 month-old child from an ethnic m inority group in Dak Nong. She was 
adm itted on day 2 o f illness follow ing transfer from a provincial hospital with a 
GCS of 7/15, scored grade 3 due to right limb weakness and left 6th and 7th 
cranial nerve palsy (lower m otor neuron), EV-A71 RT-PCR positive. Her m other 
had prim ary education only. She progressed to grade 4 w ithin one day o f 
adm ission due to respiratory failure and required ventilation. She was scanned at 
day 42 o f her illness follow ing recovery. MRI abnorm alities were noted at the 
pontom edullary junction on axial FLAIR sequence (A) but not consistent on axial 
T2W I (B).
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5.4 Summary
This is the first study to prospectively evaluate severe HFMD cases including 
grade 2a cases. I identified MRI changes in 5/32 (16%) Grade 2a cases, 6/26 
(23%) Grade 2b cases and 12/29 (41%) >Grade 2b cases. Changes in the 
posterior aspect of the pons and novel findings of subcortical white matter 
changes were found in <10% of >grade 2b cases. Changes in the dentate nuclei 
were present in all severity grades, but was significantly different between HFMD 
grades, with an association with more severe disease. Deep white matter 
changes were present in all HFMD grades, and were not significantly different 
between grades. Of note, the odds of a child with MRI changes having detectable 
CV-A10 was significantly higher as compared to non-CV-A10 cases, and the 
highest proportion of CV-A10 cases was in grade 2a.
There were no significant differences in the proportions of children presenting with 
rash, mouth ulcers and neurological symptoms between the cases with MRI 
changes and those without.
In one MRI case, who had a scan performed late in the illness (day 21), 
hypointense lesions were identified on axial FLAIR, which was not seen in scans 
performed earlier in the illness.
Comparing the scores within each grade, between those with MRI changes and 
those without, revealed significantly worse scores for those with grade 2b disease 
for fine motor and gross motor domains at the second assessment, but, 
interestingly, better cognitive scores at the same time point. This variability may 
be a chance finding reflecting the small sample size but warrants further
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investigation. Outcomes at discharge did not differ between those with MRI 
changes and those without within each grade.
5.5 Discussion
The literature reports that lesions in the dorsal pons, medulla oblongata and 
dentate nucleus are the stereotypic areas affected by EV-A71 HFMD-associated 
brainstem encephalitis. In this study, the dentate nucleus was affected in all 
severity grades but were significantly more common in those with grade 2b 
disease or worse. Subcortical white matter lesions on T2WI and FLAIR identified 
in grade >2b disease are not described in the HFMD literature, but I have 
identified these occurring in 16%, 15%, 17% of grade 2a, grade 2b, >grade 2b 
respectively.
The study results suggest the stereotypic findings of EV71 are not necessarily 
specific for EV-A71 but also occur in CVA10 and more rarely CVA6 infected 
cases. The significantly higher rates of MRI changes in CVA10 cases must be 
interpreted with caution in view of the sampling bias, where more EV-A71 cases 
were scanned overall compared to the other viruses.
MRI abnormalities in grade 2a were predominately within deep white matter. 
Adjusted Bayley scores identified there was an improvement in cognitive scores 
between assessments for this group. In more severe grades, there was a higher 
prevalence of abnormalities of the dentate nuclei of the cerebellum. Despite there 
being no significant change in Bayley scores between assessments in grade >2b, 
there were differences between assessments for grade 2b fine and gross motor
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scores. Due to small sample sizes it is difficult to explore further. However, the 
heterogeneity within grade 2b may suggest that this group should be studied in 
greater detail, as MRI imaging may be of prognostic value. Future work should 
investigate the effect on scores of grade 2b with specific abnormalities, such as in 
the dentate nuclei compared to grade 2b with no abnormalities. It would be 
advisable to have a large enough cohort to determine whether age of onset of 
disease also makes a difference to prevalence of MRI abnormalities and impact 
on scores.
In essence we agree with Lee’s cautious note in the introduction, that MRI 
changes are not obviously prognostic or have a clear correlation with clinical 
disease.
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6. Chapter 6 Discussion
6.1 In tro d u c tio n
Since the 1990s HFMD has emerged as an additional encephalitis threat to 
children under the age of five years in the Asia Pacific region. The specific 
encephalitis threat is commonly reported to be mainly associated with EV-A71 
infection, with fatality ensuing from neurogenic cardiopulmonary complications. It 
is a threat that could overwhelm public health, education and rehabilitation 
services or stay hidden from view as minor impairment results in failure to 
progress at school or withdrawal from school.
The HFMD literature focuses on virologically positive EV-A71 cases and fails to 
encompass all cases clinically diagnosed with severe HFMD. This limits the 
generalisability of the outcome data from the literature, as many viruses are co- 
circulating during HFMD seasons and/or epidemics. The study aimed to evaluate 
what outcomes were associated with clinically severe HFMD, irrespective of 
virological diagnostics, which represents the real situation clinicians are facing 
during management and follow-up of children in settings where viral diagnostics 
are not routinely performed.
My study tested the following hypotheses:
1. Children affected by severe HFMD (grade 2a, 2b and >2b as per 
Vietnamese Ministry of Health classification) under the age of 4 years have 
lower cognitive, language and motor scores than a comparative group of
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healthy children, as measured by internationally recognised adapted tools 
and measured a week post discharge and at 6 months after discharge.
2. Children with severe HFMD and MRI changes during the acute phase of the 
illness predict lower outcome scores at 6 months after discharge compared to 
severe HFMD children with no MRI changes.
I ran this prospective study from the start acknowledging that a suitable outcome 
measure was lacking. I decided to choose a detailed, standardised assessment 
test to comprehensively evaluate cognitive, language and motor scores. One 
major barrier to developing outcome tools is the lack of child development 
resources, and more specifically of trained staff. This study had to train and 
develop local professionals in a field that is evolving in Vietnam.
My thesis describes the process of adapting and validating Bayley III for Vietnam, 
comparing the study raw scores to the original and highlighting the 
methodological issues in validating a tool for a different culture. I deconstructed 
the tool to the underlying factors being measured and statistically model 
relationships between the observed variables or test items and the underlying 
factors. This procedure is standard for psychometric literature but is poorly 
understood by allied professionals who routinely use child developmental tools for 
research.
My thesis tests the above hypotheses through a prospective cohort study, with a 
healthy comparison group recruited from the district were the majority of HFMD 
are admitted from at HTD. This health comparison group was used to validate the 
Bayley III and also create Z scores form which to compare the HFMD cases. Two 
methods were used to evaluate differences in Z scores. Firstly linear regression
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comparing all HFMD grades to healthy group. The limitation of linear regression is 
when the covariate distributions in each group differed significantly. In my study, 
there were significantly different proportions of maternal education in the healthy 
cohort compared to HFMD grade 2a. Propensity weighting balancing of covariates 
aimed to limit the imbalance in covariates without wasting the participants. This 
was used to balance the healthy group and grade 2a and then to balance 
between the different severities of HFMD. Comparison between grade 2a and 
grade 2b and >2b allowed improved balance in covariates than when balanced 
with the healthy group, permitting more robust analysis.
Additionally I investigated whether MRI changes were associated with more 
severe disease, were as stereotypical as previously described and if they were 
associated with poorer neurodevelopmental outcomes. The literature suggests 
mainly ascending motor tract lesions in MRI scans, supporting the hypothesis of 
retrograde axonal transport of EV-A71 into the brainstem.236 A prospective study 
is needed to understand whether current findings are due to bias in sampling 
severe cases and only EV-A71 cases.
6.2 Results: Adaptation and validation of Bayley I I I  for Vietnam
This is the first study to psychometrically evaluate the validity and reliability of a 
Bayley III adaptation in an LMIC. Despite widespread use of Bayley III in LMICs, 
few have looked into whether the underlying structure of the test is affected by 
adaptation. This may avoid the problems faced by Rie et al. when using the 
previous version of the Bayley (BSID II) in Congo. They identified 24.4% severely 
delayed children in their healthy control group when using US references. The
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authors acknowledge the different environments, parenting styles, and access to 
toys may have influenced these findings.410 However, they state they deliberately 
used a direct translation of a western CDAT without cultural adaptation to 
compare between groups in the same setting and then compare between past 
and future studies in other settings.410 This statement underlies the lack of 
understanding of the structure and appropriate practice for interpreting results. It 
is clear that this method does not ensure that the tool is measuring the same 
underlying ability in all settings, and strict caution should be used when comparing 
different settings. In Malawi, due to similar high levels of deficits detected by 
Bayley III, re-standardisation was carried out 402 However, the pattern of the raw 
scores with age by domain is very different to that of the original US version, and 
leaves open to debate whether the Malawian tests are measuring the same 
underlying factors as the original, and whether the test is reliable and valid. A 
more recent tool developed by the Intergrowth project411 had set criteria for what 
domains the tool tested, the duration of test and ease of application for both high 
and low income countries. The test was designed with expert consensus, which 
uses items deemed suitable from a panel of experienced experts. Many of the 
items in the new tool are from Bayley III, which many of the expert panel have 
used or are familiar with for research worldwide. Hence their experience is mainly 
with Bayley items and this influences their contribution when developing new fit- 
for-purpose tools. Psychometric validation of Bayley III is not routinely done in 
LMICs, so caution should be used when items are chosen based on expert 
opinion without psychometric analysis on the perception of the item being 
universally applicable. Depression or anxiety scales undergo detailed 
psychometric evaluation when used in different ethnic groups, as is familiar with 
test developers in the field. Child development tools have been developed by 
psychologists, but are widely used by paediatricians and allied health
professionals who have only limited understanding of test structure. The 
implications are highlighted by the difficulty in comparing Bayley III to previous 
versions. The BSID II measured two constructs: psychomotor and mental index, 
and the Bayley III measures three. It has been assumed that since both versions 
have standardised scores, that they should be directly comparable. However 
there appears to be underestimation of impairment with Bayley III in Australia, 
compared to BSID II.412 This difference may be compounded by the fact that in 
essence, the tests are measuring different constructs, making it difficult to 
translate one standard score into another. Additionally, there was no 
underestimation when using the mean and standard deviations (i.e. Z scores) of a 
control group rather than the standardised scores for Bayley III.
It is unclear how to meaningfully interpret changes in raw score on Bayley III. 
Makrides et al. ran a multicentre randomised controlled trial of dietary 
docosahexaenoic acid (DHA) in pregnancy using BSID II as an outcome 
measure. They reported that “Studies showing differences between nutritional or 
environment interventions of 4 to 5 points or greater have been catalysts for 
changes in health policy” and used this difference to calculate sample sizes 413 
Such statements highlights the problems of interpreting findings based on raw 
scores and the lack of clarity of appreciating the variability of raw scores. 
Calculating Z scores for group comparison allow meaningful conclusions.
Understanding issues such as gender measurement invariance is important but 
has never been done for Bayley III. Gender differences should be determined as 
true difference in ability, or difference due to gender differentiation in response to 
test item. Makrides et al. ran a trial of high versus low dose DHA in pregnancy 
using BSID II as the outcome measure and were puzzled by the lack of
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responsiveness in boys compared to the girls.414 Measurement invariance by 
gender was never mentioned in the study and it was perceived that this was a 
true gender difference in response to DHA dose. I have no comparable gender 
information on Bayley III but I have highlighted that gender issues in child 
development are important and need to be adjusted for in analysis.
This study demonstrated that the Vietnamese adaptation of the Bayley 
neurocognitive tool is reliable and psychometrically valid. This has implications for 
interpreting differences between groups in this study and has enormous potential 
as a clinical and research outcome measure for future studies in Vietnam.
It is accepted that for research a control or healthy comparison group should be 
used to create Z scores. Different Z score changes are used to correlate with 
different levels of impairment. This method assumes that the adapted score is 
measuring the same underlying constructs as the original version. This is the first 
study in an LMIC setting to test this assumption. The Bayley tool is considered 
one of the most robust measures in early childhood, with extensive literature 
discussing its validation and reliability. The publishers of Bayley III describe the 
tool to measure hypothesised constructs of cognition, language and motor 
domains. This is the first study to evaluate the same psychometric structure 
following adaptations and look at gender measurement invariance (whether the 
same constructs are measured in both genders). The results indicate that the 
best-fit models for the Vietnamese Bayley score fit the original US version and the 
distribution of raw scores between countries do not differ significantly (using 
limited US data from the Bayley III manual). Furthermore, the results show that 
the test measures the same underlying constructs in both genders, but there are 
differences in the underlying ability, which is confirmed by the literature in this age
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range. This also confirms the need to adjust for gender in further analysis. The 
methods used are well described in the psychometric literature, but are novel in 
the application for early childhood development.
The study is limited in that the sample size is not adequate to establish 
measurement invariance between age groups. However, it is worth noting that the 
original developers did not do this, although the best hypothesised model was 
tested in different age groups and found to be similar.
The individuals assessed in this Vietnamese Bayley study were predominately 
individuals living in urban or semi-urban settings. There are research groups 
using the Bayley tool in more rural or regional specific groups. It would be of 
interest to pool data to establish measurement invariance by geographical 
location and potentially to look at age measurement invariance. It is also possible 
that the results may differ between rural and urban settings and it would be 
informative to explore this potential variation in more depth
An understanding of psychometric test evaluation and development is a necessity 
for allied professionals using these tools for research. This study explains in depth 
the process for robust psychometric evaluation and provides methodology that 
can be replicated in both low and high-income countries.
Retrospective studies looking at outcomes following EV-A71 infection have been 
limited by the lack of locally valid adaptations. Differences in outcomes described 
in the literature may reflect poor adaptation of the psychometric tool used rather 
than true differences in scores. This validation study is an essential step prior to 
investigating the main question of neurocognitive outcome in severe HFMD. In
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addition, the adaptation methodology described here has the potential to assist 
future studies in low and middle-income countries.
6.3 Results: Outcomes following severe H FM D
My study demonstrated that severe HFMD was not associated with lower Z 
scores compared to a healthy comparison group after adjusting for confounders. 
The literature in this area typically focused on the most severe cases of HFMD, 
usually associated with EV-A71 infection, who may have profound disabilities that 
limit their ability to cooperate with detailed assessments such as the Bayley tool. 
The number of severe cases in a hospitalised population has previously been 
poorly documented. These cases are relatively rare and in this study only 1 child 
(0.004%) had significant neurological complications that affected their ability to 
participate in the Bayley at the first assessment. At the second assessment their Z 
score was between -1.1 to -1.9. The added difficulty was that this child was from 
an ethnic minority group that did not use Vietnamese as their first language 
meaning it was not possible to reliably assess the language domain.
Previous studies of severe HFMD outcomes focused on EV-A71 during HFMD 
outbreaks. As reviewed in section 1.5.5 and listed in Table 1.7, none of the 
published studies used Z scores and only one used a healthy comparison group, 
preferring to state the proportion of cases which had impairments. Different 
classification of HFMD severity between retrospective studies makes direct 
comparison unreliable. Stating proportions only on those with obvious difficulties 
means more subtle defects may have been missed by crude assessments. None 
of the studies describe in detail whether the outcome measure had been locally
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validated. These retrospective studies fail to estimate the true burden of outcomes 
following HFMD outbreaks, where virological diagnostic facilities are often limited.
The literature suggests it is the cases with cardiopulmonary complications (grade
4) that have poor outcomes. Although classification differs between settings, this 
study enrolled 7 (0.03%) grade 4 cases of which 5 (71%) had fully recovered 
neurologically by discharge. Our data suggest that the majority of grade 4 cases 
recovered, and that only a small subset of these severe cases have neurological 
complications. In my study, 2 grade 2b cases had acute neurology evident on 
admission, which resolved by discharge. There was one child with grade 4 
disease who had cranial nerve palsies on admission, which persisted until follow 
up. In the literature, cases with persistent neurology are usually identified as 
having infection with EV-A71. These cases are usually grade 4 as in the study 
described here. In this study population, there were 45 cases EV-A71 infection, 
13(29%) of which had grade 2a disease, 10 (22%) had grade 2b disease, 18 
(40%) had grade 3 disease, and 4 (9%) had grade 4 disease. Huang et al. 
identified neurological sequelae in 20% of the EV-A71 cases presenting with 
cranial nerve involvement.282 The study population had 1 grade 2b (PCR: CV-A6) 
and 1 grade 4 case (EV-A71) with cranial nerve involvement and the percentage 
of EV-A71 cases presenting with cranial nerve involvement was 2% (1/45). This 
suggests that cranial nerve involvement in this prospective study group was not 
common in EV-A71 infected cases.
EV-A71 is considered in the literature to be associated with more severe clinical 
course and poorer outcomes. My prospective study clarifies that EV-A71 is indeed 
associated with more severe disease and abnormal neurology, but 75% (3/4) of 
the most severe cases had normal neurology at discharge and did not
significantly differ in neurocognitive outcomes by 6 months when compared to 
healthy controls. These results suggest it is only a small subset of children with 
the most severe grade 4 cardiopulmonary complications, who may be at risk of 
poorer outcomes at discharge and at 6 months. This has important implications 
for understanding the disease burden. These data suggest that the major disease 
burden is associated with the costs of acute hospitalization and the difficulty in 
predicting those most at risk of disease progression (resulting in high rates of 
hospitalization for observation). This also has vaccination implications, as clearly 
there are other viruses associated with severe HFMD and hospitalisation. In my 
study, the virological diagnosis of the 242 cases were 64 (26%) untypable or other 
viruses, 55 (23%) enteroviruses, (19%) EV-A71, 44 (18%) CVA6, 27 (11%) 
CVA10 and 7 (3%) CVA16. The majority of the cases were untypable, hence 
outcome results based on clinical severity is important for clinicians at the front 
line.
My study is limited by the small numbers of cases with severe disease. This may 
be due to larger public awareness about HFMD, better public health information 
on hygiene practices and better acute management of cases. The Vietnamese 
guidelines can into force following the 2011 outbreak in order to standardise care, 
and hence differences in management pre 2011 and after in Vietnam and 
surrounding regions may also limit outcome data between those two time periods.
The socioemotional domain, which was not assessed, is an important functional 
area in determining social acceptability and social participation. There is a 
concern in the literature regarding the development of attention deficit hyper­
activity disorder (ADHD) symptoms232 in later childhood and my study was not 
designed to assess this area. It is possible that infection at specific ages may
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result in a greater impact on language development (for example, in those aged 
less than two years). My study identified some reduced language scores in 
specific age groups but these changes were not persistent. These results may 
reflect a lack of cooperation from a degree of anxiety rather than a true poor 
score. Unfortunately, the study recruited insufficient numbers to compare scores 
in cases aged under and over two years. This is an important area to address in 
future studies.
6.4 Results: Brain M R I findings in severe H FM D
This is the first study exploring acute MRI changes in the brain associated with 
HFMD. The study focused on children with less severe disease who were 
scanned within two weeks of illness onset. We made the MRI scans optional, as 
there was risk involved with routine use of sedation at the MRI facility. We did not 
adjust for this in sample size calculations. We were also limited in that we did not 
record reasons for declining participation in MRI, which would have been useful 
when designing future studies with paediatric MRI in this particular patient 
population. This does introduce bias in the MRI sample selection, but the 
comparison of the sample to the total study population did not show any 
significant difference in gender, age, level of maternal education, stunting, 
duration of hospitalisation, recovery, and virological detection.
My study was the first to include MRI scans of non-severe cases and identified 
acute changes in 5 (16%), 6 (23%) and 12 (41%) of grade 2a, 2b and >2b cases 
respectively. The study demonstrated that a variety of viruses were associated 
with MRI changes, with the novel finding of showing a significant association with 
CV-A10 detection, which was most prevalent in grade 2a cases. The dentate 
nucleus abnormality is well documented in the literature but the white matter
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abnormalities are a novel finding. The sample that had MRI was representative of 
the enrolled cases in terms of age, gender and duration in hospital. Despite the 
small numbers, the grade 2b children who had MRI changes had significantly 
worse fine and gross motor scores at the second assessment after adjusting for 
maternal education and stunting. This was not identified in the other groups. This 
suggests there may be a motor prognostic value from MRI in a specific group of 
patients and should be researched further. It is also important to establish 
whether younger age influences MRI abnormalities and hence impacts on 
outcome. This would require a large cohort of infants participating in sequential 
scans to identify timing of resolution or on-going persistence.
The neuropathogenesis and neurotropism of the various enteroviruses appears to 
differ.415 There is suggestion that particular EV quasispecies contribute to 
invasion of CNS and to different neuropathology patterns seen with MRI. It may 
be this phenomena contributing to the novel white matter abnormalities seen on 
the brain MRI scans. Clearly, a more in depth understanding of the neurotropism 
of the enteroviruses is an important area to address and these novel findings 
suggest the neurotropisms to be less stereotypical than previously described.
6.5 Conclusions
I have described the first construct validity adaptation study of the Bayley III tool in 
a low-income setting. I anticipate that the methodology used in the adaptation 
process has considerable potential to assist further research exploring the impact 
of HFMD but also a wide spectrum of other diseases of huge epidemiological 
importance in Vietnam and other LMIC settings. Secondly, my study identified that
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-  in a low incidence season with low proportions of EV-A71 detection and very 
severe cases - with current management strategies in Vietnam, severe HFMD 
(grade >2a) was not associated with significant neurocognitive sequelae at six 
months, with differences in Z scores within 2 standard deviations of the mean of 
the healthy comparison group. While my study was limited by a small sample 
size, the results have the potential to better inform models of disease burden in 
Vietnam and other settings where HFMD are endemic. Thirdly, the study found 
that MRI changes occur at grade 2a, 2b and >2b of HFMD. With small samples, 
the MRI changes were significantly associated with worse fine and gross motor 
outcomes at six months for grade 2b cases only. This group have 22% risk of 
disease progression to >2b86, and MRI in this group may identify the children 
more likely to progress. The findings of white matter changes, not previously 
described associated with HFMD in the literature, raises questions about the 
neurotropism of the enteroviruses and the need to better understand the 
neuropathogenesis of these pathogens. This information would aid clinicians and 
future research on outcomes, by proposing more specific functional areas of 
development that may be affected, which would need evaluation in children as the 
developmental complexity progresses with age.
The Vietnamese adaptation of Bayley III demonstrates adequate reliability and 
validity for research purposes. This was the first evaluation of the construct 
structure of a Bayley III adaptation, but since the study means scaled scores were 
not similar to US, local norms are required. Pooling data from contemporaneous 
studies in one country is an opportunity to develop local norms for clinical use. 
Sharing of data between publishers and researchers across countries encourages 
cross-cultural validation of clinical outcome measures, but such practice is not 
standard.
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Bayley III assessment is a recommended tool to determine further specialist 
support in the clinical setting in high-income countries. However there is limited 
psychometric evaluation of its invariance over age groups, gender and culture 
despite the frequency of its use in the literature. My study is an important addition 
to understanding adaptation of western tools and outlines appropriate 
methodology to evaluate this.
Bayley III is a complicated tool, requiring high level of assessor skill and training. 
This is often seen a major limitation for its use in LMIC. However, we found 
developing the tool in the research setting involves capacity building that is 
transferable to clinical practice.
6.6 Future Directions
The western literature on long-term outcomes of encephalitis is important to 
contextualise my study. In 2000, The Encephalitis Society carried out a UK postal 
survey to 1200 members with 400 respondents, of whom 139 had encephalitis in 
childhood.416 All pathologies were included including herpes simplex virus, which 
is known to have a worse outcome. Mostly parents or carers completed the 
children’s responses. 72% of the children reported that they were unable to ‘fully 
resume their normal life’, 44% had a statement of special educational. 53% of 
those who had contracted the disease as children required significant assistance 
or regular supervision with personal care tasks and/or had very limited mobility.
The most common difficulties identified in children were concentration and
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attention problems followed by tiredness/fatigue; mood swings; and frustration 
and anger with difficulties with new learning but not with short term memory, 
planning and problem-solving. Hooper et al. identified problems with organising 
and planning daily living tasks and regulating emotions persisted over time and 
were associated with a high level of parental stress and anxiety.417 One centre in 
Nottingham, UK had 13 referrals for rehabilitation following childhood encephalitis 
in 2005 of which 70% were made by the parents, the remainder by health 
professionals 418 Even in this high income setting, parents of children who had 
encephalitis had difficulty navigating the referral pathway, accessing specialist 
services and receiving adequate support from health professionals.418
The paucity of long-term outcome data in encephalitis, suggest that there is long­
term negative educational, employment and family impact.419'421 My study 
identified differences between groups ranged within 2 standard deviations of the 
healthy children mean. The impact of even 1 standard deviation below mean on 
education may be more significant in a system where there are fifty children in a 
class using limited teaching methods and testing, with scarce specialist 
educational support. It may also affect poor families’ decision to fund education of 
their child.422 Behavioural difficulties may be managed with more punitive 
methods adding to parental stress 418 Despite this study continuing till 18 months 
follow up, it is important to evaluate this impact by following-up the HFMD and 
healthy cohorts with an assessment at school age (age 7 years). This will more 
accurately determine whether more complex, higher functioning skills have been 
affected, whether minor cognitive difficulties have a significant impact on 
schooling in this setting, and to determine socio-emotional and adaptive 
behaviour difficulties, including self-reported difficulties.
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MRI is increasingly used for prognostic information in premature neonates, 
although its sensitivity and specificity is highest with motor function, and limited 
with neurocognitive and behavioural function.423 Interestingly this is also what was 
identified in this study. Newer quantitative white matter tract measures424 require 
specialist skills but may be of benefit in grade 2b HFMD infants. We did not have 
the facilities to do this in this study, but the study findings suggest knowledge 
base would increase in pursuing this area further.
Recent work by Seydel et al. suggests transient rise in intracranial pressure in 
cerebral malaria may account for high fatality rates 425 MRI during the acute 
phase identified severe brain swelling and a decrease in brain volume in survivors 
who initially had brain swelling. Although raised intracranial pressure is not a 
predominant feature in HFMD, prospective measuring of pressures has not been 
done. With the study MRI files, the next step could be to look at cerebral 
hemisphere swelling to help determine whether this area should be explored in 
future studies.
Carter et al., researching malaria, state rehabilitation must be considered on 
equal terms to preventative health.426 Neuropsychological therapies in Vietnam 
are not included in the public health care system. However, there are effective 
public funded models of neurorehabilitation that can be delivered in low to middle 
resourced settings, such as the SARAH network in Brazil 427 This is a network of 
neurorehabilitation services working with specialists in a multi-disciplinary team to 
“progressive care” with the aim to return to school or work. SARAH supports all 
brain injury including post encephalitis and emphasises research as integral to 
improving the services for the local population. Such success requires a vision of 
locally funded neurosciences; (neurology, neuroimaging, neuropsychology,
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neurosurgery, neurorehabilitation), building capacity with evidence-based 
practical interventions suited for low resource settings. My study contributes part 
of the groundwork of robust CDAT development and local capacity building, 
working with hospital and community teams that may facilitate a future potential 
neurosciences network.
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08RS - Neurodevelopmental outcomes in severe HFMD
Enrolment ENROL
Participant number Initials
08RS-[_0_|_3_] - [_ |_ |_ ] [ I I I I M
7. A p p e n d ix  1: Case re co rd  fo rm  H FM D  cases
General information
1] Date of enrolment: [_|_] /[_|_]/[_|_] (dd/mm/yy)
2) Patient's Full name:* [ ]
3) Hospital number:* [ ]
4] Ward of enrolment: O  Ward C O  PICU
5] Gender: O  male O  female
6] Date of birth: [_ |_ 3 /[_ l_ ] /[_ l_ l_ l_ ]
dd mm yyyy
7) Address:
a. Home number/street:* [____________________________________ ]
Province/ Centrally governed city:___________________________________
Provincial City/ District:___________________________________
Town/ Ward/Commune:___________________________________
Hamlet:___________________________________
b. Contact no.l Name* [____________________________________ ]
c. Relationship to child * [_____________________________________]
d. Phone Number 1*:____ [_____________________________________ ]
e. Contact no.2 Name* [_____________________  ]
f. Relationship to child* [_____________________________________ ]
g. Phone Number 2*:_____[_____________________________________]
*Information is not recorded into the database
Completed by (initials):_____
08RS CRF 2.0 EN 7 AUG 13
Date completed: 
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History at ENROLMENT HIST
Participant number Initials
08RS-[_0_|_3_]-[_|_|_] [ I N I 1 ]
History at ENROLMENT _______________  : ______
Date of onset of illness [ | ] / [  | ] / [  | ] (dd/mm/yy)
Date of admission to this hospital [ |_] / [  | ] /[  | ] (dd/mm/yy)
Transfer from another hospital O Yes O No
If yes:
Which hospital [___________________________________ ]
Date admitted to the other hospital: [ | ] /[  | ] / [  | ] (dd/mm/yy] O
Unknown/No documentation
Grade of HFMD when child admitted to previous hospital
O Grade 1 O Grade 2a O Grade 2b(l) O Grade 2b(2] O Grade 3 O Grade
4 O unknown
What grade of HFMD does the child have today?
O Grade 1 O Grade 2a O Grade 2b[l) O Grade 2b(2) O Grade 3 O Grade
4
What grade of HFMD did the child have on the day s/he was first admitted to 
hospital?
O Same as above because child was admitted today O Grade 1 
O Grade 2a O Grade 2b(l) O Grade 2b(2) O Grade 3 O Grade 4 O 
Unknown
Did the receive any of the following, during this illness episode?
a. Cardiac arrest O Yes O No O Unknown
b. Mechanical Ventilation O Yes O No O Unknown
c. Hemofiltration O Yes O No O Unknown
d. Intravenous Immunoglobulin O Yes O No O Unknown
e. Milrinone O Yes O No O Unknown
f. IV Magnesium O Yes O No O Unknown
g. Phenobarbital O Yes O No O Unknown
h. Corticosteroids /  Methylprednisolone O Yes O No O Unknown
i. Antibiotics O Yes O No O Unknown
Completed by (initials):___________  Date completed:
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Contact History at ENROLMENT CONHIST
Participant number Initials
08RS-[_0_|_3_]-[_|_|_] [ I I I I M
Contact History at ENROLMENT
Does the patient attend:
O  Daycare facility O  Kindergarten O  School O  Stay at Home 
If attends, Daycare/Kindergarten record address
Street:* [____________________________________ ]
Province/ Centrally governed city:__________________________
Provincial City/ Tow n/ District:__________________________
Tow n/ W ard/Commune:__________________________
Hamlet:__________________________
How many adults normally live in your house (including parent/guardian]?
[ _ U
How many children under the age of 15 (including other people's children]
normally live in your house? [_|_]
In the 2 weeks before onset of illness, was there
someone in the child’s household with HFMD: O  Yes o  No O  Unkown
someone at the child's daycare/kindergarten/school with HFMD:0 Yes O  No O  
Unkown
did the child have any contact with someone with HFMD: O  Yes O  No O
Unkown
Completed by (initials):___________  Date completed:.
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Symptoms and Signs at ENROLMENT EXAM
Participant number Initials
08RS-[_0_|_3_]-[_|_|_] [ I I I I M
Symptoms and Signs at ENROLMENT
Headache: O Yes O N o O Unknown
Fever: O Yes O N o O Unknown
Cough: O Yes O N o O Unknown
Runny nose: O Yes O N o O Unknown
Vomiting: O Yes O N o O Unknown
Diarrhea: O Yes O N o O Unknown
Drowsiness: O Yes O N o O Unknown
Irritability: O Yes O N o O Unknown
Myoclonus: O Yes O N o O Unknown
Sweating O Yes O No O Unknown
Lethargy O Yes O No O  Unknown
Temperature::[_ !_ ].[—] °C
Pulse [_ |_ |_ _]/m in
Blood pressure [_
Respiratory rate [_
Weight [_| _].[_] Kg 
Height [_ |_ |_] Cm 
Head Circumference [_|_] Cm
l - U / L U J  mmHg 
I—]/m in
Respiratory pattern 
Ostridor 
Conjunctivitis:
Rash
O Normal OTachypnea O Irregular O wheeze 
O Cheyne-stokes O Apnea 
O Yes O No
O Yes O No
If Yes,Document location of rash and how many spots/vesicles visible at 
ENROLMENT
O 1-5 O >5 
O 1-5 O >5 
O 1-5 O >5
O mostly macular O both 
O N o
Hands and Feet O 0
Knees and Elbows O 0
Buttocks O 0
Descibe rash: O mostly vesicular 
Ulcer in the mouth O Yes
If Yes, Location of ulcers: □  Tongue □  Palate □  Buccal □  Lips □  Tonsil
If  today is not admission day, record any of the following which occurred since 
admission
j
Admission GCS documented O Yes O No Date of GCS: [ | ] / [  | ] / [  | ]
(dd /m m /yy]
If  Yes, state components of GCS: E: [_ ] /  4 
Nystagmus O Yes O No O Unknown
If  yes: Date first documented: [ | ] / [  | ] / [  |_
Tremor O Yes O  No O Unknown
If  yes: Date first documented: [ | ] / [  | ] / [  | ]
Ataxia O Yes O No O Unknown
If yes: Date first documented: [ | ] / [  | ] / [  | ]
Limb weakness O Yes O No O Unknown 
If  yes: Date first documented: [ | ] / [  | ] / [  | ]
V: [_ ] /  5 M: [_ ] /  6 
(dd /m m /yy) 
(dd /m m /yy) 
(dd /m m /yy]
(dd/m m /yy]
If  Yes, specify:
Lower limb
Upper limb 
O Right
O Right 
O Left
O Left
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LAB RESULTS AT ADMISSION LAB
Participant number Initials
08RS-[_0_|_3_] - [—|—|—] [ I I I 1 1 ]
LAB RESULTS AT ADMISSION -  First results available in hospital chart
Date sample taken: [ _ |_ ] / [ _ U / [ _ |_ ]  (dd/mm/yy)
White blood cell count [_!_]■[_] * 1 0 7 ml
Neutrophil % [_!_]■[_] %
Lymphocyte % [_!_].[_] %
Blood glucose [_ l_ l_ ] mg/dL or [_ l_ ].[_ ]m m ol/L
CRP [—!—]•[—]mg/L
Completed by (initials): Date completed:
08RS -  Neurodevelopmental outcomes in severe HFMD
Admission Neurological Exam ination NEU
Participant number Initials
08RS-[_0_|_3_] - [_|_|_] [ I I I I M
NEUROLOGICAL EXAM
1. Date of exam [_| ] / [  | ] / [  [ ] (dd/mm/yy)
2. Has the child had Phenobarbital within the last 24 hours? O  Yes: oral 0 Yes:
intravenous O  No O  Not known
Blantyre Coma Score
3. Best motor Localises painful stimulus[Rub knuckles on patient’s sternum]
2 O
response Withdraws limb from pain
(Firm pressure on thumbnail bed with horizontal 
pencil]
1 O
Nonspecific or absent response 0 o
4. Verbal response Appropriate cry 2 O
Innappropriate cry 1 o
None 0 o
5. Eye movements Directed (e.g follows other's face] 1 o
Not directed 0 o
Neurological Exam ination at ENROLMENT
6. Nystagmus O  Yes O  No OlJnknown (sleeping or not rousable 
to assess]
7. Tremor O  Yes O  No OlJnknown (sleeping or not 
rousable to assess]________
8. Ataxia O Yes O No O Unknown (child can not stand)
9. Limb weakness o  Yes O  No OlJnknown (sleeping or not 
rousable to assess] 
a. If Yes, specify: Upper limb O  Right O
Left
Lower limb O  Right O
Left
10. Cranial nerve palsies 
(check and circle all 
that apply]
□  Left (circle number]
□  Right (circle number]
□  Other, specify:
□  None □  Unable to assess
3 / 4 / 5 / 6 / 7
3 / 4 / S / 6 / 7
If abnormal at number 7: O Upper motor neuron O Lower motor neuron O 
Unknown
C o m p l e t e d  b y  [ i n i t i a l s ] : . D a t e  c o m p l e t e d : .
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D aily Review DAILY
Participant number Initials
08RS-[ 0 | 3 ]-
u - u  _ _
[ I N I 1 ]
DAILY REVIEW: DAY 2-6
1. Date and time of exam [_|_]/[_|_]/[_|_] (dd/mm/yy) Time: [_|_]:[_|_]
2. Has the child had Phenobarbital within the last 24 hours? O  Yes: oral O  Yes: 
intravenous O  No
Blantyre Coma Score
3. Best motor 
response
Localises painful stimulus
[Rub knuckles on patient’s sternum]
2 O
Withdraws limb from pain
(Firm pressure on thumbnail bed with horizontal pencil]
1 O
Nonspecific or absent response 0 O
4. Verbal response Appropriate cry 2 O
Innappropriate cry 1 O
None 0 O
5. Eye movements Directed (e.g follows other's face) 1 O
Not directed 0 O
6. Nystagmus O Yes O No OUnknown (sleeping or not 
rousable to assess)
7. Tremor O Yes O No OUnknown (sleeping or not 
rousable to assess)
8. Ataxia O  Yes O  No OUnknown (child can not stand)
9. Limb weakness O Yes O No OUnknown (sleeping or not 
rousable to assess) 
a. If Yes, specify: Upper limb O Right O 
Left
Lower limb O  Right O
Left
10. Cranial nerve 
palsies
(check and circle all 
that apply)
□  Left (circle number) 3 / 4 / 5 / 6 / 7
□  Right (circle number) 3 / 4 / 5 / 6 / 7
□  Other, specify:
□  None □  Unable to assess
If abnormal at number 7: O Upper motor neuron O Lower motor neuron O 
Unknown
11. Irritability: O Yes O No O Unknown
12. Vomiting O Yes O No O Unknown
13. L e t h a r g y O Yes O No O Unknown
14. F u s s in e s s O Yes O No O Unknown
15. Myoclonus: O Yes O No O Unknown
16. Sweating O Yes O No O Unknown
17. Temperature: U J . U  ° c
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08RS - Neurodevelopmental outcomes in severe HFMD
Daily Review DAILY
Participant number Initials
08RS-[ 0 | 3 ]-
[ - I - U
[ I N I 1 ]
18. Maximum Pulse [_ |_ |_ ]/m in
19. Minimum Pulse [ | | ]/min
20. Maximum Blood pressure [ | |_] / [  |_|_] mmHg
21. Minimum Blood pressure [ | |_] / [  |_|_] mmHg
22. Respiratory rate [_ |_]/m in
23. Respiratory pattern O Normal OTachypnea O Irregular O wheeze 
Ostridor O Cheyne-stokes O Apnea
24. What grade of HFMD does the child have today?
O Grade 1 O Grade 2a O Grade 2b[l) O Grade 2b(2] O Grade 3 O
Grade 4
Completed by (initials):  Date completed:
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Development and SocioEconomic DEVSOCSED
Participant number Initials
08RS-T_0_|_3_l - f_1_1_1 [ I I I I M
DEVELOPMENTAL HISTORY
a. C h ild  live s  w ith :  O  m o th e r  O  fa th e r  O bo th  O  g ra n d p a re n ts
O re la t iv e s  O  o th e r  If lives w ith  g randpa ren ts /re la tives  fo r  how  long o f 
last 12 m o n th s :0  <2 m onths 0  2-6 m onths 0  >6 m onths
INFORMATION ABOUT PREGNANCY AND BIRTH
2. B ir th  o rd e r: O  1st, O  2nd, 0 3 r d  0 > 3 rd c h ild
3. The c h ild  i s : O  a  s in g le to n  O tw in  O tr ip le t O m o r e  th a n  triplet
4. D e liv e ry  a t b ir th  O  Vaginal O  Caesarean section
5. B ir th  w e ig h t: [_ ]■ [_ ] kgs Ounknown
6. B reas tfeed ing : C h ild  w as e x c lu s iv e ly  b re a s tfe d  u n t i l  6 w eeks  (no  fo rm u la )  
O Y e s  O N o
I f  Yes, w as c h ild  e x c lu s iv e ly  b re a s tfe d  u n t i l  3 m o n th s  (no  fo rm u la )?
O Y e s  O N o
CHILD'S HISTORY
Developm ental history (gross m otor)
7. Age Sit O  =<6m months O  between 6-9months
O >9months O unknown  o  Not yet
8. Age walks O  =<12 months O  between 12-18 months
 o  >18months Ounknown________________ O  Not yet
Fine m otor
9. Age pick up small objects O  =<9 months O  between 9-12 months
O  >12months ONotyet O
unknown____________________________________________________________
Language________________________________________________________________
10. Age says mama/dada appropriately for mom and dad O  =<9 months 
O  between 9-12 months o
>12months O  unknown ONotyet______________________________________
11. 2-3 word utterance O  =<24 months O  between 24-36 months
 O  >36months Ounknown________________ O  Not yet
Ask the question and record the one most suitable option. If it is not clear then list the
options to the mother
12. What is mother's occupation? O  Stay at home/homemaker
O  Agriculture, forestry and fishing 
O  Mining 
O  Manufacture
O  Electricity, gas and water supply 
O  Construction
________________________________O  Trade and repair of motor vehicles________
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Participant number Initials
08R S-L0_L3_W _|_|_1 [ I I I I M
O  Hotels and restaurants 
O  Transport, storage and communication 
O  Financial intermediation 
O  Science and technology 
O  Real estate
O  Public administration and defence 
O  Training and education 
O  Health and social work  
O  Culture and sport 
O  Party union and associations 
O  Personal and public service 
O  Employment in private households 
O  Other employment 
O  Student
O  Unemployed________________________
13. What is father's occupation? O  Stay at home/homemaker 
O  Agriculture, forestry and fishing 
O  Mining 
O  Manufacture
O  Electricity, gas and water supply 
O  Construction
O  Trade and repair of motor vehicles 
O  Hotels and restaurants 
O  Transport, storage and communication 
O  Financial intermediation 
O  Science and technology 
O  Real estate
O  Public administration and defence 
O  Training and education 
O  Health and social work  
O  Culture and sport 
O  Party union and associations 
O  Personal and public service 
O  Employment in private households 
O  Other employment 
O  Student
O  Unemployed________________________
14. What is the highest level of mother's education attained?
O  Never been to school 
O  Attended some primary school 
O  Completed primary school (5th gr) 
O  Completed lower secondary school
(9th gr)
_______________________________________O  Completed higher secondary school
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Participant number Initials
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(12th gr)
O  Completed university/college
degree
O  Completed postgraduate degree
15. What is the highest level of father's education attained?
O  Never been to school
O  Attended some primary school
O  Completed primary school (5th gr)
O  Completed lower secondary school
(9th gr)
O  Completed higher secondary school
(12th gr)
O  Completed university/college
degree
O  Completed postgraduate degree
Refers to accomodation in HCMC
16. Do you own or rent your accomodation? O  Own O  Rent O  H o u s e
o w n ed  by re la tives________________________________________________
The house/household refers to their accommodation in HCMC, not their 
hometown.
If  the child usually lives with grandparents and the parents live in HCMC away 
from their child, document details about the parents' accommodation in HCMC.
Ask the question and list the options to the parent. Record the parent's answer.
17. How many levels in your house? O  1 O  >1_______________________
18. What is the floor of your house made from? (This refers to the surface you 
walk on, not what is underneath the surface)
O  Cement 
O  Earth/sand 
O  Ceramic tiles 
O  Cane/palm/bamboo 
_____________________________________________ O  None of above___________
19. What is the roof of your home made from? O  Metal
O  Calamine/Cement fibre 
O  Ceramic tiles 
O  Cement 
O  Thatch/palm leaf 
O  Other, specify
r i_________ ____________________________________________
20. What kind of toilet do members of your household usually use?
O  Own flush toilet 
O  Shared flush toilet 
O  Traditional pit toilet 
O  Ventilation improved pit toilet 
_______________________________________ O  No facility/bush/field___________
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O  None of above
21. How many rooms are there in your house that are used for living and/or 
sleeping [_ |_ ]
(excluding bathroom and kitchen]?
( C o u n t  a l l  t h e  in d o o r  r o o m s  in  y o u r  h o u s e  n o t  in c lu d in g  b a t h r o o m s  a n d  k itc h e n s .  I f  a  r o o m  h a s  a  
k i t c h e n  o r  t o i l e t / s h o w e r  in  i t  b u t  is  a ls o  u s e d  r e g u la r l y  f o r  s le e p in g  o r  o t h e r  a c t i v i t ie s  b e s id e s
Does your house have:
22. Electricity? O  Yes O  No
23. Internet access? O  Yes O  No
24. A television? O  Yes O  No
25. A refrigerator? O  Yes O  No
26. An air-conditioner? O  Yes O  No
How many of the following are owned by people in your household:
27. Bicycle? \_ ]
28. Motorbike? [_J
29. Car? [_J
30. What is the main type of fuel you use for cooking? O  Wood 
O  Gas
O  Electricity 
O  Coal 
O  Kerosene 
O  Straw 
O  None of above
31. Where do you get your drinking water (main source]? O  Private tap
O  Public standpipe 
O  Bottled water 
O  Well in own
residence
O  Public well 
O  Rain water 
O  Spring
O  River/lake/pond  
O  None of the above
32. Do you usually treat the water prior to drinking?
added
O  Boil 
O  Bleach/chlorine
O  Filter
O  Solar disinfection 
O  No treatment 
O  N o n e o f th e  above
Completed by [initials]:_____
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Discharge Summary DISC
Participant number Initials
08RS-[_0_|_3_]-[—|—|—] [ I I I 1 1 ]
DISCHARGE SUMMARY OF HOSPITAL STAY (Complete from hospital file)
1. Date of discharge: [ | ] / [  | ] /[  | ] (dd/mm/yy)
(or date of study withdrawl [ | ] / [  | ] / [  | ]
(dd/mm/yy))____________________________________________________________
2. Discharge Diagnosis HFMD: O  Yes O  No
3. If No, specify discharge diagnosis: □  skin infection
□  upper respiratory tract infection
□  sepsis
□  pneumonia
□  meningitis
□  other viral infection 
□ o th e r
4. Highest Grade HFMD during admission: OGrade 1 O  Grade 2a OGrade 
2 b (l)  O  Grade 2b(2)
O  Grade 3 O  Grade 4 O  Not
Applicable
5. Date of onset of Highest Grade HFMD: [ | ] / [  | ] /[  | ] (dd/mm/yy)
6. Ventilator associated pneumonia O  Yes O  No
Definition of sepsis: ALL OF THESE
• rectal temperature >38.5°C or <35°C
• signs and symptoms of infection
• tachycardia (may be absent in hypothermic patients)
PLUS >=1 of following:
• organ dysfunction,
• altered mental status
• hypoxemia (arterial Pa02/FI02 <300)
• increased serum lactate level (> upper limit of lab normal)
7. Treated for sepsis during admission O  Yes O  No
8. Result of hospital throat swab PCR: a. OEV positive OEV negative
ONot done
I f  EV positive: b. O  EV-71 positive OEV-71 negative
10. Outcome at discharge:
O  Full recovery without complication: no obvious neurological 
problem, normal age appropriate development, feeds and breathes 
without medical intervention.
O  Incomplete recovery: see list below 
_________ O  Transferred to another hospital_____________________________
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08RS-[_0_|_3_]-[_1_|_] [ I I I 1 1 ]
O  Taken home without approval 
O  Death
_________O  Discharged to die___________________________________________
11. If incomplete recovery choose as many of the relevant options listed.
□  Seizures (requiring medication to continue after discharge)
□  Hypertonicity (stiffness/abnormal posturing)
□  Limb Paralysis
□  Persistent cranial nerve palsy
□  Diaphragmatic weakness
□  Discharged with tracheostomy
□  Discharged with nasogastric tube
□  Behavioural/Personality changes (more talkative, aggressive or 
inappropriate)
C o m p l e t e d  b y  ( i n i t i a l s ) : _____________ D a t e  c o m p l e t e d :
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1. Date of assessment L U / L U / L U  (dd/m m /yy)
2. Attends with O  mother O  father Oboth O  grandparents Orelatives 
O  o th e r
3. In the two weeks before admission to HTD with HFMD, was the child living in HCMC:
OYes ONo
4. Address child comes to review from: O  sam e as fro n t page O  d iffe re n t  
Iress:
Home number/street:* [____________________________________ ]
Province/ Centrally governed city:___________________________________
Provincial City/ District:___________________________________
Town/ Ward/Commune:___________________________________
Hamlet:
5. Verify phone numbers on contact page -  correct if necessary*
Study nurse documents the following
6. tracheostomy in place O  Yes O  No
7. nasogastric feeding O  Yes O  No
8. Was the child re-admitted between discharge and review: O Y es  O N o
9. What was the diagnosis: O  re s p ira to ry  illness O d ia rrh o e a o  O fe v e r O  
o th e r p lease specify______________
10. Patient has
□  Bayley/Movement ABC by psychologist
□  Neurological examination by Dr Saras
□  Review by PICU doctor
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